<SEC-DOCUMENT>0001140361-24-047402.txt : 20241120
<SEC-HEADER>0001140361-24-047402.hdr.sgml : 20241120
<ACCEPTANCE-DATETIME>20241120170016
ACCESSION NUMBER:		0001140361-24-047402
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20241120
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241120
DATE AS OF CHANGE:		20241120

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vulcan Materials CO
		CENTRAL INDEX KEY:			0001396009
		STANDARD INDUSTRIAL CLASSIFICATION:	MINING, QUARRYING OF NONMETALLIC MINERALS (NO FUELS) [1400]
		ORGANIZATION NAME:           	01 Energy & Transportation
		IRS NUMBER:				208579133
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33841
		FILM NUMBER:		241481139

	BUSINESS ADDRESS:	
		STREET 1:		1200 URBAN CENTER DRIVE
		CITY:			BIRMINGHAM
		STATE:			AL
		ZIP:			35242
		BUSINESS PHONE:		(205) 298-3000

	MAIL ADDRESS:	
		STREET 1:		1200 URBAN CENTER DRIVE
		CITY:			BIRMINGHAM
		STATE:			AL
		ZIP:			35242

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Virginia Holdco, Inc.
		DATE OF NAME CHANGE:	20070409
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20038893_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:vmc="http://vulcanmaterials.com/20241120" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_6334dbfcb013442292fbb814d36088ef" contextRef="c20241120to20241120" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_1fbf912ed7e34a9eb234c5e178bd6621" contextRef="c20241120to20241120">0001396009</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="vmc-20241120.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20241120to20241120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001396009</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-20</xbrli:startDate><xbrli:endDate>2024-11-20</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
    <div>
      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, DC 20549</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 25%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/></div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
        </div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_8873fe67f3694099b143e3a1920ace86" contextRef="c20241120to20241120">8-K</ix:nonNumeric></div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported):&#160; <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_a0bbd591469749659f83d5866758516e" contextRef="c20241120to20241120" format="ixt:date-monthname-day-year-en">November 20, 2024</ix:nonNumeric></div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_2836f37c5fd04b0faed925ebf95d42f9" contextRef="c20241120to20241120">VULCAN MATERIALS COMPANY</ix:nonNumeric><br/>
        </div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Exact name of registrant as specified in its charter)</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td rowspan="1" style="width: 32%; vertical-align: top; font-weight: bold; text-align: center; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_2c2cf80184cf43849e0713457548a40a" contextRef="c20241120to20241120" format="ixt-sec:stateprovnameen">New Jersey</ix:nonNumeric><br/>
              </td>

    <td colspan="1" rowspan="1" style="width: 2%; vertical-align: top; font-weight: bold; text-align: left; padding-bottom: 2px; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td rowspan="1" style="width: 32%; vertical-align: top; font-weight: bold; text-align: center; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_44ccd777e81e499a974a4e48facdfdaa" contextRef="c20241120to20241120">001-33841</ix:nonNumeric><br/>
              </td>

    <td colspan="1" rowspan="1" style="width: 2%; vertical-align: top; font-weight: bold; text-align: left; padding-bottom: 2px; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
              </td>

    <td rowspan="1" style="width: 32%; vertical-align: top; font-weight: bold; text-align: center; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_5cbd6db2fa0c424faa64fa9642ea5f52" contextRef="c20241120to20241120">20-8579133</ix:nonNumeric><br/>
              </td>

  </tr>

  <tr>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div>
                  <div>
                    <div>
                      <div style="text-align: center;">(State or other jurisdiction of incorporation)</div>
                    </div>
                  </div>
                </div>
              </td>

    <td colspan="1" style="width: 2%; vertical-align: top; text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: center;">(Commission File Number)</div>
              </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
              </td>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: center;">(IRS Employer Identification No.)</div>
              </td>

  </tr>


</table>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_650f1d9662b747f5a73076df7d6c2977" contextRef="c20241120to20241120">1200 Urban Center Drive</ix:nonNumeric><br/>
        </div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_57398aa0c7024556a538e5287901521e" contextRef="c20241120to20241120">Birmingham</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_355ae274a3f248739fcee8f2005a1040" contextRef="c20241120to20241120" format="ixt-sec:stateprovnameen">Alabama</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_873b75b12245402396309cba4cde1bc3" contextRef="c20241120to20241120">35242</ix:nonNumeric></div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Address of principal executive offices) (zip code)</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_0f89f7fbee694d20acdcd1e268a51908" contextRef="c20241120to20241120">205</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_42f14049bf634430b591988d0798d3d0" contextRef="c20241120to20241120">298-3000</ix:nonNumeric></div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Registrant&#8217;s telephone number, including area code</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
          provisions:</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 16pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_2b93b9c28c0d4142b0ef91837e39ccc3" contextRef="c20241120to20241120" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
                <div>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 16pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_f31bcaf55f174b3e8af4e6f73b69a792" contextRef="c20241120to20241120" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
                <div>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 16pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_007438a6ba624c788f101cc454eecc2d" contextRef="c20241120to20241120" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
                <div>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 16pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_d8204477b11d449d8d57165ae39793eb" contextRef="c20241120to20241120" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
                <div>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
              </td>

  </tr>


</table>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: center;">Title of each class</div>
              </td>

    <td style="width: 34%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: center;">Trading Symbol(s)</div>
              </td>

    <td style="width: 33%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: center;">Name of each exchange on which registered</div>
              </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_6ffa83ed11a9401a84f564fed3c61ed5" contextRef="c20241120to20241120">Common Stock, $1 par value</ix:nonNumeric><br/>
              </td>

    <td style="width: 34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_9445cc606bcb43fc8a9c5a7fd1d6eab9" contextRef="c20241120to20241120">VMC</ix:nonNumeric><br/>
                </div>
              </td>

    <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_6f80ed1663db4498b490d536ecdfc646" contextRef="c20241120to20241120" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric><br/>
                </div>
              </td>

  </tr>


</table>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule
          12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

        <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </span></div>

        <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company&#160; &#160; &#160; &#160; <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_b29941f2eb26460f9487abc14027b3f6" contextRef="c20241120to20241120" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

        <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </span></div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
          financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160; &#160; &#9744;</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div>
          <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="font-weight: bold;">Financial Statements and Exhibits.</div>
              </td>

  </tr>


</table>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Exhibits are filed herewith in connection with the issuance of $500 million aggregate principal amount of 4.950% Senior Notes
          due 2029, $750 million aggregate principal amount of 5.350% Senior Notes due 2034, and $750 million aggregate principal amount of 5.700% Senior Notes due 2054 by Vulcan Materials Company (the &#8220;Company&#8221;) on November 20, 2024, pursuant to the
          Company&#8217;s automatic shelf registration statement on Form S-3 (File No. 333-277793) (the &#8220;Registration Statement&#8221;).</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(d)</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
                <div>Exhibits</div>
              </td>

  </tr>


</table>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div style="text-align: left; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The following exhibits are incorporated by reference into the Registration Statement as exhibits thereto and are filed as part
          of this Current Report:</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left;"><span style="text-decoration: underline;">Exhibit No.</span></div>
              </td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left;"><span style="text-decoration: underline;">Description</span></div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
              </td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: justify;"><a href="ef20038893_ex1-1.htm">1.1</a></div>
              </td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: justify;">Underwriting Agreement, dated as of <span style="color: rgb(0, 0, 0);">November 18, 2024, between Vulcan Materials Company and Truist Securities, Inc., Wells Fargo Securities, LLC, BofA Securities, Inc.,
                    Goldman Sachs &amp; Co. LLC and U.S. Bancorp Investments, Inc. as representatives of the several Underwriters</span></div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
              </td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: justify;"><a href="ef20038893_ex4-1.htm">4.1</a></div>
              </td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: justify;">Eleventh Supplemental Indenture, dated as of <span style="color: rgb(0, 0, 0);">November 20, 2024, between Vulcan Materials Company and Regions Bank, as Trustee</span></div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
              </td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: justify;"><a href="ef20038893_ex5-1.htm">5.1</a></div>
              </td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: justify;">Opinion of Womble Bond Dickinson (US) LLP</div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
              </td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: justify;"><a href="ef20038893_ex5-1.htm">23.1</a></div>
              </td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: justify;">Consent of Womble Bond Dickinson (US) LLP (included as part of Exhibit 5.1)</div>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
              </td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
              </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: justify;">104</div>
              </td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: justify;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
              </td>

  </tr>


</table>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        </div>

        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
          undersigned hereunto duly authorized.</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                  <div style="text-align: left; font-weight: bold;">VULCAN MATERIALS COMPANY</div>
                </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td rowspan="1" colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
                </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                  <div style="text-align: justify;">Date: November 20, 2024</div>
                </td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                  <div style="text-align: justify;">By:</div>
                </td>

    <td style="vertical-align: top; border-bottom: 2px solid black; font-family: 'Times New Roman'; font-size: 10pt; width: 47%;">
                  <div style="text-align: justify;">/s/ Denson N. Franklin III</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td rowspan="1" style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td rowspan="1" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; width: 5%; white-space: nowrap;">
                  <div style="text-align: justify;">Name:<br/>
                  </div>
                </td>

    <td rowspan="1" style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">Denson N. Franklin III</td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td rowspan="1" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; width: 5%; white-space: nowrap;">
                  <div style="text-align: left;">Title:<br/>
                  </div>
                </td>

    <td rowspan="1" style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
                  <div>Senior Vice President, General Counsel and Secretary</div>
                </td>

  </tr>


</table>
        </div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

      </div>

      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

  </div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ef20038893_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">




  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right;"><font style="font-weight: bold; font-style: italic;">Exhibit 1.1</font><br>
      </div>
      <div><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Vulcan Materials Company</div>
      <div style="text-align: center;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">4.950% Senior Notes due 2029</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.350% Senior Notes due 2034</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.700% Senior Notes due 2054</div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 10%; color: #000000; text-align: center;"></div>
      <br>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Underwriting Agreement</u></div>
      <div style="text-align: center;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z870320bb89d2400d8047e0f6927003bc">

          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="text-align: right; text-indent: -18pt; margin-left: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">November 18, 2024</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Truist Securities, Inc.</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Wells Fargo Securities, LLC</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">BofA Securities, Inc.</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Goldman Sachs &amp; Co. LLC</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">U.S. Bancorp Investments, Inc.</font></div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z3b40545b916b49568b11f7c3b0f6d6c2">

          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">As Representatives of the several Underwriters</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">named in Schedule I hereto,</font></div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 100%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">c/o Truist Securities, Inc.</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">3333 Peachtree Road</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div>
                <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Atlanta, Georgia 30326</font></div>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 100%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">c/o Wells Fargo Securities, LLC</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">550 South Tryon Street, 5th Floor</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Charlotte, North Carolina 28202</font></div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 100%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">c/o BofA Securities, Inc.</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">One Bryant Park</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">New York, New York 10036</font></div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 100%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">c/o Goldman Sachs &amp; Co. LLC</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">200 West Street</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">New York, New York 10282</font></div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 100%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">c/o U.S. Bancorp Investments, Inc.</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">214 N. Tryon Street, 26th Floor</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Charlotte, North Carolina 28202</font></div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 100%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Ladies and Gentlemen:</font></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Vulcan Materials Company, a New Jersey corporation (the &#8220;Company&#8221;), proposes, subject to the terms and conditions stated herein, to issue and sell
        to each of the several Underwriters named in Schedule I hereto (the &#8220;Underwriters&#8221;), for whom Truist Securities, Inc., Wells Fargo Securities, LLC, BofA Securities, Inc., Goldman Sachs &amp; Co. LLC and U.S. Bancorp Investments, Inc. are acting as
        representatives of the several Underwriters named in Schedule I hereto (in such capacities, the &#8220;Representatives&#8221; or &#8220;you&#8221;), the respective aggregate principal amounts set forth in Schedule I of the Company&#8217;s $500,000,000 4.950% Senior Notes due
        2029 (the &#8220;2029 Notes&#8221;), $750,000,000 5.350% Senior Notes due 2034 (the &#8220;2034 Notes&#8221;) and $750,000,000 5.700% Senior Notes due 2054 (the &#8220;2054 Notes&#8221; and, together with the 2029 Notes and the 2034 Notes, the &#8220;Securities&#8221;).</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%-%-%-->
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Securities will be issued pursuant to the senior debt indenture, dated as of December 11, 2007 (the &#8220;Base Indenture&#8221;), between the Company and
        Regions Bank, as trustee and successor to the initial trustee (in such capacity, the &#8220;Trustee&#8221;), filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K on the date thereof.&#160; Certain terms of the Securities will be established pursuant to
        a supplemental indenture to the Base Indenture to be dated as of November 20, 2024 (the &#8220;Eleventh Supplemental Indenture&#8221; and together with the Base Indenture, the &#8220;Indenture&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The Company represents and warrants to, and agrees
          with, each of the Underwriters that:</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">An &#8220;automatic shelf registration
          statement&#8221; as defined under Rule 405 under the Securities Act of 1933, as amended (the &#8220;Act&#8221;), on Form S-3 (File No. 333-277793) in respect of the Securities has been filed by the Company with the Securities and Exchange Commission (the
          &#8220;Commission&#8221;) not earlier than three years prior to the date hereof; such registration statement, and any post-effective amendment thereto, became effective on filing; and no stop order suspending the effectiveness of such registration statement
          or any part thereof has been issued under the Act and no proceeding for that purpose has been initiated, or to the knowledge of the Company, has been threatened by the Commission, and no notice of objection of the Commission to the use of such
          registration statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Act has been received by the Company (the base prospectus filed as part of such registration statement, in the form in which it has most recently
          been filed with the Commission on or prior to the date of this Underwriting Agreement (this &#8220;Agreement&#8221;), is hereinafter called the &#8220;Base Prospectus&#8221;; any preliminary prospectus (including any preliminary prospectus supplement) relating to the
          Securities filed with the Commission pursuant to Rule 424(b) under the Act is hereinafter called a &#8220;Preliminary Prospectus&#8221;; the various parts of such registration statement, including all exhibits thereto and any prospectus supplement relating
          to the Securities that is filed with the Commission and deemed by virtue of Rule 430B under the Act to be part of such registration statement, each as amended at the time such part of the registration statement became effective, are hereinafter
          collectively called the &#8220;Registration Statement&#8221;; the Base Prospectus, as amended and supplemented immediately prior to the Applicable Time (as defined in Section 1(c) hereof), is hereinafter called the &#8220;Pricing Prospectus&#8221;; the form of the final
          prospectus relating to the Securities filed with the Commission pursuant to Rule 424(b) under the Act in accordance with Section 5(a) hereof is hereinafter called the &#8220;Prospectus&#8221;; any reference herein to the Base Prospectus, the Pricing
          Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 11 and Item 12 of Form S-3 under the Act, as of the date of such prospectus; any
          reference to any amendment or supplement to the Base Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any post-effective amendment to the Registration Statement, any prospectus supplement relating
          to the Securities filed with the Commission pursuant to Rule 424(b) under the Act and any documents filed under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and incorporated by reference into such Base Prospectus,
          Preliminary Prospectus or Prospectus, in each case after the date of the Base Prospectus, such Preliminary Prospectus, or the Prospectus, as the case may be; any reference to any amendment to the Registration Statement shall be deemed to refer to
          and include any annual report of the Company filed pursuant to Section 13(a) or 15(d) of the Exchange Act after the effective date of the Registration Statement that is incorporated by reference in the Registration Statement; and any &#8220;issuer free
          writing prospectus&#8221; as defined in Rule 433 under the Act relating to the Securities is hereinafter called an &#8220;Issuer Free Writing Prospectus&#8221;);</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-2-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">No order preventing or suspending the use of any Preliminary Prospectus or any Issuer Free Writing Prospectus has been issued by the Commission, and each Preliminary Prospectus, at the time of filing thereof,
            conformed in all material respects to the requirements of the Act and the Trust Indenture Act of 1939, as amended (the &#8220;Trust Indenture Act&#8221;), and the rules and regulations of the Commission thereunder, and did not contain an untrue statement
            of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font><font style="font-size: 10pt; font-family: 'Times New Roman';">, </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">however</font><font style="font-size: 10pt; font-family: 'Times New Roman';">, that this representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity with the Underwriter Information (as defined in Section
            9(b));</font></font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">For the purposes of this Agreement, the &#8220;Applicable Time&#8221; is 5:50 p.m. (Eastern time) on the date of this Agreement; the Pricing Prospectus as supplemented by the final term sheet prepared and filed pursuant to
            Section 5(a) hereof and the Issuer Free Writing Prospectuses, if any, identified on Schedule II(a) hereto, taken together (collectively, the &#8220;Pricing Disclosure Package&#8221;) as of the Applicable Time, did not include any untrue statement of a
            material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; and each Issuer Free Writing Prospectus, if any, listed on
            Schedule II(b) hereto does not conflict with the information contained in the Registration Statement, the Pricing Prospectus or the Prospectus and each such Issuer Free Writing Prospectus, as supplemented by and taken together with the Pricing
            Disclosure Package as of the Applicable Time, did not include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were
            made, not misleading; </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font><font style="font-size: 10pt; font-family: 'Times New Roman';">, </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">however</font><font style="font-size: 10pt; font-family: 'Times New Roman';">, that this representation and warranty shall not apply to statements or omissions made in the Pricing Prospectus or an Issuer
            Free Writing Prospectus in reliance upon and in conformity with the Underwriter Information;</font></font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">The documents incorporated by reference in the Pricing Prospectus and the Prospectus, when they became effective or were filed with the Commission, as the case may be, conformed in all material respects to the
            requirements of the Act or the Exchange Act, as applicable, and the applicable rules and regulations of the Commission thereunder, and when read together with the other information in the Registration Statement, the Pricing Disclosure Package
            and the Prospectus, at the respective times the Registration Statement and any amendments thereto became effective, as of the Applicable Time, at the date of the Prospectus and at the Time of Delivery (as defined below), did not and will not
            contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; any further
            documents so filed and incorporated by reference in the Pricing Disclosure Package and the Prospectus or any further amendment or supplement thereto, when such documents become effective or are filed with the Commission, as the case may be,
            will conform in all material respects to the requirements of the Act or the Exchange Act, as applicable, and the rules and regulations of the Commission thereunder and will not contain an untrue statement of a material fact or omit to state a
            material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font><font style="font-size: 10pt; font-family: 'Times New Roman';">, </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">however</font><font style="font-size: 10pt; font-family: 'Times New Roman';">, that this representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity with the Underwriter Information; and no such documents were filed with the
            Commission since the Commission&#8217;s close of business on the business day immediately prior to the date of this Agreement and prior to the execution of this Agreement, except as set forth on Schedule II(c) hereto;</font></font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-3-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">The Registration Statement conforms, and the Prospectus and any further amendments or supplements to the Registration Statement and the Prospectus will conform, as of the applicable effective date as to the
            Registration Statement and as of the applicable filing date and as of the Time of Delivery as to the Prospectus, in all material respects to the requirements of the Act and the Trust Indenture Act and the rules and regulations of the Commission
            thereunder and do not and will not, as of the applicable effective date as to each part of the Registration Statement and as of the applicable filing date as to the Prospectus and any amendment or supplement thereto, and as of the Time of
            Delivery, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font><font style="font-size: 10pt; font-family: 'Times New Roman';">, </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">however</font><font style="font-size: 10pt; font-family: 'Times New Roman';">, that this representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity with the Underwriter Information or to any statements in or omissions from the
            Statement of Eligibility of the Trustee under the Indenture;</font></font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">Neither the Company nor any of
          its subsidiaries has sustained since the respective dates of the latest audited financial statements included or incorporated by reference in the Pricing Prospectus and the Prospectus any material loss or interference with its business from fire,
          explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, which is material to the Company and its subsidiaries taken as a whole otherwise than as set
          forth or contemplated in the Pricing Prospectus and the Prospectus (exclusive of any amendment or supplement thereto); and, since the respective dates as of which information is given in the Registration Statement, the Pricing Prospectus and the
          Prospectus, there has not been any material change in the capital stock or long term debt (which is debt with a maturity of a year or more) of the Company or any of its significant subsidiaries (as defined in Rule 1-02(w) of Regulation S-X)
          (&#8220;Significant Subsidiaries&#8221;) or any material adverse change in or affecting the business, management, financial position, shareholders&#8217; equity, results of operations, or to the knowledge of the Company, in the business prospects of the Company
          and its subsidiaries taken as a whole, otherwise than as set forth or contemplated in the Pricing Prospectus and the Prospectus (exclusive of any amendment or supplement thereto);</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">(i)&#160; The Company and its
          Significant Subsidiaries have good and valid title to all of the properties and assets reflected in the financial statements included or incorporated by reference in the Pricing Prospectus and Prospectus, subject to no lien, mortgage, pledge,
          charge or encumbrance of any kind except those reflected in such financial statements or which are not material in nature or amount; and (ii) the Company and its Significant Subsidiaries use or occupy their leased properties under valid and
          binding leases; except in each case as would not individually or in the aggregate have a material adverse effect on the business, consolidated financial position, shareholders&#8217; equity, results of operations, or to the knowledge of the Company, in
          the business prospects of the Company and any of its subsidiaries taken as a whole (a &#8220;Material Adverse Effect&#8221;);</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">The Company has been duly
          incorporated and is validly existing as a corporation in good standing under the laws of the State of New Jersey, with corporate power and authority to own its properties and conduct its business as described in the Pricing Prospectus and the
          Prospectus, and has been duly qualified as a foreign corporation for the transaction of business and is in good standing under the laws of each other jurisdiction in which such qualification is required, except where the failure to so qualify or
          be in good standing would not result in a Material Adverse Effect; and each Significant Subsidiary of the Company has been duly organized and is validly existing as a corporation or other organization in good standing under the laws of the
          jurisdiction in which it is chartered or organized;</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-4-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">The Company has, as of
          September 30, 2024, an authorized capitalization as set forth in the Pricing Prospectus and the Prospectus and all of the issued shares of capital stock of the Company have been duly and validly authorized and issued and are fully paid and
          non-assessable;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">The Securities have been duly
          authorized and, when issued and delivered pursuant to this Agreement and the Indenture, will have been duly executed, authenticated, issued and delivered and will constitute valid and legally binding obligations of the Company entitled to the
          benefits provided by the Indenture under which they are to be issued; the Indenture has been duly authorized by the Company and duly qualified under the Trust Indenture Act and, constitutes a valid and legally binding instrument, enforceable in
          accordance with its terms, except as (i) the enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting the enforcement of creditors&#8217; rights generally and (ii) rights of acceleration and the availability of
          other remedies may be limited by equitable principles of general applicability;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">The issue and sale of the
          Securities and the compliance by the Company with all of the provisions of the Securities, the Indenture and this Agreement and the consummation of the transactions herein and therein contemplated will not conflict with or result in a breach or
          violation of any of the terms or provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the
          Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries is subject, except for such conflicts, breaches, violations or defaults that would not individually or in the
          aggregate have a Material Adverse Effect, nor will such action result in any violation of any statute or any order, rule or regulation of any court or governmental agency or body having jurisdiction over the Company or any of its subsidiaries or
          any of their properties, except for such violations that would not individually or in the aggregate have a Material Adverse Effect, nor will such action result in any violation of the provisions of the Certificate of Incorporation or By-laws of
          the Company; and no material consent, approval, authorization, order, registration or qualification of or with any such court or governmental agency or body is required for the issue and sale of the Securities or the consummation by the Company
          of the transactions contemplated by this Agreement or the Indenture except such as have been or will have been prior to the Time of Delivery, obtained under the Act and the Trust Indenture Act and such consents, approvals, authorizations,
          registrations or qualifications as may be required under state securities or Blue Sky laws in connection with the purchase and distribution of the Securities by the Underwriters;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(l)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">Neither the Company nor any of
          its Significant Subsidiaries is in violation of its Certificate of Incorporation or By-laws (or other organizational documents) or in default in the performance or observance of any obligation, covenant or condition contained in any indenture,
          mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which it is a party or by which it or any of its properties may be bound, except for defaults that would not have a Material Adverse Effect;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(m)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">The Securities and the Indenture
          will conform in all material aspects to the descriptions thereof in the Pricing Prospectus and the Prospectus;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(n)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">Other than as set forth in the
          Pricing Prospectus and the Prospectus, there are no legal, governmental or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries or proceedings (&#8220;Actions&#8221;) pending to which the Company or any of its subsidiaries is a
          party or of which any property or assets of the Company or any of its subsidiaries is the subject which, if determined adversely to the Company or any of its subsidiaries, would individually or in the aggregate have a Material Adverse Effect;
          and, to the Company&#8217;s knowledge, no such proceedings are threatened or contemplated by governmental authorities or others; there are no current or pending Actions that are required under the Act to be described in the Registration Statement or
          the Pricing Disclosure Package that are not so described therein;</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-5-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(o)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">The Company is not and, after
          giving effect to the offering and sale of the Securities and the application of the proceeds thereof, will not be an &#8220;investment company&#8221;, as such term is defined in the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;);</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(p)</font>&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">Other than as set forth in the
          Pricing Prospectus and the Prospectus, the property, assets and operations of the Company and its Significant Subsidiaries comply in all material respects with all applicable federal, state and local law, common law, doctrine, rule, order,
          decree, judgment, injunction, license, permit and regulation relating to environmental matters (the &#8220;Environmental Laws&#8221;), except to the extent that failure to comply with such Environmental Laws would not have a Material Adverse Effect; to the
          knowledge of the Company, none of the property, assets or operations of the Company and its Significant Subsidiaries is the subject of any federal, state or local investigation evaluating whether any remedial action is needed to respond to a
          release into the environment of any substance regulated by, or form the basis of liability under, any Environmental Laws (a &#8220;Hazardous Material&#8221;), or is in contravention of any Environmental Law that would have a Material Adverse Effect; neither
          the Company nor any subsidiary has received any notice or claim, nor are there pending or, to the Company&#8217;s knowledge, threatened lawsuits against them with respect to violations of an Environmental Law or in connection with the release of any
          Hazardous Material into the environment that would reasonably be expected to have a Material Adverse Effect; and neither the Company nor any subsidiary has any contingent liability in connection with any release of Hazardous Material into the
          environment, that is material with respect to the Company and its subsidiaries taken as a whole;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(q)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">(A) (i) At the time of filing
          the Registration Statement, (ii) at the time of the most recent amendment thereto for the purposes of complying with Section 10(a)(3) of the Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to
          Section 13 or 15(d) of the Exchange Act or form of prospectus), and (iii) at the time the Company or any person acting on its behalf (within the meaning, for this clause only, of Rule 163(c) under the Act) made any offer relating to the
          Securities in reliance on the exemption of Rule 163 under the Act, the Company was a &#8220;well-known seasoned issuer&#8221; as defined in Rule 405 under the Act; and (B) at the earliest time after the filing of the Registration Statement that the Company
          or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) under the Act) of the Securities, the Company was not an &#8220;ineligible issuer&#8221; as defined in Rule 405 under the Act;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(r)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">Deloitte &amp; Touche LLP, who
          have expressed its opinion with respect to certain financial statements of the Company and the Company&#8217;s internal control over financial reporting, all included or incorporated by reference in the Registration Statement, Pricing Prospectus and
          Prospectus, was and will be an independent registered public accounting firm with respect to the Company as of the Applicable Time and the Time of Delivery, as required by the Act and the Exchange Act and the applicable rules and regulations of
          the Commission thereunder and the rules of the Public Company Accounting Oversight Board (United States);</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-6-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(s)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">The Company maintains a system
          of internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) that complies with the requirements of the Exchange Act and has been designed by the Company&#8217;s principal executive officer and
          principal financial officer, or under their supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted
          accounting principles and that the interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus fairly present the information
          called for in all material respects and are prepared in accordance with the Commission's rules and guidelines applicable thereto.&#160; The Company&#8217;s internal control over financial reporting is effective and the Company is not aware of any material
          weaknesses in its internal control over financial reporting;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(t)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">This Agreement has been duly
          authorized, executed and delivered by the Company;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(u)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">Since the date of the latest
          audited financial statements of the Company included or incorporated by reference in the Pricing Prospectus and the Prospectus, there has been no change in the Company&#8217;s internal control over financial reporting that has materially affected, or
          is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">The Company maintains disclosure
          controls and procedures (as such term is defined in Rule 13a-15(e) under the Exchange Act) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that material information
          relating to the Company and its subsidiaries is made known to the Company&#8217;s principal executive officer and principal financial officer by others within those entities; and such disclosure controls and procedures are effective;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(w)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">Neither the Company nor any of
          its subsidiaries nor, to the knowledge of the Company or any of its subsidiaries, any director, officer, agent, employee, affiliate or other person acting on behalf of the Company or any of its subsidiaries has taken any action, directly or
          indirectly, that has resulted or would result in (i) the use of any funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii) a violation by any such persons of the Foreign Corrupt
          Practices Act of 1977, as amended, and the rules and regulations thereunder (the &#8220;FCPA&#8221;), or any other applicable anti-bribery or anti-corruption laws; (iii) the making or taking of an act in furtherance of any offer, payment, promise to pay or
          authorization of the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any &#8220;foreign official&#8221; (as such term is defined in the FCPA) or any foreign political party or official
          thereof or any candidate for foreign political office, in contravention of the FCPA or any other applicable anti-bribery or anti-corruption law; or (iv) the making, offering, requesting or taking of or the agreement to take, an act in furtherance
          of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit.&#160; The Company and its subsidiaries and, to the knowledge of the
          Company and its subsidiaries, its and their other affiliates have conducted their businesses in compliance with the FCPA and other applicable anti-bribery and anti-corruption laws and have instituted, maintain and enforce, and will continue to
          maintain and enforce, policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith;</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-7-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(x)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">The operations of the Company and
          its subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the applicable
          money laundering statutes of all applicable jurisdictions where the Company or any of its subsidiaries conducts business, the rules and regulations thereunder and any related or similar applicable rules, regulations or guidelines issued,
          administered or enforced by any governmental or regulatory agency (collectively, the &#8220;Anti-Money Laundering Laws&#8221;) and no action, suit or proceeding by or before any court or governmental or regulatory agency, authority or body or any arbitrator
          involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(y)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">None of the Company, any of its
          subsidiaries nor, to the knowledge of the Company or any of its subsidiaries, any director, officer, agent, employee, affiliate or representative of the Company or any of its subsidiaries is an individual or entity (&#8220;Person&#8221;) currently the
          subject or target of any sanctions administered or enforced by the United States Government (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of Treasury, or the U.S. Department of State and including,
          without limitation, the designation as a &#8220;specially designated national&#8221; or &#8220;blocked person&#8221;), the United Nations Security Council, the European Union, His Majesty&#8217;s Treasury, or other relevant sanctions authority (collectively, &#8220;Sanctions&#8221;), nor
          is controlled by an individual or entity that is currently subject to Sanctions, nor is the Company or any of its subsidiaries located, organized or resident in a country or territory that is the subject or target of Sanctions, including, without
          limitation, the Crimea Region and the non-government controlled areas of the Zaporizhia and Kherson Regions of Ukraine, Cuba, Iran, North Korea, Syria, the so-called Donetsk People&#8217;s Republic of Ukraine and the so-called Luhansk People&#8217;s Republic
          of Ukraine (each, a &#8220;Sanctioned Country&#8221;); and the Company shall not, directly or, to the best knowledge of the Company or any of its subsidiaries, indirectly, use the proceeds of the offering and sale of the Securities, or lend, contribute or
          otherwise make available such proceeds to any of its subsidiaries, joint venture partners or other Person, (i) to fund or facilitate any activities of or business with any Person, or in any country or territory, that, at the time of such funding
          or facilitation, is the subject of Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner that will result in a violation by any Person (including any Person participating in the
          offering and sale of the Securities, whether as underwriter, initial purchaser, advisor, investor or otherwise) of Sanctions.&#160; Since April 24, 2019, the Company and its subsidiaries have not knowingly engaged in and are not now knowingly engaged
          in any dealings or transactions with any Person that at the time of the dealing or transaction is or was the subject or target of Sanctions or with any Sanctioned Country;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(z)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">The financial statements filed
          with the Commission as a part of or incorporated by reference in the Registration Statement and included or incorporated by reference in the Pricing Disclosure Package and the Prospectus present fairly the consolidated financial position of the
          Company and its subsidiaries as of and at the dates indicated and the results of their operations and cash flows for the periods specified.&#160; The supporting schedules included or incorporated by reference in the Registration Statement present
          fairly the information required to be stated therein.&#160; Such financial statements and supporting schedules comply as to form with the applicable accounting requirements of Regulation S&#8209;X and have been prepared in conformity with generally accepted
          accounting principles as applied in the United States applied on a consistent basis throughout the periods involved, except as may be expressly stated in the related notes thereto.&#160; No other financial statements or supporting schedules are
          required to be included or incorporated by reference in the Registration Statement.&#160; The financial data set forth in the Preliminary Prospectus and the Prospectus under the captions &#8220;Summary&#8212;Summary Consolidated Financial Data and Other Financial
          Data&#8221; and &#8220;Capitalization&#8221; fairly present the information set forth therein on a basis consistent with that of the audited financial statements contained in the Registration Statement.&#160; The interactive data in eXtensible Business Reporting
          Language included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus fairly present the information called for in all material respects and have been prepared in accordance with the
          Commission&#8217;s rules and guidelines applicable thereto;</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-8-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(aa)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">The Company has not distributed
          and will not distribute, prior to the later of the Time of Delivery and the completion of the Underwriters&#8217; distribution of the Securities, any offering material in connection with the offering and sale of the Securities other than the
          Preliminary Prospectus, the Prospectus and any Issuer Free Writing Prospectus reviewed and consented to by the Representatives;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(bb)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">None of the transactions
          contemplated by this Agreement (including, without limitation, the use of the proceeds from the sale of the Securities) will violate or result in a violation of Section 7 of the Exchange Act, or any regulation promulgated thereunder, including,
          without limitation, Regulations T, U, and X of the Board of Governors of the Federal Reserve System;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(cc)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">The Company taken as a whole is,
          and immediately after the Time of Delivery will be, Solvent.&#160; As used herein, the term &#8220;Solvent&#8221; means, with respect to any person on a particular date, that on such date (i) the fair market value of the assets of such person is greater than the
          total amount of liabilities (including contingent liabilities) of such person, (ii) the present fair salable value of the assets of such person is greater than the amount that will be required to pay the probable liabilities of such person on its
          debts as they become absolute and matured, (iii) such person is able to realize upon its assets and pay its debts and other liabilities, including contingent obligations, as they mature and (iv) such person does not have unreasonably small
          capital;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(dd)</font>&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">The Company has not taken and
          will not take, directly or indirectly, any action designed to or that might be reasonably expected to cause or result in stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ee)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">The Company and its directors and
          officers, in their capacities as such, are in compliance in all material respects with the applicable provisions of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith (as amended, the &#8220;Sarbanes-Oxley
          Act&#8221;), including Section 402 related to loans and Sections 302 and 906 related to certifications;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ff)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">The Company and its Significant
          Subsidiaries&#8217; information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases (collectively, &#8220;IT Systems&#8221;) are adequate for, and operate and perform in all material respects as
          required in connection with the operation of the business of the Company and its Significant Subsidiaries as currently conducted, and, to the Company&#8217;s knowledge, free and clear of all material bugs, errors, defects, Trojan horses, time bombs,
          malware and other corruptants.&#160; The Company and its Significant Subsidiaries have implemented and maintained commercially reasonable controls, policies, procedures, and safeguards to maintain and protect their material confidential information
          and the integrity, continuous operation, redundancy and security of all IT Systems and data (including all personal, personally identifiable, sensitive, confidential or regulated data (&#8220;Personal Data&#8221;)) used in connection with their businesses,
          and, to the Company&#8217;s knowledge, there have been no breaches, violations, outages or unauthorized uses of or accesses to same, except for those that have been remedied without material cost or liability or the duty to notify any other person, nor
          any incidents under internal review or investigations relating to the same.&#160; The Company and its Significant Subsidiaries are presently in material compliance with all applicable laws or statutes and all judgments, orders, rules and regulations
          of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from
          unauthorized use, access, misappropriation or modification; and</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-9-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(gg)</font>&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">No forward-looking statement
          (within the meaning of Section 27A of the Act and Section 21E of the Exchange Act) included or incorporated by reference in any of the Registration Statement, the Pricing Disclosure Package or the Prospectus has been made without a reasonable
          basis or has been disclosed other than in good faith.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Subject to the terms and conditions herein set
          forth, the Company agrees to issue and sell to each of the Underwriters, and each of the Underwriters agrees, severally and not jointly, to purchase from the Company, (x) the 2029 Notes at a purchase price of 99.288% of the aggregate principal
          amount thereof, (y) the 2034 Notes at a purchase price of 99.240% of the aggregate principal amount thereof and (z) the 2054 Notes at a purchase price of 98.567% of the aggregate principal amount thereof, in each case, plus accrued interest, if
          any, from November 20, 2024 to the Time of Delivery hereunder, the aggregate principal amount of the Securities, set forth opposite the name of such Underwriter in Schedule I hereto.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Upon the authorization by you of the release of
          the Securities, the several Underwriters propose to offer the Securities for sale upon the terms and conditions set forth in the Prospectus.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">4.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Securities to be purchased
          by each Underwriter hereunder will be represented by one or more definitive global Securities in book-entry form which will be deposited by or on behalf of the Company with The Depository Trust Company (&#8220;DTC&#8221;) or its designated custodian.&#160; The
          Company will deliver the Securities to the Representatives, for the account of each Underwriter, against payment by or on behalf of such Underwriter of the purchase price therefor by wire transfer of Federal (same-day) funds to the account
          specified by the Company to the Representatives at least twenty-four hours in advance, by causing DTC to credit the Securities to the account of the Representatives at DTC.&#160; The Company will cause the certificates or security entitlements for the
          Securities to be made available to the Representatives for checking at least twenty-four hours prior to the Time of Delivery (as defined below) at the office of DTC or its designated custodian (the &#8220;Designated Office&#8221;).&#160; The time and date of such
          delivery and payment shall be 9:30 a.m., New York City time, on November 20, 2024 (the &#8220;Closing Date&#8221;) or such other time and date as the Representatives and the Company may agree upon in writing.&#160; Such time and date are herein called the &#8220;Time
          of Delivery.&#8221;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The documents to be delivered at
          the Time of Delivery by or on behalf of the parties hereto pursuant to Section 8 hereof, including the cross-receipt for the Securities and any additional documents requested by the Underwriters pursuant to Section 8(j) hereof, will be delivered
          at the offices of Cahill Gordon &amp; Reindel <font style="font-size: 10pt; font-family: 'Times New Roman'; font-variant: small-caps;">llp</font>, 32 Old Slip, New York, New York 10005, and the Securities will be delivered at the Designated
          Office, all at the Time of Delivery.&#160; A telephonic or electronic meeting will be held on the New York Business Day immediately preceding the Time of Delivery, at which meeting the final drafts of the documents to be delivered pursuant to the
          preceding sentence will be available for review by the parties hereto.&#160; For the purposes of this Section 4, &#8220;New York Business Day&#8221; shall mean each Monday, Tuesday, Wednesday, Thursday and Friday which is not a day on which banking institutions
          in New York City are generally authorized or obligated by law or executive order to close.</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-10-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The Company agrees with each of the Underwriters:</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">To prepare the Prospectus in a
          form approved by you and to file such Prospectus pursuant to Rule 424(b) under the Act not later than the Commission&#8217;s close of business on the second business day following the date of this Agreement; to make no further amendment or any
          supplement to the Registration Statement, the Base Prospectus or the Prospectus prior to the Time of Delivery which shall be disapproved by you in your reasonable judgment promptly after reasonable notice thereof; to advise you, promptly after it
          receives notice thereof, of the time when any amendment to the Registration Statement has been filed or becomes effective or any amendment or supplement to the Prospectus has been filed and to furnish you with copies thereof; to prepare a final
          term sheet, containing a description of the Securities, substantially in the form attached as Schedule III hereto, and to file such final term sheet pursuant to Rule 433(d) under the Act within the time required by such Rule; to file promptly all
          other material required to be filed by the Company with the Commission pursuant to Rule 433(d) under the Act; to file within the required time periods all reports and any definitive proxy or information statements required to be filed by the
          Company with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a prospectus (or in lieu thereof, the notice referred to in Rule 173(a)
          under the Act) is required under the Act in connection with the offering or sale of the Securities; to advise you, promptly after it receives notice thereof, of the issuance by the Commission of any stop order or of any order preventing or
          suspending the use of any Preliminary Prospectus or other prospectus in respect of the Securities, of any notice of objection of the Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant to Rule
          401(g)(2) under the Act, of the suspension of the qualification of the Securities for offering or sale in any jurisdiction, of the initiation or threatening of any proceeding for any such purpose, or of any request by the Commission for the
          amending or supplementing of the Registration Statement or the Prospectus or for additional information; and, in the event of the issuance of any stop order or of any order preventing or suspending the use of any Preliminary Prospectus or other
          prospectus or suspending any such qualification, to promptly use its best efforts to obtain the withdrawal of such order; and in the event of any such issuance of a notice of objection, promptly to take such steps including, without limitation,
          amending the Registration Statement or filing a new registration statement, at its own expense, as may be necessary to permit offers and sales of the Securities by the Underwriters (references herein to the Registration Statement shall include
          any such amendment or new registration statement);</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">If required by Rule 430B(h)
          under the Act, to prepare a form of prospectus in a form approved by you and to file such form of prospectus pursuant to Rule 424(b) under the Act not later than may be required by Rule 424(b) under the Act; and to make no further amendment or
          supplement to such form of prospectus which shall be disapproved by you promptly after reasonable notice thereof;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">Promptly from time to time to take such action as you may reasonably require to qualify the Securities for offering and sale under the securities laws of such jurisdictions as you may reasonably require and to
            maintain such qualification so as to permit the continuance of sales and dealings therein in such jurisdictions for as long as may be necessary to complete the distribution of the Securities up to one year from the date hereof, </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font><font style="font-size: 10pt; font-family: 'Times New Roman';"> that in connection therewith, the Company shall not be required to qualify as a foreign
            corporation or to file a general consent to service of process in any jurisdiction or to qualify as a foreign corporation or as a broker or dealer in securities in any jurisdiction in which it is not so qualified or to subject itself to
            taxation in respect of doing business in any jurisdiction in which it is not otherwise so subject;</font></font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-11-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">To furnish the Underwriters with
          (i) electronic copies of the Prospectus on the second New York Business Day succeeding the date of this Agreement and from time to time, and (ii) written copies of the Prospectus, in each case in such quantities as you may reasonably request,
          and, if the delivery of a prospectus (or in lieu thereof, the notice referred to in Rule 173(a) under the Act) is required at any time prior to the expiration of nine months after the time of issue of the Prospectus in connection with the
          offering or sale of the Securities and if at such time any event shall have occurred as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state any material fact
          necessary in order to make the statements therein, in the light of the circumstances under which they were made when such Prospectus (or in lieu thereof, the notice referred to in Rule 173(a) under the Act) is delivered, not misleading, or, if
          for any other reason it shall be necessary during such same period to amend or supplement the Prospectus or to file under the Exchange Act any document incorporated by reference in the Prospectus in order to comply with the Act, the Exchange Act
          or the Trust Indenture Act, to notify you and upon your request to file such document and to prepare and furnish without charge to each Underwriter and to any dealer in securities as many written and electronic copies as you may from time to time
          reasonably request of an amended Prospectus or a supplement to the Prospectus which will correct such statement or omission or effect such compliance; and in case any Underwriter is required to deliver a prospectus (or in lieu thereof, the notice
          referred to in Rule 173(a) under the Act) in connection with sales of any of the Securities at any time nine months or more after the time of issue of the Prospectus, upon your request but at the expense of such Underwriter, to prepare and
          deliver to such Underwriter as many written and electronic copies as you may request of an amended or supplemented Prospectus complying with Section 10(a)(3) of the Act;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font>&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">To make generally available to
          its securityholders and to the Representatives as soon as practicable, but in any event not later than sixteen months after the effective date of the Registration Statement (as defined in Rule 158(c) under the Act), an earnings statement of the
          Company and its subsidiaries (which need not be audited) complying with Section 11(a) of the Act and the rules and regulations of the Commission thereunder (including, at the option of the Company, Rule 158);</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">During the period beginning from
          the date hereof and continuing to and including the Time of Delivery, not to offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise dispose, except as provided hereunder of, any securities of the
          Company that are substantially similar to the Securities, without your prior written consent;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">To pay the required Commission
          filing fees relating to the Securities within the time required by Rule 456(b)(1) under the Act without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r) under the Act;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">To use the net proceeds received
          by it from the sale of the Securities pursuant to this Agreement in the manner specified in the Pricing Prospectus and the Prospectus under the caption &#8220;Use of Proceeds&#8221;;</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-12-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">During the period beginning at
          the Applicable Time and ending on the later of the Time of Delivery or such date, as in the opinion of counsel for the Underwriters, the Prospectus is no longer required by law to be delivered in connection with sales by an Underwriter or dealer,
          including in circumstances where such requirement may be satisfied pursuant to Rule 172, to comply with all applicable securities and other laws, rules and regulations, including, without limitation, the Sarbanes-Oxley Act, and use its best
          efforts to cause the Company&#8217;s directors and officers, in their capacities as such, to comply with such laws, rules and regulations, including, without limitation, the provisions of the Sarbanes-Oxley Act;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">Not to take, directly or
          indirectly, any action designed to cause or result in, or that has constituted or might reasonably be expected to constitute, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any securities of the Company to
          facilitate the sale or resale of the Securities; and</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">The Company shall cooperate with
          the Representatives and counsel for the Underwriters to qualify or register the Securities for sale under (or obtain exemptions from the application of) the state securities or Blue Sky laws or Canadian provincial securities laws or other foreign
          laws of those jurisdictions designated by the Representatives and consented to by the Company, and the Company shall comply in all material respects with such laws and shall continue such qualifications, registrations and exemptions in effect so
          long as required for the distribution of the Securities.&#160; The Company shall not be required to (i) qualify as a foreign corporation or other entity or as a dealer in securities in any such jurisdiction where it would not otherwise be required to
          so qualify, (ii) file any general consent to service of process in any such jurisdiction or (iii) subject itself to taxation in any such jurisdiction if it is not otherwise so subject.&#160; The Company will advise the Representatives promptly of the
          suspension of the qualification or registration of (or any such exemption relating to) the Securities for offering, sale or trading in any jurisdiction or any initiation or threat of any proceeding for any such purpose, and in the event of the
          issuance of any order suspending such qualification, registration or exemption, the Company shall use its best efforts to obtain the withdrawal thereof at the earliest possible moment.</font></div>
      <div>&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">6.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">&#160; The Company represents and
          agrees that, other than the final term sheet prepared and filed pursuant to Section 5(a) hereof, without the prior consent of the Representatives, it has not made and will not make any offer relating to the Securities that would constitute a
          &#8220;free writing prospectus&#8221; as defined in Rule 405 under the Act;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">each Underwriter represents and
          agrees that, without the prior consent of the Company and the Representatives, other than the final term sheet prepared and filed pursuant to Section 5(a) hereof, it has not made and will not make any offer relating to the Securities that would
          constitute an Issuer Free Writing Prospectus or any other free writing prospectus that would be required to be filed with the Commission; and</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">any such free writing prospectus
          the use of which has been consented to by the Company and the Representatives (including the final term sheet prepared and filed pursuant to Section 5(a) hereof) is listed on Schedule II(a) or Schedule II(b) hereto, as applicable;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The Company has complied and
          will comply with the requirements of Rule 433 under the Act applicable to any Issuer Free Writing Prospectus, including timely filing with the Commission or retention where required and legending; and</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-13-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Company agrees that if at
          any time following issuance of an Issuer Free Writing Prospectus any event occurred or occurs as a result of which such Issuer Free Writing Prospectus would conflict with the information in the Registration Statement, the Pricing Prospectus or
          the Prospectus or would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances then prevailing, not misleading, the Company will give
          prompt notice thereof to the Representatives and, if requested by the Representatives, will prepare and furnish without charge to each Underwriter an Issuer Free Writing Prospectus or other document which will correct such conflict, statement or
          omission; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">however</font>, that this representation and
          warranty shall not apply to any statements or omissions in an Issuer Free Writing Prospectus made in reliance upon and in conformity with information furnished in writing to the Company by an Underwriter through the Representatives expressly for
          use therein.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The Company covenants and agrees with the several
          Underwriters that the Company will pay or cause to be paid the following:&#160; (i) the fees, disbursements and expenses of the Company&#8217;s counsel and accountants in connection with the registration and sale of the Securities under the Act and all
          other expenses in connection with the preparation, printing, reproduction and filing of the Registration Statement, the Base Prospectus, any Preliminary Prospectus, any Issuer Free Writing Prospectus and the Prospectus and amendments and
          supplements thereto and the mailing and delivering of copies thereof to the Underwriters and dealers; (ii) the cost of printing or producing any agreement among Underwriters, this Agreement, the Indenture, the Blue Sky Memorandum, closing
          documents (including any compilations thereof) and any other documents in connection with the offering, purchase, sale and delivery of the Securities; (iii) all reasonable expenses in connection with the qualification of the Securities for
          offering and sale under state securities laws as provided in Section 5(c) hereof, including the reasonable fees and disbursements of counsel for the Underwriters in connection with such qualification and in connection with the Blue Sky survey;
          (iv) any fees charged by securities rating services for rating the Securities; (v) the filing fees incident to, and the reasonable fees and disbursements of counsel for the Underwriters in connection with, any required review by the Financial
          Industry Regulatory Authority, Inc. of the terms of the sale of the Securities; (vii) the cost of preparing the Securities; (viii) the fees and expenses of the Trustee and any agent of the Trustee and the fees and disbursements of counsel for the
          Trustee in connection with the Indenture and the Securities; (ix) all expenses incurred by the Company in connection with any &#8220;road show&#8221; presentation to potential investors and (x) all other costs and expenses incident to the performance of its
          obligations hereunder which are not otherwise specifically provided for in this Section 7.&#160; It is understood, however, that, except as provided in this Section 7 and Sections 9 and 12 hereof, the Underwriters will pay all of their own costs and
          expenses, including the fees of their counsel, transfer taxes on resale of any of the Securities by them, and any advertising expenses connected with any offers they may make.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The obligations of the Underwriters to purchase and
          pay for the Securities hereunder shall be subject, in their discretion, to the condition that all representations and warranties and other statements of the Company herein are, at and as of the Applicable Time and the Time of Delivery, true and
          correct, the condition that the Company shall have performed all of its obligations hereunder theretofore to be performed, and the following additional conditions:</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">The Prospectus shall have been
          filed with the Commission pursuant to Rule 424(b) under the Act within the applicable time period prescribed for such filing by the rules and regulations under the Act and in accordance with Section 5(a) hereof; the final term sheet contemplated
          by Section 5(a) hereof, and any other material required to be filed by the Company pursuant to Rule 433(d) under the Act, shall have been filed with the Commission within the applicable time periods prescribed for such filings by Rule 433; no
          stop order suspending the effectiveness of the Registration Statement or any part thereof shall have been issued and no proceeding for that purpose or pursuant to Section 8A of the Act shall have been initiated or threatened by the Commission and
          no notice of objection of the Commission to the use of the Preliminary Prospectus, the Prospectus, the Registration Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Act shall have been received by the
          Company; no stop order suspending or preventing the use of the Prospectus or any Issuer Free Writing Prospectus shall have been initiated or threatened by the Commission; and all requests for additional information on the part of the Commission
          shall have been complied with to your reasonable satisfaction;</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-14-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">Cahill Gordon &amp; Reindel </font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-variant: small-caps;">llp</font><font style="font-size: 10pt; font-family: 'Times New Roman';">, counsel for
            the Underwriters, shall have furnished to you such written opinion or opinions, dated such Time of Delivery, with respect to such matters as you may reasonably request, and such counsel shall have received such papers and information as they
            may reasonably request to enable them to pass upon such matters, and may rely upon the opinion of Womble Bond Dickinson (US) LLP with respect to matters of New Jersey law;</font></font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">Denson N. Franklin III, Senior
          Vice President, General Counsel and Secretary for the Company, shall have furnished to you his written opinion dated the Time of Delivery, in form and substance satisfactory to you, and he may rely upon the opinion of Womble Bond Dickinson (US)
          LLP, counsel for the Company, with respect to matters of New Jersey law;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">Womble Bond Dickinson (US) LLP,
          counsel for the Company, shall have furnished to you their written opinion and negative assurance letter, each dated the Time of Delivery, in form and substance satisfactory to you;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">On the date of the Prospectus at
          a time prior to the execution of this Agreement, at 9:30 a.m., New York City time, on the effective date of any post effective amendment to the Registration Statement filed subsequent to the date of this Agreement and also at the Time of
          Delivery, Deloitte &amp; Touche LLP shall have furnished to you a letter or letters, dated the respective dates of delivery thereof, in form and substance satisfactory to you;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">(i) Neither the Company nor any
          of its subsidiaries shall have sustained since the date of the latest audited financial statements of the Company included or incorporated by reference in the Pricing Prospectus and the Prospectus any loss or interference with its business from
          fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, which is material to the Company and its subsidiaries taken as a whole, otherwise than as
          set forth or contemplated in the Pricing Prospectus and the Prospectus (exclusive of any amendment or supplement thereto), and (ii) since the respective dates as of which information is given in the Pricing Prospectus and the Prospectus there
          shall not have been any material change in the capital stock or long term debt (which is debt with a maturity of a year or more) of the Company or any of its subsidiaries or any material change or effect in or affecting the business, business
          prospects, management, or consolidated financial position, shareholders&#8217; equity or results of operations of the Company and its subsidiaries taken as a whole, otherwise than as set forth or contemplated in the Pricing Prospectus (exclusive of any
          amendment or supplement thereto), the effect of which, in any such case described in clause (i) or (ii), is in your judgment so material and adverse as to make it impracticable or inadvisable to proceed with the public offering or the delivery of
          the Securities on the terms and in the manner contemplated in the Prospectus;</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-15-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">On or after the Applicable Time
          (i) no downgrading shall have occurred in the rating accorded the Company&#8217;s debt securities by any &#8220;nationally recognized statistical rating organization&#8221;, as that term is defined by the Commission in Section 3(a)(62) of the Exchange Act, and
          (ii) no such organization shall have publicly announced that it has under surveillance or review, with possible negative implications, its rating of any of the Company&#8217;s debt securities;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">On or after the Applicable Time
          there shall not have occurred any of the following:&#160; (i) a suspension or material limitation in trading in securities generally on the New York Stock Exchange; (ii) a suspension or material limitation in trading in the Company&#8217;s securities on the
          New York Stock Exchange; (iii) a general moratorium on commercial banking activities declared by either Federal or New York, Alabama or New Jersey State authorities or a material disruption in commercial banking or securities settlement or
          clearance services in the United States; (iv) the outbreak or escalation of hostilities involving the United States or the declaration by the United States of a national emergency or war; or (v) the occurrence of any other calamity or crisis or
          any change in financial, political or economic conditions in the United States or elsewhere, if the effect of any such event specified in clause (iv) or (v) in your judgment makes it impracticable or inadvisable to proceed with the public
          offering or the delivery of the Securities on the terms and in the manner contemplated in the Prospectus;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">The Company shall have complied
          with the provisions of Section 5(d) hereof with respect to the furnishing of prospectuses on the New York Business Day next succeeding the date of this Agreement;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-size: 10pt;">The Company shall have furnished
          or caused to be furnished to you at the Time of Delivery certificates of officers of the Company satisfactory to you as to the accuracy of the representations and warranties of the Company herein at and as of such time, as to the performance by
          the Company of all of its obligations hereunder to be performed at or prior to such time, as to the matters set forth in subsections (a) and (h) of this Section 8 and as to such other matters as you may reasonably request; and</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt;">On the date hereof and on the
          Closing Date, the Representatives shall have received a written certificate executed by the Chief Financial Officer of the Company, dated as of the date hereof and as of the Closing Date, respectively, regarding certain information in the Pricing
          Prospectus and the Prospectus, respectively, and in form and substance reasonably satisfactory to the Representatives.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">9.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The Company will indemnify and
          hold harmless each Underwriter against any losses, claims, damages or liabilities, joint or several, to which such Underwriter may become subject, under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in
          respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, the Base Prospectus, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus,
          or any amendment or supplement thereto, any Issuer Free Writing Prospectus, any &#8220;roadshow&#8221; as defined in Rule 433(g) under the Act (a &#8220;roadshow&#8221;), or any &#8220;issuer information&#8221; filed or required to be filed pursuant to Rule 433(d) under the Act, or
          arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse each Underwriter for any legal or other
          expenses reasonably incurred by such Underwriter in connection with investigating or defending any such action or claim within 30 days after receipt of invoicing for such expense; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">however</font>, that the Company shall not be liable in any such case to the extent that any such loss, claim, damage or
          liability arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in the Registration Statement, the Base Prospectus, any Preliminary Prospectus, the Pricing Prospectus or the
          Prospectus, or any amendment or supplement thereto, or any Issuer Free Writing Prospectus, in reliance upon and in conformity with the Underwriter Information.</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-16-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Each Underwriter will indemnify
          and hold harmless the Company against any losses, claims, damages or liabilities to which the Company may become subject, under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out
          of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, the Base Prospectus, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or any amendment or
          supplement thereto, or any Issuer Free Writing Prospectus, or any roadshow, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements
          therein not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in the Registration Statement, the Base Prospectus, any Preliminary
          Prospectus, the Pricing Prospectus or the Prospectus or any such amendment or supplement thereto, or any Issuer Free Writing Prospectus, or any roadshow, in reliance upon and in conformity with the Underwriter Information; and will reimburse the
          Company for any legal or other expenses reasonably incurred by the Company in connection with investigating or defending any such action or claim within 30 days after receipt of invoicing for such expenses.&#160; The Company acknowledges that the
          first sentence of the fifth paragraph, the third sentence of the seventh paragraph and the first and second sentences of the ninth paragraph, in each case, under the caption &#8220;Underwriting (Conflicts of Interest)&#8221; in the Preliminary Prospectus and
          the Prospectus, constitute the only written information furnished to the Company by any Underwriter through the Representatives expressly for use in the Preliminary Prospectus, the Pricing Prospectus or the Prospectus or any such amendment or
          supplement thereto, or any Issuer Free Writing Prospectus (such information, the &#8220;Underwriter Information&#8221;).</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Promptly after receipt by an
          indemnified party under subsection (a) or (b) above of notice of the commencement of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection, notify the
          indemnifying party in writing of the commencement thereof; but the omission so to notify the indemnifying party shall not relieve it from any liability which it may have to any indemnified party otherwise than under such subsection (except to the
          extent that the indemnifying party is materially prejudiced by reason of such failure).&#160; In case any such action shall be brought against any indemnified party and it shall notify the indemnifying party of the commencement thereof, the
          indemnifying party shall be entitled to participate therein and, to the extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel satisfactory to such indemnified party
          (who shall not, except with the consent of the indemnified party, be counsel to the indemnifying party), <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">however</font>, such indemnified party shall have the right to employ its own counsel in any such action and to participate in the defense thereof, but the fees and expenses of such counsel
          shall be at the expense of such indemnified party, unless:&#160; (i) the employment of such counsel has been specifically authorized in writing by the indemnifying party; (ii) the indemnifying party has failed promptly to assume the defense and employ
          counsel reasonably satisfactory to the indemnified party; or (iii) the named parties to any such action (including any impleaded parties) include both such indemnified party and the indemnifying party or any affiliate of the indemnifying party,
          and such indemnified party shall have reasonably concluded that either (x) there may be one or more legal defenses available to it which are different from or additional to those available to the indemnifying party or such affiliate of the
          indemnifying party or (y) a conflict may exist between such indemnified party and the indemnifying party or such affiliate of the indemnifying party (it being understood, however, that the indemnifying party shall not, in connection with any one
          such action or separate but substantially similar or related actions in the same jurisdiction arising out of the same general allegations or circumstances, be liable for the fees and expenses of more than one separate firm of attorneys (in
          addition to a single firm of local counsel) for all such indemnified parties, which firm shall be designated in writing by the Representatives and that all such reasonable fees and expenses shall be reimbursed as they are incurred).&#160; Upon receipt
          of notice from the indemnifying party to such indemnified party of its election so to assume the defense thereof, the indemnifying party shall not be liable to such indemnified party under such subsection for any legal expenses of other counsel
          or any other expenses, in each case subsequently incurred by such indemnified party, in connection with the defense thereof other than reasonable costs of investigation.&#160; No indemnifying party shall, without the written consent of the indemnified
          party, effect the settlement or compromise of, or consent to the entry of any judgment with respect to, any pending or threatened action or claim in respect of which indemnification or contribution may be sought hereunder (whether or not the
          indemnified party is an actual or potential party to such action or claim) unless such settlement, compromise or judgment (i) includes an unconditional release of the indemnified party from all liability arising out of such action or claim and
          (ii) does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any indemnified party.</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-17-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">If the indemnification provided
          for in this Section 9 is unavailable to or insufficient to hold harmless an indemnified party under subsection (a) or (b) above in respect of any losses, claims, damages or liabilities (or actions in respect thereof) referred to therein, then
          each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of such losses, claims, damages or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect the
          relative benefits received by the Company on the one hand and the Underwriters on the other from the offering of the Securities.&#160; If, however, the allocation provided by the immediately preceding sentence is not permitted by applicable law or if
          the indemnifying party was materially prejudiced as a result of the failure by the indemnified party to give the notice required under subsection (c) above, then each indemnifying party shall contribute to such amount paid or payable by such
          indemnified party in such proportion as is appropriate to reflect not only such relative benefits but also the relative fault of the Company on the one hand and the Underwriters on the other in connection with the statements or omissions which
          resulted in such losses, claims, damages or liabilities (or actions in respect thereof), as well as any other relevant equitable considerations.&#160; The relative benefits received by the Company on the one hand and the Underwriters on the other
          shall be deemed to be in the same proportion as the total net proceeds from the offering (before deducting expenses) received by the Company bear to the total underwriting discounts and commissions received by the Underwriters, in each case as
          set forth in the table on the cover page of the Prospectus.&#160; The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to
          state a material fact relates to information supplied by the Company on the one hand or the Underwriters on the other and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or
          omission.&#160; The Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to this subsection (d) were determined by pro rata allocation (even if the Underwriters were treated as one entity for such
          purpose) or by any other method of allocation which does not take account of the equitable considerations referred to above in this subsection (d).&#160; The aggregate amount paid or payable by an indemnified party as a result of the losses, claims,
          damages or liabilities (or actions in respect thereof) referred to above in this subsection (d) shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any
          such action or claim.&#160; Notwithstanding the provisions of this subsection (d), no Underwriter shall be required to contribute any amount in excess of the amount by which the total price at which the Securities underwritten by it and distributed to
          the public were offered to the public exceeds the amount of any damages which such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.&#160; No person guilty of
          fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.&#160; The Underwriters&#8217; obligations in this subsection (d) to
          contribute are several in proportion to their respective underwriting obligations and not joint.</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-18-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The obligations of the Company
          under this Section 9 shall be in addition to any liability which the Company may otherwise have and shall extend, upon the same terms and conditions, to each person, if any, who controls any Underwriter within the meaning of the Act and each
          broker-dealer affiliate of any Underwriter; and the obligations of the Underwriters under this Section 9 shall be in addition to any liability which the respective Underwriters may otherwise have and shall extend, upon the same terms and
          conditions, to each officer and director of the Company and to each person, if any, who controls the Company within the meaning of the Act.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">10.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">If any Underwriter shall default
          in its obligation to purchase the Securities which it has agreed to purchase hereunder, you may in your discretion arrange for you or another party or other parties to purchase such Securities on the terms contained herein.&#160; If within thirty six
          hours after such default by any Underwriter you do not arrange for the purchase of such Securities, then the Company shall be entitled to a further period of thirty six hours within which to procure another party or other parties satisfactory to
          you to purchase such Securities on such terms.&#160; In the event that, within the respective prescribed periods, you notify the Company that you have so arranged for the purchase of such Securities, or the Company notifies you that it has so arranged
          for the purchase of such Securities, you or the Company shall have the right to postpone the Time of Delivery for a period of not more than seven days, in order to effect whatever changes may thereby be made necessary in the Registration
          Statement or the Prospectus, or in any other documents or arrangements, and the Company agrees to file promptly any amendments or supplements to the Registration Statement or the Prospectus which in your opinion may thereby be made necessary.&#160;
          The term &#8220;Underwriter&#8221; as used in this Agreement shall include any person substituted under this Section 10 with like effect as if such person had originally been a party to this Agreement with respect to such Securities.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">If, after giving effect to any
          arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by you and the Company as provided in subsection (a) above, the aggregate principal amount of such Securities which remains unpurchased does not exceed
          one eleventh of the aggregate principal amount of all the Securities, then the Company shall have the right to require each non-defaulting Underwriter to purchase the principal amount of Securities which such Underwriter agreed to purchase
          hereunder and, in addition, to require each non-defaulting Underwriter to purchase its pro rata share (based on the principal amount of Securities which such Underwriter agreed to purchase hereunder) of the Securities of such defaulting
          Underwriter or Underwriters for which such arrangements have not been made; but nothing herein shall relieve a defaulting Underwriter from liability for its default.</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-19-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">If, after giving effect to any
          arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by you and the Company as provided in subsection (a) above, the aggregate principal amount of Securities which remains unpurchased exceeds one eleventh of
          the aggregate principal amount of all the Securities, or if the Company shall not exercise the right described in subsection (b) above to require non-defaulting Underwriters to purchase Securities of a defaulting Underwriter or Underwriters, then
          this Agreement shall thereupon terminate, without liability on the part of any non-defaulting Underwriter or the Company, except for the expenses to be borne by the Company and the Underwriters as provided in Section 7 hereof and the indemnity
          and contribution agreements in Section 9 hereof; but nothing herein shall relieve a defaulting Underwriter from liability for its default.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The respective indemnities, agreements,
          representations, warranties and other statements of the Company and the several Underwriters , as set forth in this Agreement or made by or on behalf of them, respectively, pursuant to this Agreement, shall remain in full force and effect,
          regardless of any (A) investigation (or any statement as to the results thereof) made by or on behalf of any Underwriter or any controlling person of any Underwriter, or the Company, or any officer or director or controlling person of the
          Company, and shall survive delivery of and payment for the Securities or (B) acceptance of the Securities and payment for them hereunder.&#160; The provisions of Section 7, Section 9, this Section 11, Section 12 and Section 19 shall survive the
          termination or cancellation of this Agreement pursuant to Section 8(i).</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">12.</font>&#160;&#160; &#160; &#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">If this Agreement shall be terminated pursuant to
          Section 10 hereof, the Company shall not then be under any liability to any Underwriter except as provided in Sections 7 and 9 hereof; but, if for any other reason, the Securities are not delivered by or on behalf of the Company as provided
          herein, the Company will reimburse the Underwriters through you for all out of pocket expenses approved in writing by you, including reasonable fees and disbursements of counsel, reasonably incurred by the Underwriters in making preparations for
          the purchase, sale and delivery of the Securities, but the Company shall then be under no further liability to any Underwriter except as provided in Sections 7 and 9 hereof.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">13.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">In all dealings hereunder, you shall act on behalf
          of each of the Underwriters, and the parties hereto shall be entitled to act and rely upon any statement, request, notice or agreement on behalf of any Underwriter made or given by you jointly.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">All statements, requests, notices and agreements hereunder shall be in writing, and if to the Underwriters shall be delivered or sent by mail, telex
        or facsimile transmission to you as the Representatives in care of: Truist Securities, Inc., 3333 Peachtree Road, 11th Floor, Atlanta, Georgia 30326, Attention: Investment Grade Debt Capital Markets, Facsimile: (404) 926-5027, Wells Fargo
        Securities, LLC, 550 South Tryon Street, 5th Floor, Charlotte, North Carolina 28202, Attention: Transaction Management, Email: tmgcapitalmarkets@wellsfargo.com, BofA Securities, Inc., 114 W. 47th Street, NY8-114-07-01, New York, New York 10036,
        Attention: High Grade Transaction Management/Legal, Facsimile: (646) 855-5958, Goldman Sachs &amp; Co. LLC, 200 West Street, New York, New York 10282, Attention: Registration Department and U.S. Bancorp Investments, Inc., 214 N. Tryon Street, 26th
        Floor, Charlotte, North Carolina 28202, Attention: Credit Fixed Income, Facsimile: 704-335-2393; and if to the Company shall be delivered or sent by mail, telex or facsimile transmission to the address of the Company set forth in the Registration
        Statement, Attention: Secretary; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">however</font>, that any
        notice to an Underwriter pursuant to Section 9(c) hereof shall be delivered or sent by mail, telex or facsimile transmission to such Underwriter at its address set forth in its Underwriters&#8217; Questionnaire, or telex constituting such Questionnaire,
        which address will be supplied to the Company by you upon request.&#160; Any such statements, requests, notices or agreements shall take effect upon receipt thereof.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-20-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), the Underwriters are
        required to obtain, verify and record information that identifies their respective clients, including the Company, which information may include the name and address of their respective clients, as well as other information that will allow the
        underwriters to properly identify their respective clients.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">14.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">This Agreement shall be binding upon, and inure
          solely to the benefit of, the Underwriters, the Company and, to the extent provided in Sections 9 and 11 hereof, the officers and directors of the Company and each person who controls the Company or any Underwriter, and their respective heirs,
          executors, administrators, successors and assigns, and no other person shall acquire or have any right under or by virtue of this Agreement.&#160; No purchaser of any of the Securities from any Underwriter shall be deemed a successor or assign by
          reason merely of such purchase.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">15.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Time shall be of the essence of this Agreement.&#160; As
          used herein, the term &#8220;business day&#8221; shall mean any day when the Commission&#8217;s office in Washington, D.C. is open for business.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">16.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Company acknowledges and agrees that (i) the
          purchase and sale of the Securities pursuant to this Agreement is an arm&#8217;s-length commercial transaction between the Company, on the one hand, and the several Underwriters, on the other, (ii) in connection therewith and with the process leading
          to such transaction each Underwriter is acting solely as a principal and not the agent, fiduciary or financial advisor of the Company, (iii) no Underwriter has assumed an advisory or fiduciary responsibility in favor of the Company with respect
          to the offering contemplated hereby or the process leading thereto (irrespective of whether such Underwriter has advised or is currently advising the Company on other matters) or any other obligation to the Company except the obligations
          expressly set forth in this Agreement, (iv) the Company has consulted its own legal and financial advisors to the extent it deemed appropriate and (v) none of the activities of the Underwriters in connection with the transactions contemplated
          herein constitutes a recommendation, investment advice, or solicitation of any action by the Underwriters with respect to any entity or natural person.&#160; The Company agrees that it will not claim that the Underwriters, or any of them, has rendered
          advisory services of any nature or respect, or owes a fiduciary or similar duty to the Company, in connection with such transaction or the process leading thereto.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">17.</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">It is understood and agreed among the parties hereto
          that the Representatives are primarily responsible for managing the offering of the Securities.&#160; Further, the Company confirms that, pursuant to its agreement with the other Underwriters, no such other Underwriter is or will be primarily
          responsible for managing the offering of the Securities.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">18.</font>&#160;&#160; &#160; &#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">This Agreement supersedes all prior agreements and
          understandings (whether written or oral) between the Company and the Underwriters, or any of them, with respect to the subject matter hereof.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">19.</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED AND
          INTERPRETED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICTS OF LAW PRINCIPLES THEREOF.&#160; THE COMPANY (ON ITS BEHALF AND TO THE EXTENT PERMITTED BY APPLICABLE LAW, ON BEHALF OF ITS SHAREHOLDERS AND
          AFFILIATES) AND EACH OF THE UNDERWRITERS HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO
          THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY).&#160; EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR
          OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE
          MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 19.</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-21-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">20.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Any legal suit, action or proceeding arising out of
          or based upon this Agreement or the transactions contemplated hereby (&#8220;Related Proceedings&#8221;) shall be instituted in the federal courts of the United States of America located in the City and County of New York or the courts of the State of New
          York in each case located in the City and County of New York in the Borough of Manhattan (collectively, the &#8220;Specified Courts&#8221;), and each party irrevocably submits to the exclusive jurisdiction (except for suits, actions, or proceedings
          instituted in regard to the enforcement of a judgment of any Specified Court in a Related Proceeding (a &#8220;Related Judgment&#8221;), as to which such jurisdiction is non-exclusive) of the Specified Courts in any Related Proceeding.&#160; Service of any
          process, summons, notice or document by mail to such party&#8217;s address set forth above shall be effective service of process for any Related Proceeding brought in any Specified Court.&#160; The parties irrevocably and unconditionally waive any objection
          to the laying of venue of any Related Proceeding in the Specified Courts and irrevocably and unconditionally waive and agree not to plead or claim in any Specified Court that any Related Proceeding brought in any Specified Court has been brought
          in an inconvenient forum.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">21.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">This Agreement constitutes the entire agreement of
          the parties to this Agreement and supersedes all prior written or oral and all contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof.&#160; This Agreement may be executed in two or more
          counterparts, each one of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.&#160; Any signature to this Agreement may be delivered by facsimile, electronic mail (including pdf) or
          any electronic signature complying with the U.S. Federal ESIGN Act of 2000 or the New York Electronic Signature and Records Act or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered
          and be valid and effective for all purposes to the fullest extent permitted by applicable law.&#160; Each of the parties hereto represents and warrants to the other parties that it has the capacity and authority to execute this Agreement through
          electronic means.&#160; This Agreement may not be amended or modified unless in writing by all of the parties hereto, and no condition herein (express or implied) may be waived unless waived in writing by each party whom the condition is meant to
          benefit.&#160; The Section headings herein are for the convenience of the parties only and shall not affect the construction or interpretation of this Agreement.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">22.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Notwithstanding anything herein to the contrary,
          the Company is authorized to disclose to any persons the U.S. federal and state income tax treatment and tax structure of the potential transaction and all materials of any kind (including tax opinions and other tax analyses) provided to the
          Company relating to that treatment and structure, without the Underwriters, imposing any limitation of any kind.&#160; However, any information relating to the tax treatment and tax structure shall remain confidential (and the foregoing sentence shall
          not apply) to the extent necessary to enable any person to comply with securities laws.&#160; For this purpose, &#8220;tax structure&#8221; is limited to any facts that may be relevant to that treatment.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">23.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Recognition of the U.S. Special Resolution Regimes.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">In the event that any
          Underwriter that is a Covered Entity (as defined below) becomes subject to a proceeding under a U.S. Special Resolution Regime (as defined below), the transfer from such Underwriter of this Agreement, and any interest and obligation in or under
          this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of
          the United States.</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-22-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">In the event that any of the
          Underwriters that is a Covered Entity or a BHC Act Affiliate (as defined below) of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights (as defined below) under this Agreement that may be
          exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state
          of the United States.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">For purposes of this Section 23, (i) the term &#8220;BHC Act Affiliate&#8221; has the meaning assigned to the term &#8220;affiliate&#8221; in, and shall be interpreted in
        accordance with, 12 U.S.C. &#167; 1841(k); (ii) &#8220;Covered Entity&#8221; means any of the following: (x) a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b), (y) a &#8220;covered bank&#8221; as that term is defined in,
        and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b), or (z) a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b); (iii) &#8220;Default Right&#8221; has the meaning assigned to that term in, and shall be
        interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable; and (iv) &#8220;U.S. Special Resolution Regime&#8221; means each of (x) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (y) Title II of the
        Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">24.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">If the foregoing is in accordance with your
          understanding, please sign and return to us a counterpart hereof, and upon the acceptance hereof by you, on behalf of each of the Underwriters, this Agreement and such acceptance hereof shall constitute a binding agreement between each of the
          Underwriters and the Company.&#160; It is understood that your acceptance of this Agreement on behalf of each of the Underwriters is pursuant to the authority set forth in a form of Agreement among Underwriters, the form of which shall be submitted to
          the Company for examination upon request, but without warranty on your part as to the authority of the signers thereof.</font></div>
      <div>&#160;</div>
      <div style="text-align: center; text-indent: 27pt; font-family: 'Times New Roman'; font-size: 10pt;">[Signatures Follow on Next Page]</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal; color: rgb(0, 0, 0);">-23-</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc9e511da3c334071a421714afe4626e7">

          <tr>
            <td colspan="1" style="width: 49%; vertical-align: top;"><br>
            </td>
            <td colspan="3" rowspan="1" style="vertical-align: top;">
              <div><font style="font-family: 'Times New Roman'; font-size: 10pt;">Very truly yours,</font></div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 49%; vertical-align: top;"><br>
            </td>
            <td colspan="3" rowspan="1" style="vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 49%; vertical-align: top;"><br>
            </td>
            <td colspan="3" rowspan="1" style="vertical-align: top;">
              <div><font style="font-family: 'Times New Roman'; font-size: 10pt;">VULCAN MATERIALS COMPANY</font></div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 49%; vertical-align: top;"><br>
            </td>
            <td colspan="3" rowspan="1" style="vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 49%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">By:</font></div>
            </td>
            <td style="width: 23.5%; vertical-align: top; border-bottom: 2px solid black;">
              <div><font style="font-family: 'Times New Roman'; font-size: 10pt;">/s/ Mary Andrews Carlisle</font></div>
            </td>
            <td style="width: 23.5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="1" style="width: 53%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Name:<br>
                </font></div>
            </td>
            <td style="width: 42%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Mary Andrews Carlisle</font></td>
          </tr>
          <tr>
            <td colspan="1" style="width: 53%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Title:<br>
                </font></div>
            </td>
            <td style="width: 42%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Senior Vice President and Chief </font><br>
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Financial Officer</font></div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[Signature Page to Underwriting Agreement]</div>
        <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5e7cf0982a2c415289817a0f5bdd4244">

          <tr>
            <td colspan="3" style="vertical-align: top;">
              <div><font style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Accepted as of the date hereof:</font></div>
            </td>
          </tr>
          <tr>
            <td colspan="3" rowspan="1" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td colspan="3" style="vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">TRUIST SECURITIES, INC.</font></div>
            </td>
          </tr>
          <tr>
            <td colspan="3" style="vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Acting as Representative of the</font></div>
            </td>
          </tr>
          <tr>
            <td colspan="3" style="vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">several underwriters named in</font></div>
            </td>
          </tr>
          <tr>
            <td colspan="3" style="vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">the attached Schedule I.</font></div>
            </td>
          </tr>
          <tr>
            <td colspan="3" rowspan="1" style="vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 5%; padding-bottom: 2px;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">By:</font></div>
            </td>
            <td style="vertical-align: top; width: 25%; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-size: 10pt;">/s/ Robert Nordlinger</font></td>
            <td style="vertical-align: top; width: 70%; padding-bottom: 2px;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
            <td style="vertical-align: top; width: 5%;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Name:<br>
                </font></div>
            </td>
            <td style="vertical-align: top; width: 90%;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Robert Nordlinger</font></td>
          </tr>
          <tr>
            <td colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
            <td style="vertical-align: top; width: 5%;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Title:<br>
                </font></div>
            </td>
            <td style="vertical-align: top; width: 90%;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Authorized Signatory</font></td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">WELLS FARGO SECURITIES, LLC</font></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Acting as Representative of the</font></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">several underwriters named in</font></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">the attached Schedule I.</font></div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="vertical-align: top; width: 5%; padding-bottom: 2px;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">By:</font></div>
            </td>
            <td style="vertical-align: top; width: 25%; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-size: 10pt;">/s/ Carolyn Hurley</font></td>
            <td style="vertical-align: top; width: 70%; padding-bottom: 2px;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
            <td style="vertical-align: top; width: 5%;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Name:<br>
                </font></div>
            </td>
            <td style="vertical-align: top; width: 90%;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Carolyn Hurley</font></td>
          </tr>
          <tr>
            <td colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
            <td style="vertical-align: top; width: 5%;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Title:<br>
                </font></div>
            </td>
            <td style="vertical-align: top; width: 90%;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Managing Director</font></td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="3" style="vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">BOFA SECURITIES, INC.</font></div>
            </td>
          </tr>
          <tr>
            <td colspan="3" style="vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Acting as Representative of the</font></div>
            </td>
          </tr>
          <tr>
            <td colspan="3" style="vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">several underwriters named in</font></div>
            </td>
          </tr>
          <tr>
            <td colspan="3" style="vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">the attached Schedule I.</font></div>
            </td>
          </tr>
          <tr>
            <td colspan="3" style="vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 5%; padding-bottom: 2px;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">By:</font></div>
            </td>
            <td style="vertical-align: top; width: 25%; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-size: 10pt;">/s/ Christopher Cote</font></td>
            <td style="vertical-align: top; width: 70%; padding-bottom: 2px;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="1" style="vertical-align: top; width: 5%;"><br>
            </td>
            <td style="vertical-align: top; width: 5%;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Name:<br>
                </font></div>
            </td>
            <td style="vertical-align: top; width: 90%;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Christopher Cote</font></td>
          </tr>
          <tr>
            <td colspan="1" style="vertical-align: top; width: 5%;"><br>
            </td>
            <td style="vertical-align: top; width: 5%;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Title:&#160; <br>
                </font></div>
            </td>
            <td style="vertical-align: top; width: 90%;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Managing Director</font></td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 99.9%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">GOLDMAN SACHS &amp; CO. LLC</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 99.9%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Acting as Representative of the</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 99.9%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">several underwriters named in</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 99.9%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">the attached Schedule I.</font></div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">By:</font></div>
            </td>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-size: 10pt;">/s/ Jonathan Zwart</font></td>
            <td style="width: 70%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Name:<br>
                </font></div>
            </td>
            <td style="width: 90%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Jonathan Zwart</font></td>
          </tr>
          <tr>
            <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Title:<br>
                </font></div>
            </td>
            <td style="width: 90%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Managing Director</font></td>
          </tr>

      </table>
      <div><br>
      </div>
      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[Signature Page to Underwriting Agreement]</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z7d0fb6fc9b5c49519268c50ea401333a">

          <tr>
            <td style="width: 99.9%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">U.S. BANCORP INVESTMENTS, INC.</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 99.9%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Acting as Representative of the</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 99.9%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">several underwriters named in</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 99.9%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">the attached Schedule I.</font></div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">By:</font></div>
            </td>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; font-size: 10pt;">/s/ Charles P. Carpenter</font></td>
            <td style="width: 70%; vertical-align: top; padding-bottom: 2px;"><br>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Name:<br>
                </font></div>
            </td>
            <td style="width: 90%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Charles P. Carpenter</font></td>
          </tr>
          <tr>
            <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Title:<br>
                </font></div>
            </td>
            <td style="width: 90%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Senior Vice President</font></td>
          </tr>

      </table>
      <div><br>
      </div>
      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[Signature Page to Underwriting Agreement]</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
        </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%Sch. I-%%-->
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SCHEDULE I</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" class="cfttable" id="z4d3d9b5b51c44039b63d16be0cbdf580" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

          <tr>
            <td valign="bottom" style="vertical-align: bottom;">
              <div style="text-align: left; text-indent: -3.55pt; margin-left: 3.55pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Underwriters</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Aggregate Principal</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Amount of</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2029 Notes to be</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Purchased</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Aggregate Principal</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Amount of</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2034 Notes to be<br>
                &#160;Purchased</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Aggregate Principal</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Amount of</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2054 Notes to be <br>
                Purchased</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 64%; background-color: #CCEEFF;">
              <div style="text-align: left; text-indent: -3.55pt; margin-left: 3.55pt; font-family: 'Times New Roman'; font-size: 10pt;">Truist Securities, Inc.</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">100,000,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">150,000,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">150,000,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 64%;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Wells Fargo Securities, LLC 1</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">87,500,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">127,500,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">127,500,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 64%; background-color: #CCEEFF;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">BofA Securities, Inc.</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">95,000,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">101,250,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">101,250,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 64%;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Goldman Sachs &amp; Co. LLC 1</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">65,000,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">138,750,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">101,250,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 64%; background-color: #CCEEFF;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Bancorp Investments, Inc.</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">65,000,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">101,250,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">138,750,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 64%;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Regions Securities LLC</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">67,500,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">101,250,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">101,250,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 64%; background-color: #CCEEFF;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">FHN Financial Securities Corp.<br>
              </div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">10,000,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">15,000,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">15,000,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 64%;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Siebert Williams Shank &amp; Co., LLC.<br>
              </div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">10,000,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">15,000,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">15,000,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 64%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 27pt;">Total</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
              <div>
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div>
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">500,000,000</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
              <div>
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div>
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">750,000,000</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">
              <div>
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div>
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">750,000,000</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">Sch. I-1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%Sch. II-%%-->
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SCHEDULE II</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb7615657286a4cf4bf741861db913ce7">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">Issuer Free Writing Prospectuses included in the Pricing Disclosure Package:</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: left; text-indent: -36pt; margin-left: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">None.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc6262ed9d7f04db28a1d51f148c6b7da">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">Issuer Free Writing Prospectuses not included in the Pricing Disclosure Package:</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: left; text-indent: -36pt; margin-left: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">None.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z629a03ef08ab4d60b624ec0628ae0556">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">Additional Documents Incorporated by Reference:</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: left; text-indent: -36pt; margin-left: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">None.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">Sch. II-1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SCHEDULE III</div>
      <div>&#160;</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pricing Term Sheet</div>
      <div>&#160;</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">See attached.</div>
      <div>&#160;</div>
      <div><br>
      </div>
      <div>
        <div style="text-align: center;">&#160;<font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">Sch. III-1</font></div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>ef20038893_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt; font-weight: normal;">
  </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: left;">
      <div style="text-align: right;"><font style="font-weight: bold; font-size: 10pt;">Exhibit 4.1</font><font style="font-size: 10pt; font-weight: normal;"><br>
        </font></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
        <div style="font-size: 10pt;">
          <div style="font-weight: normal; font-size: 10pt;"><br>
          </div>
          <div style="font-weight: normal; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">Execution Version</div>
          </div>
          <div style="font-weight: normal; font-size: 10pt;"><br>
          </div>
          <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">VULCAN MATERIALS COMPANY<font style="font-family: 'Times New Roman';"><br>
            <br>
            </font>and<font style="font-family: 'Times New Roman';"><br>
            <br>
            </font>REGIONS BANK,<font style="font-family: 'Times New Roman';"><br>
            <br>
            </font>as Trustee<font style="font-family: 'Times New Roman';"><br>
            <br>
            </font>ELEVENTH SUPPLEMENTAL INDENTURE<font style="font-family: 'Times New Roman';"><br>
            <br>
            </font>Dated as of November 20, 2024<font style="font-family: 'Times New Roman';"><br>
            <br>
            </font>to<font style="font-family: 'Times New Roman';"><br>
            <br>
            </font>SENIOR DEBT INDENTURE<font style="font-family: 'Times New Roman';"><br>
            <br>
            </font>Dated as of December 11, 2007<font style="font-family: 'Times New Roman';"><br>
            <br>
            </font>4.950% Senior Notes due 2029</div>
          <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.350% Senior Notes due 2034</div>
          <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.700% Senior Notes due 2054</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <!--PROfilePageNumberReset%LCR%1%-%-%-->
          <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">TABLE OF CONTENTS</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <table cellspacing="0" cellpadding="0" border="0" id="zb74f7f885f564e799d481c21dc11ef35" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">&#160;</td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">&#160;</td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';"><u>Page</u></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt;" colspan="3">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE I.</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt;" colspan="3">
                  <div style="text-align: center; font-family: 'Times New Roman';">DEFINITIONS</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 1.01</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Definition of Terms</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">2</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt;" colspan="3" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="3">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE II.</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt;" colspan="3">
                  <div style="text-align: center; font-family: 'Times New Roman';">GENERAL TERMS AND CONDITIONS OF THE 2029 NOTES</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="3" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 2.01</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Designation and Principal Amount</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">3</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 2.02</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Maturity</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">3</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 2.03</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Further Issues</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">4<br>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 2.04</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Form and Payment</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">4</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 2.05</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Global Securities</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">4</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 2.06</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Definitive Form</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">4</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 2.07</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Interest</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">4</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 2.08</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Authorized Denominations</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">4</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 2.09</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Redemption</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">5</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 2.10</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Change of Control.</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">5</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 2.11</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Appointment of Agents.</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">6</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 2.12</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Securities Filings.</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">6</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt;" colspan="3" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="3">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE III.</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt;" colspan="3">
                  <div style="text-align: center; font-family: 'Times New Roman';">GENERAL TERMS AND CONDITIONS OF THE 2034 NOTES</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="3" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 3.01</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Designation and Principal Amount</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">7</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 3.02</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Maturity</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">8</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 3.03</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Further Issues</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">8</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 3.04</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Form and Payment</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">8</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 3.05</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Global Securities</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">8</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 3.06</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Definitive Form</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">8</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 3.07</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Interest</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">9<br>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 3.08</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Authorized Denominations</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">9</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 3.09</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Redemption</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">9</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 3.10</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Change of Control.</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">9</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 3.11</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Appointment of Agents.</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">10</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 3.12</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Securities Filings.</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">11</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt;" colspan="3" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="3">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE IV.</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt;" colspan="3">
                  <div style="text-align: center; font-family: 'Times New Roman';">GENERAL TERMS AND CONDITIONS OF THE 2054 NOTES</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="3" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 4.01</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Designation and Principal Amount</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">12</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 4.02</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Maturity</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">12</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 4.03</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Further Issues</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">12</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 4.04</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Form and Payment</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">12</div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-i-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 4.05</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Global Securities</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">12</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 4.06</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Definitive Form</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">12</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 4.07</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Interest</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">13</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 4.08</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Authorized Denominations</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">13</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 4.09</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Redemption</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">13</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 4.10</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Change of Control.</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">13</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 4.11</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Appointment of Agents.</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">15</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 4.12</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Securities Filings.</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">15</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="3" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt;" colspan="3">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE V.</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="3">
                  <div style="text-align: center; font-family: 'Times New Roman';">FORM OF NOTES</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt;" colspan="3" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 5.01</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Form of 2029 Notes</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">16</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 5.02</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Form of 2034 Notes</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">16</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 5.03</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Form of 2054 Notes</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">16</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt;" colspan="3" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="3">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE VI.</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt;" colspan="3">
                  <div style="text-align: center; font-family: 'Times New Roman';">ORIGINAL ISSUE OF NOTES</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="3" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 6.01</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Original Issue of 2029 Notes</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">16</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 6.02</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Original Issue of 2034 Notes</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">16</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 6.03</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Original Issue of 2054 Notes</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">16</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="3" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt;" colspan="3">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE VII.</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="3">
                  <div style="text-align: center; font-family: 'Times New Roman';">MISCELLANEOUS</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: top; font-weight: normal; font-size: 10pt;" colspan="3" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 7.01</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Ratification of Indenture</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">17</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 7.02</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Trustee Not Responsible for Recitals</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">17</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 7.03</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Governing Law</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">17</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 7.04</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Separability</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">17</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Section 7.05</div>
                </td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Counterparts</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">17</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;">&#160;</td>
                <td style="width: 86%; vertical-align: top; font-weight: normal; font-size: 10pt;">&#160;</td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1" colspan="2">
                  <div style="text-align: left; font-family: 'Times New Roman';">EXHIBIT A Form of 2029 Note</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">A-1</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt;" rowspan="1" colspan="2">
                  <div style="text-align: left; font-family: 'Times New Roman';">EXHIBIT B Form of 2034 Note</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">B-1</div>
                </td>
              </tr>
              <tr>
                <td style="width: 10%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1" colspan="2">
                  <div style="text-align: left; font-family: 'Times New Roman';">EXHIBIT C Form of 2054 Note</div>
                </td>
                <td style="width: 4%; vertical-align: top; font-weight: normal; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: right;">C-1</td>
              </tr>

          </table>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-ii-</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">ELEVENTH SUPPLEMENTAL INDENTURE, dated as of November 20, 2024 (this &#8220;<font style="font-family: 'Times New Roman';"><u>Supplemental Indenture</u></font>&#8221;), between Vulcan Materials Company, a corporation duly organized and existing under the laws of the State of New Jersey, having its principal office at 1200 Urban Center Drive, Birmingham,
            Alabama 35242 (the &#8220;<font style="font-family: 'Times New Roman';"><u>Company</u></font>&#8221;), and Regions Bank, an Alabama banking corporation, as trustee (the &#8220;<font style="font-family: 'Times New Roman';"><u>Trustee</u></font>&#8221;).</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">WHEREAS, the Company executed and delivered the Senior Debt Indenture, dated as of December 11, 2007, to
            Wilmington Trust Company, as initial trustee (succeeded by Regions Bank) (as heretofore supplemented, the &#8220;<font style="font-family: 'Times New Roman';"><u>Indenture</u></font>&#8221;), to provide for the issuance of the Company&#8217;s notes or
            other evidences of indebtedness (the &#8220;<font style="font-family: 'Times New Roman';"><u>Securities</u></font>&#8221;), to be issued in one or more series;</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">WHEREAS, pursuant to the terms of the Indenture, the Company desires to provide for the establishment of new
            series of its notes under the Indenture to be known as its: (a) &#8220;4.950% Senior Notes due 2029&#8221; (the &#8220;<font style="font-family: 'Times New Roman';"><u>2029 Notes</u></font>&#8221;), (b) &#8220;5.350% Senior Notes due 2034&#8221; (the &#8220;<font style="font-family: 'Times New Roman';"><u>2034 Notes</u></font>&#8221;) and (c) &#8220;5.700% Senior Notes due 2054&#8221; (the &#8220;<font style="font-family: 'Times New Roman';"><u>2054 Notes</u></font>&#8221; and, together with the 2029 Notes and
            the 2034 Notes, the &#8220;<font style="font-family: 'Times New Roman';"><u>Notes</u></font>&#8221;),<font style="font-family: 'Times New Roman'; color: rgb(255, 0, 0);">&#160;</font>the form and substance of each such series and the terms,
            provisions and conditions thereof to be set forth as provided in the Indenture and this Supplemental Indenture;</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">WHEREAS, for the purpose of issuing the 2029 Notes, the 2034 Notes and the 2054 Notes, the Company wishes to
            enter into this Supplemental Indenture;</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">WHEREAS, the Board of Directors of the Company (the &#8220;<font style="font-family: 'Times New Roman';"><u>Board</u></font>&#8221;)
            on October 11, 2024, and the Pricing Committee (appointed by the Board on October 11, 2024) on November 18, 2024, have duly adopted resolutions, and through such resolutions have duly authorized (i) the issuance of each of the 2029 Notes, the
            2034 Notes and the 2054 Notes and (ii) the proper officers of the Company to execute any and all appropriate documents necessary or appropriate to effect each such issuance;</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">WHEREAS, this Supplemental Indenture is being entered into pursuant to the provisions of Article Two and Section
            901(7) of the Indenture;</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">WHEREAS, the Company has requested that the Trustee execute and deliver this Supplemental Indenture; and</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">WHEREAS, all things necessary to make this Supplemental Indenture a valid agreement of the Company, in accordance
            with its terms, and to make each of the 2029 Notes, the 2034 Notes and the 2054 Notes, when executed by the Company and authenticated and delivered by the Trustee or an authentication agent, the valid obligations of the Company, have been
            performed, and the execution and delivery of this Supplemental Indenture has been duly authorized in all respects;</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">NOW THEREFORE, in consideration of the premises and the purchase and acceptance of each of the 2029 Notes, the
            2034 Notes and the 2054 Notes by the Holders thereof, and for the purpose of setting forth, as provided in the Indenture, the forms and terms of each of the 2029 Notes, the 2034 Notes and the 2054 Notes, the Company covenants and agrees, with
            the Trustee, as follows:</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <!--PROfilePageNumberReset%Num%2%-%-%-->
          <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ARTICLE I.</font></div>
          <div style="text-align: center; font-weight: bold;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';">DEFINITIONS</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 1.01</font><font style="font-weight: normal; font-size: 10pt;">&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Definition of Terms</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">Unless the context otherwise requires:</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 99pt;">each term defined in the Indenture has the same meaning when used in this Supplemental Indenture;</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 99pt;">the singular includes the plural and vice versa; and</div>
          <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 99pt;">&#160;</div>
          <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 99pt;">headings are for convenience of reference only and do not affect interpretation.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Below Investment Grade Ratings Event</u></font>&#8221;
            means that on any day commencing 60 days prior to the first public announcement by the Company of any Change of Control (or pending Change of Control) and ending 60 days following consummation of such Change of Control (which period will be
            extended following consummation of a Change of Control for up to an additional 60 days for so long as either of the Rating Agencies has publicly announced that it is considering a possible ratings change), the applicable series of Notes are
            downgraded to a rating that is below Investment Grade by each of the Rating Agencies (regardless of whether the rating prior to such downgrade was Investment Grade or below Investment Grade).</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Change of Control</u></font>&#8221; means the occurrence of any of
            the following:&#160; (1) the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act) (other than the Company
            or one of its subsidiaries) becomes the beneficial owner (as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the Voting Stock of the Company or other Voting Stock into which the Voting Stock
            of the Company is reclassified, consolidated, exchanged or changed, measured by voting power rather than number of shares; (2) the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or
            consolidation), in one or more series of related transactions, of all or substantially all of the assets of the Company and the assets of its subsidiaries, taken as a whole, to one or more Persons (other than the Company or one of its
            subsidiaries); or (3) the first day on which a majority of the members of the Board of Directors of the Company is composed of members who are not Continuing Directors.&#160; Notwithstanding the foregoing, a transaction will not be deemed to involve
            a Change of Control if (1) the Company becomes a direct or indirect wholly-owned subsidiary of a holding company and (2)(A) the direct or indirect holders of the Voting Stock of such holding company immediately following that transaction are
            substantially the same as the holders of the Voting Stock of the Company immediately prior to that transaction or (B) immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence)
            is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of such holding company.</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Change of Control Repurchase Event</u></font>&#8221; means, with
            respect to a series of Notes, the occurrence of both a Change of Control and a Below Investment Grade Ratings Event.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-2-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Continuing Directors</u></font>&#8221; means, as of any date of
            determination, any member of the Company&#8217;s Board of Directors who (1) was a member of such Board of Directors on the date the applicable series of Notes were initially issued or (2) was nominated for election, elected or appointed to such Board
            of Directors with the approval of a majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination, election or appointment (either by a specific vote or by approval of the Company&#8217;s proxy
            statement in which such member was named as a nominee for election as a director, without objection to such nomination).</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Investment Grade</u></font>&#8221; means a rating of Baa3 or better
            by Moody&#8217;s (or its equivalent under any successor rating categories of Moody&#8217;s); a rating of BBB- or better by S&amp;P (or its equivalent under any successor rating categories of S&amp;P); and the equivalent investment grade credit rating from
            any additional Rating Agency or Rating Agencies selected by the Company.</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Moody&#8217;s</u></font>&#8221; means Moody&#8217;s Investors Service, Inc. or
            any successor to its rating agency business.</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Rating Agency</u></font>&#8221; means (a) each of Moody&#8217;s and
            S&amp;P; and (b) if either of Moody&#8217;s or S&amp;P ceases to rate the applicable series of Notes or fails to make a rating of the applicable series of Notes publicly available for reasons outside of the Company&#8217;s control, a &#8220;nationally recognized
            statistical rating organization&#8221; within the meaning of Section 3(a)(62) under the Exchange Act, selected by the Company (and certified by a resolution of the Company&#8217;s Board of Directors) as a replacement agency for the agency that ceased such
            rating or failed to make it publicly available.</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>S&amp;P</u></font>&#8221; means S&amp;P Global Ratings, a division of
            S&amp;P Global Inc. or any successor to its rating agency business.</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Voting Stock</u></font>&#8221; of any specified &#8220;person&#8221; (as that
            term is used in Section 13(d)(3) of the Exchange Act) as of any date means the capital stock of such person that is at the time entitled to vote generally in the election of the board of directors of such person.</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#160;</div>
          <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ARTICLE II.</font><font style="font-weight: bold; font-size: 10pt;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><br>
                </font>GENERAL TERMS AND CONDITIONS OF THE 2029 NOTES</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 2.01</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Designation and Principal Amount</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">There is hereby authorized and established a series of Securities under the Indenture, designated as the &#8220;4.950% Senior
            Notes due 2029,&#8221; which is not limited in aggregate principal amount.&#160; The aggregate principal amount of the 2029 Notes to be issued shall be as set forth in any Company Order for the authentication and delivery of the 2029 Notes, pursuant to
            Section 303 of the Indenture.</div>
          <div>&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 2.02</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Maturity</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The Stated Maturity of principal for the 2029 Notes will be December 1, 2029.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-3-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 2.03</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Further Issues</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The Company may from time to time, without the consent of the Holders of the 2029 Notes, issue additional notes of that
            series.&#160; Any such additional notes will have the same ranking, interest rate, maturity date and other terms as the 2029 Notes.&#160; Any such additional notes, together with the 2029 Notes herein provided for, will constitute a single series of
            Securities under the Indenture. Any such additional notes will not be offered with the same CUSIP number as the 2029 Notes unless such additional notes are considered to be fungible for U.S. federal income tax purposes with the 2029 Notes.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 2.04</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Form and Payment</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">Principal of, premium, if any, and interest on the 2029 Notes shall be payable in U.S. dollars.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 2.05</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Global Securities</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">Upon the original issuance, the 2029 Notes will be represented by one or more Global Securities registered in the name of
            Cede &amp; Co., the nominee of the Depository Trust Company (&#8220;<font style="font-family: 'Times New Roman';"><u>DTC</u></font>&#8221;).&#160; The Company will issue the 2029 Notes in denominations of $2,000.00 and integral multiples of $1,000.00
            in excess thereof and will deposit the Global Securities with DTC or its custodian and register the Global Securities in the name of Cede &amp; Co.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 2.06</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Definitive Form</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">If (a) the Depositary is at any time unwilling or unable to continue as depositary or ceases to be a registered clearing
            agency and, in either case, a successor depositary is not appointed by the Company within 90 days of notice thereof, (b) an Event of Default has occurred with regard to the 2029 Notes and has not been cured or waived, or (c) the Company at any
            time and in its sole discretion determines not to have the 2029 Notes represented by Global Securities, the Company may issue the 2029 Notes in definitive form in exchange for such Global Securities.&#160; In any such instance, an owner of a
            beneficial interest in 2029 Notes will be entitled to physical delivery in definitive form of 2029 Notes, equal in principal amount to such beneficial interest and to have the 2029 Notes registered in its name as shall be established in a
            Company Order.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 2.07</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Interest</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The 2029 Notes will bear interest (computed on the basis of a 360-day year consisting of twelve 30-day months) from
            November 20, 2024 at the rate of 4.950% per annum, payable semi-annually; interest payable on each Interest Payment Date will include interest accrued from November 20, 2024 or from the most recent Interest Payment Date to which interest has
            been paid or duly provided for; the Interest Payment Dates on which such interest shall be payable are June 1 and December 1, commencing on June 1, 2025; and the record date for the interest payable on any Interest Payment Date is the close of
            business on May 15 or November 15 (whether or not such day is a Business Day), as the case may be, next preceding the relevant Interest Payment Date.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 2.08</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Authorized Denominations</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The 2029 Notes shall be issuable in denominations of $2,000.00 and integral multiples of $1,000.00 in excess thereof.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-4-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 2.09</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Redemption</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The 2029 Notes are subject to redemption at the option of the Company as set forth in the form of 2029 Note attached as <font style="font-family: 'Times New Roman';"><u>Exhibit A</u></font> hereto.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 2.10</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Change of Control</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(a)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Upon the occurrence of a Change of Control Repurchase Event, unless the Company has exercised its right to redeem all of the 2029
                Notes in accordance with the redemption terms as set forth in the 2029 Notes or has defeased the 2029 Notes as set forth in the 2029 Notes, the Company shall make an irrevocable offer to each Holder of the 2029 Notes to repurchase all or
                any part (equal to or in excess of $2,000.00 and in integral multiples of $1,000.00) of such Holder&#8217;s 2029 Notes at a repurchase price in cash equal to 101% of the aggregate principal amount of 2029 Notes repurchased plus accrued and unpaid
                interest, if any, on the 2029 Notes repurchased to, but not including, the date of repurchase.</font></font></div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(b)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Within 30 days following a Change of Control Repurchase Event or, at the Company&#8217;s option, prior to a Change of Control, but in
                either case, after the public announcement of such Change of Control, the Company shall mail, or shall cause to be mailed, a notice to each Holder of the 2029 Notes, with a copy to the Trustee:</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; text-indent: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(i) &#160; &#160; &#160; &#160; &#160;&#160; </font><font style="font-weight: normal;"><font style="font-weight: normal;">de</font>scribing the transaction or transactions that constitute or may constitute the Change of Control Repurchase Event;</font></div>
              <div style="text-align: justify; font-family: 'Times New Roman';"><font style="font-weight: normal;"> <br>
                </font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; text-indent: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: normal;">offering
                  to repurchase all 2029 Notes tendered;</font></div>
              <div style="text-align: justify; font-family: 'Times New Roman';"><font style="font-weight: normal;"> <br>
                </font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: normal;">setting forth the payment date (the &#8220;<font style="font-family: 'Times New Roman';"><u>2029 Change of Control Payment Date</u></font>&#8221;) for the repurchase of the 2029 Notes, which date will be no
                  earlier than 30 days and no later than 60 days from the date such notice is mailed;<br>
                  <br>
                </font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: normal;">if mailed prior to the date of consummation of the Change of Control, stating that the offer to repurchase is conditioned on a Change of Control Repurchase Event occurring on or prior to the 2029 Change of
                  Control Payment Date specified in such notice;</font></div>
              <div style="text-align: justify; font-family: 'Times New Roman';"><font style="font-weight: normal;"> <br>
                </font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: normal;">disclosing that any 2029 Note not tendered for repurchase will continue to accrue interest; and</font></div>
              <div style="text-align: justify; font-family: 'Times New Roman';"><font style="font-weight: normal;"> <br>
                </font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: normal;">specifying the procedures for tendering 2029 Notes.</font></div>
              <div style="text-align: justify; font-family: 'Times New Roman';"><font style="font-weight: normal;"> <br>
                </font></div>
            </div>
          </div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(c)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company shall comply with the requirements of Rule 14e-1 under the Exchange Act, and any other securities laws and regulations
                thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the 2029 Notes as a result of a Change of Control Repurchase Event.&#160; To the extent that the provisions of any securities laws or
                regulations conflict with the Change of Control Repurchase Event provisions of the 2029 Notes, the Company will comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations under the
                Change of Control Repurchase Event provisions of the 2029 Notes by virtue of such conflict.</font></font></div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-5-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(d)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">On the 2029 Change of Control Payment Date, the Company shall, to the extent lawful:</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(i) &#160; &#160; &#160; &#160; &#160;&#160; </font><font style="font-weight: normal;">accept for payment all 2029 Notes or portions thereof properly tendered pursuant to such offer;</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;"> <br>
                </font></div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(ii) &#160; &#160; &#160; &#160;&#160; </font><font style="font-weight: normal;">deposit with the Paying Agent an amount equal to the aggregate purchase price in respect of all 2029 Notes or portions thereof properly tendered; and</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;"> <br>
                </font></div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(iii) &#160; &#160; &#160; &#160; </font><font style="font-weight: normal;">deliver or cause to be delivered to the Trustee the 2029 Notes properly accepted, together with an Officers&#8217; Certificate stating the aggregate principal amount of 2029 Notes or portions thereof being repurchased by the Company.</font></div>
            </div>
          </div>
          <div style="margin-left: 63pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;"> <br>
            </font></div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(e)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Upon receipt of the required funds, the Paying Agent will promptly distribute to each Holder of the 2029 Notes properly tendered the
                purchase price for such 2029 Notes deposited with the Paying Agent by the Company, the Company will execute and the Trustee, upon the execution and delivery by the Company of such 2029 Notes, will promptly authenticate and deliver (or cause
                to be transferred by book-entry) to each Holder a new 2029 Note equal in principal amount to any unpurchased portion of any 2029 Notes surrendered; provided that each new 2029 Note will be in a principal amount of an integral multiple of
                $1,000.00.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(f)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company shall not be required to make an offer to repurchase the 2029 Notes upon a Change of Control Repurchase Event if a third
                party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the Company and such third party purchases all 2029 Notes properly tendered and not withdrawn under its offer.&#160; In
                addition, the Company shall not repurchase any 2029 Notes if there has occurred and is continuing on the 2029 Change of Control Payment Date an Event of Default in respect of any series of notes under the Indenture, other than a default in
                the payment of all or any portion of the aggregate purchase price in respect of all 2029 Notes or portions thereof properly tendered in connection with a Change of Control Repurchase Event.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 2.11</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Appointment of Agents</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">Regions Bank will initially be the Security Registrar and Paying Agent for the 2029 Notes and will act as such only at its
            offices at Regions Bank, Corporate Trust Department, 1900 5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Avenue North, 26<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor, Birmingham, Alabama 35203; or any other address that the Securities Registrar and Paying Agent may designate with respect to itself
            from time to time by notice to the Trustee, the Company and the Holders.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 2.12</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Securities Filings</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(a)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Notwithstanding that the Company is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act or is otherwise
                required to report on an annual and quarterly basis on forms provided for in those annual and quarterly reporting pursuant to rules and regulations promulgated by the Commission, so long as the 2029 Notes are outstanding (unless defeased in
                a legal defeasance), the Company will (x) file with the Commission (unless the Commission will not accept such filing), and (y) make available to the Trustee and, upon written request, the Holders of the 2029 Notes, without cost to any such
                Holder, from the date that the 2029 Notes are issued:</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-6-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(i) &#160; &#160; &#160; &#160; &#160; </font><font style="font-weight: normal;">within the time periods specified by the Exchange Act (including all applicable extension periods), an annual report on Form 10-K (or any successor or comparable form) containing the information required to be contained therein
                  (or required in such successor or comparable form); and</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;"> <br>
                </font></div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: normal;">within the time periods specified by the Exchange Act (including all applicable extension periods), a quarterly report on Form 10-Q (or any successor or comparable form) containing the information required to be contained therein
                  (or required in such successor or comparable form).</font></div>
            </div>
          </div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;"> <br>
            </font></div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(b)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">In the event that the Company is not permitted to file its annual or quarterly reports with the Commission pursuant to the Exchange
                Act, the Company shall nevertheless make available such Exchange Act reports to the Trustee and the Holders of the 2029 Notes as if the Company was subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act within the
                time periods specified by the Exchange Act (including all applicable extension periods), which requirement may be satisfied by posting such reports on the Company&#8217;s website within the applicable time periods specified in Sections 2.12(a)(i)
                and (a)(ii) above.</font></font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(c)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Notwithstanding the foregoing, the availability of the reports referred to in Sections 2.12(a)(i) and (a)(ii) above on the
                Commission&#8217;s Electronic Data Gathering, Analysis and Retrieval system (or any successor system, including the Commission&#8217;s Interactive Data Electronic Application system) and the Company&#8217;s website within the applicable time periods
                specified in Sections 2.12(a)(i) and (a)(ii) above will be deemed to satisfy the delivery obligations under this Section 2.12.</font></font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(d)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Delivery of reports, information and documents to the Trustee and, if applicable, to the Security Registrar and Paying Agent is for
                informational purposes only and their respective receipt of such reports shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company&#8217;s or any other
                Person&#8217;s compliance with any of its covenants under the Indenture, this Supplemental Indenture or the 2029 Notes (as to which the Trustee, Security Registrar and Paying Agent are entitled to rely exclusively on Officers&#8217; Certificates).&#160;
                None of the Trustee, the Security Registrar or Paying Agent shall be obligated to monitor or confirm, on a continuing basis or otherwise, the Company&#8217;s or any other Person&#8217;s compliance with the covenants described herein or with respect to
                any reports or other documents filed under the Indenture or this Supplemental Indenture.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ARTICLE III.</font><font style="font-weight: bold; font-size: 10pt;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><br>
                </font>GENERAL TERMS AND CONDITIONS OF THE 2034 NOTES</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 3.01</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Designation and Principal Amount</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">There is hereby authorized and established a series of Securities under the Indenture, designated as the &#8220;5.350% Senior
            Notes due 2034,&#8221; which is not limited in aggregate principal amount.&#160; The aggregate principal amount of the 2034 Notes to be issued shall be as set forth in any Company Order for the authentication and delivery of the 2034 Notes, pursuant to
            Section 303 of the Indenture.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-7-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 3.02</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Maturity</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The Stated Maturity of principal for the 2034 Notes will be December 1, 2034.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 3.03</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Further Issues</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The Company may from time to time, without the consent of the Holders of the 2034 Notes, issue additional notes of that
            series.&#160; Any such additional notes will have the same ranking, interest rate, maturity date and other terms as the 2034 Notes.&#160; Any such additional notes, together with the 2034 Notes herein provided for, will constitute a single series of
            Securities under the Indenture. Any such additional notes will not be offered with the same CUSIP number as the 2034 Notes unless such additional notes are considered to be fungible for U.S. federal income tax purposes with the 2034 Notes.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 3.04</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Form and Payment</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">Principal of, premium, if any, and interest on the 2034 Notes shall be payable in U.S. dollars.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 3.05</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Global Securities</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">Upon the original issuance, the 2034 Notes will be represented by one or more Global Securities registered in the name of
            Cede &amp; Co., the nominee of DTC.&#160; The Company will issue the 2034 Notes in denominations of $2,000.00 and integral multiples of $1,000.00 in excess thereof and will deposit the Global Securities with DTC or its custodian and register the
            Global Securities in the name of Cede &amp; Co.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 3.06</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Definitive Form</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">If (a) the Depositary is at any time unwilling or unable to continue as depositary or ceases to be a registered clearing
            agency and, in either case, a successor depositary is not appointed by the Company within 90 days of notice thereof, (b) an Event of Default has occurred with regard to the 2034 Notes and has not been cured or waived, or (c) the Company at any
            time and in its sole discretion determines not to have the 2034 Notes represented by Global Securities, the Company may issue the 2034 Notes in definitive form in exchange for such Global Securities.&#160; In any such instance, an owner of a
            beneficial interest in 2034 Notes will be entitled to physical delivery in definitive form of 2034 Notes, equal in principal amount to such beneficial interest and to have the 2034 Notes registered in its name as shall be established in a
            Company Order.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-8-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 3.07</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Interest</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The 2034 Notes will bear interest (computed on the basis of a 360-day year consisting of twelve 30-day months) from
            November 20, 2024 at the rate of 5.350% per annum, payable semi-annually; interest payable on each Interest Payment Date will include interest accrued from November 20, 2024 or from the most recent Interest Payment Date to which interest has
            been paid or duly provided for; the Interest Payment Dates on which such interest shall be payable are June 1 and December 1, commencing on June 1, 2025; and the record date for the interest payable on any Interest Payment Date is the close of
            business on May 15 or November 15 (whether or not such day is a Business Day), as the case may be, next preceding the relevant Interest Payment Date.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 3.08</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Authorized Denominations</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The 2034 Notes shall be issuable in denominations of $2,000.00 and integral multiples of $1,000.00 in excess thereof.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 3.09</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Redemption</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The 2034 Notes are subject to redemption at the option of the Company as set forth in the form of 2034 Note attached as <font style="font-family: 'Times New Roman';"><u>Exhibit B</u></font> hereto.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 3.10</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Change of Control</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(a)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Upon the occurrence of a Change of Control Repurchase Event, unless the Company has exercised its right to redeem all of the 2034
                Notes in accordance with the redemption terms as set forth in the 2034 Notes or has defeased the 2034 Notes as set forth in the 2034 Notes, the Company shall make an irrevocable offer to each Holder of the 2034 Notes to repurchase all or
                any part (equal to or in excess of $2,000.00 and in integral multiples of $1,000.00) of such Holder&#8217;s 2034 Notes at a repurchase price in cash equal to 101% of the aggregate principal amount of 2034 Notes repurchased plus accrued and unpaid
                interest, if any, on the 2034 Notes repurchased to, but not including, the date of repurchase.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(b)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Within 30 days following a Change of Control Repurchase Event or, at the Company&#8217;s option, prior to a Change of Control, but in
                either case, after the public announcement of such Change of Control, the Company shall mail, or shall cause to be mailed, a notice to each Holder of the 2034 Notes, with a copy to the Trustee:</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(i) &#160; &#160; &#160; &#160; &#160;&#160; </font><font style="font-weight: normal;">describing the transaction or transactions that constitute or may constitute the Change of Control Repurchase Event;</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman';"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;"> <br>
                </font></div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: normal;">offering to repurchase all 2034 Notes tendered;</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman';"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;"> <br>
                </font></div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: normal;">setting forth the payment date (the &#8220;<font style="font-family: 'Times New Roman';"><u>2034 Change of Control Payment Date</u></font>&#8221;) for the repurchase of the 2034 Notes, which date will be no earlier than 30 days and no later
                  than 60 days from the date such notice is mailed;</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman';"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;"> <br>
                </font></div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: normal;">if mailed prior to the date of consummation of the Change of Control, stating that the offer to repurchase is conditioned on a Change of Control Repurchase Event occurring on or prior to the 2034 Change of Control Payment Date
                  specified in such notice;</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman';"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;"> <br>
                </font></div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: normal;">disclosing that any 2034 Note not tendered for repurchase will continue to accrue interest; and</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman';"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;"> <br>
                </font></div>
              <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-9-</font></div>
                <div style="page-break-after: always;" class="BRPFPageBreak">
                  <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
              </div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: normal;">specifying the procedures for tendering 2034 Notes.</font></div>
            </div>
          </div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;"> <br>
            </font></div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(c)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company shall comply with the requirements of Rule 14e-1 under the Exchange Act, and any other securities laws and regulations
                thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the 2034 Notes as a result of a Change of Control Repurchase Event.&#160; To the extent that the provisions of any securities laws or
                regulations conflict with the Change of Control Repurchase Event provisions of the 2034 Notes, the Company will comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations under the
                Change of Control Repurchase Event provisions of the 2034 Notes by virtue of such conflict.</font></font></div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(d)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">On the 2034 Change of Control Payment Date, the Company shall, to the extent lawful:</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: normal;">accept for payment all 2034 Notes or portions thereof properly tendered pursuant to such offer;</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: normal;"><font style="text-align: left; font-family: 'Times New Roman';"> <br>
                </font></div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: normal;">deposit with the Paying Agent an amount equal to the aggregate purchase price in respect of all 2034 Notes or portions thereof properly tendered; and</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: normal;"><font style="text-align: left; font-family: 'Times New Roman';"> <br>
                </font></div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(iii) &#160; &#160; &#160; &#160; </font><font style="font-weight: normal;">deliver or cause to be delivered to the Trustee the 2034 Notes properly accepted, together with an Officers&#8217; Certificate stating the aggregate principal amount of 2034 Notes or portions thereof being repurchased by the Company.</font></div>
            </div>
          </div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;"> <br>
            </font></div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(e)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Upon receipt of the required funds, the Paying Agent will promptly distribute to each Holder of the 2034 Notes properly tendered the
                purchase price for such 2034 Notes deposited with the Paying Agent by the Company, the Company will execute and the Trustee, upon the execution and delivery by the Company of such 2034 Notes, will promptly authenticate and deliver (or cause
                to be transferred by book-entry) to each Holder a new 2034 Note equal in principal amount to any unpurchased portion of any 2034 Notes surrendered; provided that each new 2034 Note will be in a principal amount of an integral multiple of
                $1,000.00.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(f)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company shall not be required to make an offer to repurchase the 2034 Notes upon a Change of Control Repurchase Event if a
                third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the Company and such third party purchases all 2034 Notes properly tendered and not withdrawn under its
                offer.&#160; In addition, the Company shall not repurchase any 2034 Notes if there has occurred and is continuing on the 2034 Change of Control Payment Date an Event of Default in respect of any series of notes under the Indenture, other than a
                default in the payment of all or any portion of the aggregate purchase price in respect of all 2034 Notes or portions thereof properly tendered in connection with a Change of Control Repurchase Event.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 3.11</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Appointment of Agents</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">Regions Bank will initially be the Security Registrar and Paying Agent for the 2034 Notes and will act as such only at its
            offices at Regions Bank, Corporate Trust Department, 1900 5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Avenue North, 26<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor, Birmingham, Alabama 35203; or any other address that the Securities Registrar and Paying Agent may designate with respect to itself
            from time to time by notice to the Trustee, the Company and the Holders.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-10-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 3.12</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Securities Filings</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(a)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Notwithstanding that the Company is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act or is otherwise
                required to report on an annual and quarterly basis on forms provided for in those annual and quarterly reporting pursuant to rules and regulations promulgated by the Commission, so long as the 2034 Notes are outstanding (unless defeased in
                a legal defeasance), the Company will (x) file with the Commission (unless the Commission will not accept such filing), and (y) make available to the Trustee and, upon written request, the Holders of the 2034 Notes, without cost to any such
                Holder, from the date that the 2034 Notes are issued:</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: normal;">within the time periods specified by the Exchange Act (including all applicable extension periods), an annual report on Form 10-K (or any successor or comparable form) containing the information required to be contained therein
                  (or required in such successor or comparable form); and</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;"> <br>
                </font></div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(ii) &#160; &#160; &#160; &#160;&#160; </font><font style="font-weight: normal;">within the time periods specified by the Exchange Act (including all applicable extension periods), a quarterly report on Form 10-Q (or any successor or comparable form) containing the information required to be contained therein
                  (or required in such successor or comparable form).</font></div>
            </div>
          </div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;"> <br>
            </font></div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(b)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">In the event that the Company is not permitted to file its annual or quarterly reports with the Commission pursuant to the Exchange
                Act, the Company shall nevertheless make available such Exchange Act reports to the Trustee and the Holders of the 2034 Notes as if the Company was subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act within the
                time periods specified by the Exchange Act (including all applicable extension periods), which requirement may be satisfied by posting such reports on the Company&#8217;s website within the applicable time periods specified in Sections 3.12(a)(i)
                and (a)(ii) above.</font></font></div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(c)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Notwithstanding the foregoing, the availability of the reports referred to in Sections 3.12(a)(i) and (a)(ii) above on the
                Commission&#8217;s Electronic Data Gathering, Analysis and Retrieval system (or any successor system, including the Commission&#8217;s Interactive Data Electronic Application system) and the Company&#8217;s website within the applicable time periods
                specified in Sections 3.12(a)(i) and (a)(ii) above will be deemed to satisfy the delivery obligations under this Section 3.12.</font></font></div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(d)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Delivery of reports, information and documents to the Trustee and, if applicable, to the Security Registrar and Paying Agent is for
                informational purposes only and their respective receipt of such reports shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company&#8217;s or any other
                Person&#8217;s compliance with any of its covenants under the Indenture, this Supplemental Indenture or the 2034 Notes (as to which the Trustee, Security Registrar and Paying Agent are entitled to rely exclusively on Officers&#8217; Certificates).&#160;
                None of the Trustee, the Security Registrar or Paying Agent shall be obligated to monitor or confirm, on a continuing basis or otherwise, the Company&#8217;s or any other Person&#8217;s compliance with the covenants described herein or with respect to
                any reports or other documents filed under the Indenture or this Supplemental Indenture.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-11-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ARTICLE IV.</font><font style="font-weight: bold; font-size: 10pt;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><br>
                </font>GENERAL TERMS AND CONDITIONS OF THE 2054 NOTES</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 4.01</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Designation and Principal Amount</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">There is hereby authorized and established a series of Securities under the Indenture, designated as the &#8220;5.700% Senior
            Notes due 2054,&#8221; which is not limited in aggregate principal amount.&#160; The aggregate principal amount of the 2054 Notes to be issued shall be as set forth in any Company Order for the authentication and delivery of the 2054 Notes, pursuant to
            Section 303 of the Indenture.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 4.02</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Maturity</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The Stated Maturity of principal for the 2054 Notes will be December 1, 2054.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 4.03</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Further Issues</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The Company may from time to time, without the consent of the Holders of the 2054 Notes, issue additional notes of that
            series.&#160; Any such additional notes will have the same ranking, interest rate, maturity date and other terms as the 2054 Notes.&#160; Any such additional notes, together with the 2054 Notes herein provided for, will constitute a single series of
            Securities under the Indenture. Any such additional notes will not be offered with the same CUSIP number as the 2054 Notes unless such additional notes are considered to be fungible for U.S. federal income tax purposes with the 2054 Notes.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 4.04</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Form and Payment</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">Principal of, premium, if any, and interest on the 2054 Notes shall be payable in U.S. dollars.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 4.05</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Global Securities</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">Upon the original issuance, the 2054 Notes will be represented by one or more Global Securities registered in the name of
            Cede &amp; Co., the nominee of DTC.&#160; The Company will issue the 2054 Notes in denominations of $2,000.00 and integral multiples of $1,000.00 in excess thereof and will deposit the Global Securities with DTC or its custodian and register the
            Global Securities in the name of Cede &amp; Co.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 4.06</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Definitive Form</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">If (a) the Depositary is at any time unwilling or unable to continue as depositary or ceases to be a registered clearing
            agency and, in either case, a successor depositary is not appointed by the Company within 90 days of notice thereof, (b) an Event of Default has occurred with regard to the 2054 Notes and has not been cured or waived, or (c) the Company at any
            time and in its sole discretion determines not to have the 2054 Notes represented by Global Securities, the Company may issue the 2054 Notes in definitive form in exchange for such Global Securities.&#160; In any such instance, an owner of a
            beneficial interest in 2054 Notes will be entitled to physical delivery in definitive form of 2054 Notes, equal in principal amount to such beneficial interest and to have the 2054 Notes registered in its name as shall be established in a
            Company Order.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-12-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 4.07</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Interest</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The 2054 Notes will bear interest (computed on the basis of a 360-day year consisting of twelve 30-day months) from
            November 20, 2024 at the rate of 5.700% per annum, payable semi-annually; interest payable on each Interest Payment Date will include interest accrued from November 20, 2024 or from the most recent Interest Payment Date to which interest has
            been paid or duly provided for; the Interest Payment Dates on which such interest shall be payable are June 1 and December 1, commencing on June 1, 2025; and the record date for the interest payable on any Interest Payment Date is the close of
            business on May 15 or November 15 (whether or not such day is a Business Day), as the case may be, next preceding the relevant Interest Payment Date.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 4.08</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Authorized Denominations</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The 2054 Notes shall be issuable in denominations of $2,000.00 and integral multiples of $1,000.00 in excess thereof.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 4.09</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Redemption</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The 2054 Notes are subject to redemption at the option of the Company as set forth in the form of 2054 Note attached as <font style="font-family: 'Times New Roman';"><u>Exhibit C</u></font> hereto.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 4.10</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Change of Control</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(a)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Upon the occurrence of a Change of Control Repurchase Event, unless the Company has exercised its right to redeem all of the 2054
                Notes in accordance with the redemption terms as set forth in the 2054 Notes or has defeased the 2054 Notes as set forth in the 2054 Notes, the Company shall make an irrevocable offer to each Holder of the 2054 Notes to repurchase all or
                any part (equal to or in excess of $2,000.00 and in integral multiples of $1,000.00) of such Holder&#8217;s 2054 Notes at a repurchase price in cash equal to 101% of the aggregate principal amount of 2054 Notes repurchased plus accrued and unpaid
                interest, if any, on the 2054 Notes repurchased to, but not including, the date of repurchase.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(b)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Within 30 days following a Change of Control Repurchase Event or, at the Company&#8217;s option, prior to a Change of Control, but in
                either case, after the public announcement of such Change of Control, the Company shall mail, or shall cause to be mailed, a notice to each Holder of the 2054 Notes, with a copy to the Trustee:</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(i) &#160; &#160; &#160; &#160; &#160;&#160; </font><font style="font-weight: normal;">describing the transaction or transactions that constitute or may constitute the Change of Control Repurchase Event;</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;"> <br>
                </font></div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(ii) &#160; &#160; &#160; &#160; &#160; </font><font style="font-weight: normal;">offering to repurchase all 2054 Notes tendered;</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;"> <br>
                </font></div>
              <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-13-</font></div>
                <div style="page-break-after: always;" class="BRPFPageBreak">
                  <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
              </div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: normal;">setting forth the payment date (the &#8220;<font style="font-family: 'Times New Roman';"><u>2054 Change of Control Payment Date</u></font>&#8221;) for the repurchase of the 2054 Notes, which date will be no earlier than 30 days and no later
                  than 60 days from the date such notice is mailed;</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;"> <br>
                </font></div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(iv) &#160; &#160; &#160; &#160; </font><font style="font-weight: normal;">if mailed prior to the date of consummation of the Change of Control, stating that the offer to repurchase is conditioned on a Change of Control Repurchase Event occurring on or prior to the 2054 Change of Control Payment Date
                  specified in such notice;</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;"> <br>
                </font></div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: normal;">disclosing that any 2054 Note not tendered for repurchase will continue to accrue interest; and</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;"> <br>
                </font></div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: normal;">specifying the procedures for tendering 2054 Notes.</font></div>
            </div>
          </div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;"> <br>
            </font></div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(c)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company shall comply with the requirements of Rule 14e-1 under the Exchange Act, and any other securities laws and regulations
                thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the 2054 Notes as a result of a Change of Control Repurchase Event.&#160; To the extent that the provisions of any securities laws or
                regulations conflict with the Change of Control Repurchase Event provisions of the 2054 Notes, the Company will comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations under the
                Change of Control Repurchase Event provisions of the 2054 Notes by virtue of such conflict.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(d)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">On the 2054 Change of Control Payment Date, the Company shall, to the extent lawful:</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(i) &#160; &#160; &#160; &#160; &#160;&#160; </font><font style="font-weight: normal;">accept for payment all 2054 Notes or portions thereof properly tendered pursuant to such offer;</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;"> <br>
                </font></div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(ii) &#160; &#160; &#160; &#160;&#160; </font><font style="font-weight: normal;">deposit with the Paying Agent an amount equal to the aggregate purchase price in respect of all 2054 Notes or portions thereof properly tendered; and</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;"> <br>
                </font></div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: normal;">deliver or cause to be delivered to the Trustee the 2054 Notes properly accepted, together with an Officers&#8217; Certificate stating the aggregate principal amount of 2054 Notes or portions thereof being repurchased by the Company.</font></div>
            </div>
          </div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;"> <br>
            </font></div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(e)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Upon receipt of the required funds, the Paying Agent will promptly distribute to each Holder of the 2054 Notes properly tendered the
                purchase price for such 2054 Notes deposited with the Paying Agent by the Company, the Company will execute and the Trustee, upon the execution and delivery by the Company of such 2054 Notes, will promptly authenticate and deliver (or cause
                to be transferred by book-entry) to each Holder a new 2054 Note equal in principal amount to any unpurchased portion of any 2054 Notes surrendered; provided that each new 2054 Note will be in a principal amount of an integral multiple of
                $1,000.00.</font></font></div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(f)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company shall not be required to make an offer to repurchase the 2054 Notes upon a Change of Control Repurchase Event if a third
                party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the Company and such third party purchases all 2054 Notes properly tendered and not withdrawn under its offer.&#160; In
                addition, the Company shall not repurchase any 2054 Notes if there has occurred and is continuing on the 2054 Change of Control Payment Date an Event of Default in respect of any series of notes under the Indenture, other than a default in
                the payment of all or any portion of the aggregate purchase price in respect of all 2054 Notes or portions thereof properly tendered in connection with a Change of Control Repurchase Event.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-14-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 4.11</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Appointment of Agents</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">Regions Bank will initially be the Security Registrar and Paying Agent for the 2054 Notes and will act as such only at its
            offices at Regions Bank, Corporate Trust Department, 1900 5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Avenue North, 26<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor, Birmingham, Alabama 35203; or any other address that the Securities Registrar and Paying Agent may designate with respect to itself
            from time to time by notice to the Trustee, the Company and the Holders.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 4.12</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Securities Filings</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(a)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Notwithstanding that the Company is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act or is
                otherwise required to report on an annual and quarterly basis on forms provided for in those annual and quarterly reporting pursuant to rules and regulations promulgated by the Commission, so long as the 2054 Notes are outstanding (unless
                defeased in a legal defeasance), the Company will (x) file with the Commission (unless the Commission will not accept such filing), and (y) make available to the Trustee and, upon written request, the Holders of the 2054 Notes, without cost
                to any such Holder, from the date that the 2054 Notes are issued:</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(i) &#160; &#160; &#160; &#160;&#160; </font><font style="font-weight: normal;">within the time periods specified by the Exchange Act (including all applicable extension periods), an annual report on Form 10-K (or any successor or comparable form) containing the information required to be contained therein
                  (or required in such successor or comparable form); and</font></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: normal;"><font style="text-align: left; font-family: 'Times New Roman';"> <br>
                </font></div>
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-weight: normal;">(ii) &#160; &#160; &#160; &#160; </font><font style="font-weight: normal;">within the time periods specified by the Exchange Act (including all applicable extension periods), a quarterly report on Form 10-Q (or any successor or comparable form) containing the information required to be contained therein
                  (or required in such successor or comparable form).</font></div>
            </div>
          </div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;"> <br>
            </font></div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(b)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">In the event that the Company is not permitted to file its annual or quarterly reports with the Commission pursuant to the Exchange
                Act, the Company shall nevertheless make available such Exchange Act reports to the Trustee and the Holders of the 2054 Notes as if the Company was subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act within the
                time periods specified by the Exchange Act (including all applicable extension periods), which requirement may be satisfied by posting such reports on the Company&#8217;s website within the applicable time periods specified in Sections 4.12(a)(i)
                and (a)(ii) above.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(c)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Notwithstanding the foregoing, the availability of the reports referred to in Sections 4.12(a)(i) and (a)(ii) above on the
                Commission&#8217;s Electronic Data Gathering, Analysis and Retrieval system (or any successor system, including the Commission&#8217;s Interactive Data Electronic Application system) and the Company&#8217;s website within the applicable time periods
                specified in Sections 4.12(a)(i) and (a)(ii) above will be deemed to satisfy the delivery obligations under this Section 4.12.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-15-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">(d)</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Delivery of reports, information and documents to the Trustee and, if applicable, to the Security Registrar and Paying Agent is
                for informational purposes only and their respective receipt of such reports shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company&#8217;s or any
                other Person&#8217;s compliance with any of its covenants under the Indenture, this Supplemental Indenture or the 2054 Notes (as to which the Trustee, Security Registrar and Paying Agent are entitled to rely exclusively on Officers&#8217;
                Certificates).&#160; None of the Trustee, the Security Registrar or Paying Agent shall be obligated to monitor or confirm, on a continuing basis or otherwise, the Company&#8217;s or any other Person&#8217;s compliance with the covenants described herein or
                with respect to any reports or other documents filed under the Indenture or this Supplemental Indenture.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ARTICLE V.</font><font style="font-weight: bold; font-size: 10pt;"> <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><br>
                </font>FORM OF NOTES</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 5.01</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Form of 2029 Notes</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The 2029 Notes and the Trustee&#8217;s Certificate of Authentication to be endorsed thereon are to be substantially in the form
            set forth in <font style="font-family: 'Times New Roman';"><u>Exhibit A</u></font> hereto.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 5.02</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Form of 2034 Notes</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The 2034 Notes and the Trustee&#8217;s Certificate of Authentication to be endorsed thereon are to be substantially in the form
            set forth in <font style="font-family: 'Times New Roman';"><u>Exhibit B</u></font> hereto.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 5.03</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Form of 2054 Notes</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The 2054 Notes and the Trustee&#8217;s Certificate of Authentication to be endorsed thereon are to be substantially in the form
            set forth in <font style="font-family: 'Times New Roman';"><u>Exhibit C</u></font> hereto.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ARTICLE VI.</font><font style="font-weight: bold; font-size: 10pt;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><br>
                </font>ORIGINAL ISSUE OF NOTES</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 6.01</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Original Issue of 2029 Notes</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The 2029 Notes may, upon execution of this Supplemental Indenture, be executed by the Company and delivered to the Trustee
            for authentication, and the Trustee shall, upon Company Order, authenticate and deliver such 2029 Notes as in such Company Order provided.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 6.02</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Original Issue of 2034 Notes</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The 2034 Notes may, upon execution of this Supplemental Indenture, be executed by the Company and delivered to the Trustee
            for authentication, and the Trustee shall, upon Company Order, authenticate and deliver such 2034 Notes as in such Company Order provided.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 6.03</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Original Issue of 2054 Notes</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The 2054 Notes may, upon execution of this Supplemental Indenture, be executed by the Company and delivered to the Trustee
            for authentication, and the Trustee shall, upon Company Order, authenticate and deliver such 2054 Notes as in such Company Order provided.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-16-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ARTICLE VII.</font><font style="font-weight: bold; font-size: 10pt;">&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><br>
                </font>MISCELLANEOUS</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 7.01</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Ratification of Indenture</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The Indenture, as supplemented by this Supplemental Indenture, is in all respects ratified and confirmed, and this
            Supplemental Indenture shall be deemed part of the Indenture in the manner and to the extent herein and therein provided; <font style="font-family: 'Times New Roman'; font-style: italic;">provided </font>that the provisions of this
            Supplemental Indenture apply solely with respect to the 2029 Notes, 2034 Notes and 2054 Notes.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 7.02</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Trustee Not Responsible for Recitals</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">The recitals herein contained are made by the Company and not by the Trustee, and the Trustee assumes no responsibility for
            the correctness thereof. The Trustee makes no representation as to the validity or sufficiency of this Supplemental Indenture.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 7.03</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Governing Law</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">This Supplemental Indenture and each 2029 Note, 2034 Note and 2054 Note shall be governed by and construed in accordance
            with the laws of the State of New York.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 7.04</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Separability</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">In case any one or more of the provisions contained in this Supplemental Indenture or the 2029 Notes, the 2034 Notes and
            the 2054 Notes shall for any reason be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this Supplemental Indenture or of the 2029 Notes, 2034
            Notes and 2054 Notes but this Supplemental Indenture and the 2029 Notes, the 2034 Notes and the 2054 Notes shall be construed as if such invalid or illegal or unenforceable provision had never been contained herein or therein.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal;">Section 7.05</font><font style="font-weight: normal; font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Counterparts</u></font>.</font></font></div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; text-indent: 36pt;">This Supplemental Indenture may be executed in any number of counterparts each of which shall be an original; but such
            counterparts shall together constitute but one and the same instrument.</div>
          <div style="font-weight: normal; font-size: 10pt;">&#160;</div>
        </div>
        </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-17-</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the day
        and year first above written.</div>
      <div style="font-size: 10pt; font-weight: normal;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z40fd138606dd493595f06fd530187438" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">VULCAN MATERIALS COMPANY</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1">&#160;</td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; font-weight: normal;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman';"><u>/s/ Ryan Hall</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1"><br>
            </td>
            <td style="vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman';">Name: Ryan Hall</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1"><br>
            </td>
            <td style="vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman';">Title: Vice President and Treasurer</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">REGIONS BANK,</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">as Trustee</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; font-weight: normal;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman';"><u>/s/ John Hudson Holcomb, IV</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1"><br>
            </td>
            <td style="vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman';">Name: John Hudson Holcomb, IV</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1"><br>
            </td>
            <td style="vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman';">Title: Assistant Vice President</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-weight: normal;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z4932d57c4113400c813bad496ae8efa1" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">Acknowledged:</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1" colspan="2">&#160;&#160;</td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman';">REGIONS BANK,</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; margin-left: 9pt;">as Paying Agent and Security Registrar</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1">&#160;</td>
            <td style="width: 44%; vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1">&#160;</td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; font-size: 10pt; font-weight: normal;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 44%; vertical-align: top; font-size: 10pt; font-weight: normal;">
              <div style="text-align: left; font-family: 'Times New Roman';"><u>/s/ John Hudson Holcomb, IV</u></div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; font-size: 10pt; font-weight: normal;">&#160;</td>
            <td style="width: 44%; vertical-align: top; font-size: 10pt; font-weight: normal;">
              <div style="text-align: left; font-family: 'Times New Roman';">Name: John Hudson Holcomb, IV</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; font-size: 10pt; font-weight: normal;">&#160;</td>
            <td style="width: 44%; vertical-align: top; font-size: 10pt; font-weight: normal;">
              <div style="text-align: left; font-family: 'Times New Roman';">Title: Assistant Vice President</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; font-weight: normal;">&#160;</td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-weight: normal;"><br>
      </div>
      <div style="font-size: 10pt; font-weight: normal;">
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[Signature Page to Eleventh Supplemental Indenture]</div>
        <div style="font-size: 10pt; font-weight: normal;"> <br>
          <div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div style="text-align: right; font-weight: bold;">EXHIBIT A</div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;">FORM OF 2029 NOTE</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">[<font style="font-weight: bold;">THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE OF
                A DEPOSITARY.&#160; THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE AND NO TRANSFER OF THIS SECURITY (EXCEPT AS
                A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY) MAY BE REGISTERED EXCEPT IN SUCH LIMITED CIRCUMSTANCES.</font></div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; font-weight: bold;">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#8220;DTC&#8221;) TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER,
              EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE &amp; CO. OR SUCH NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE &amp; CO. OR TO SUCH OTHER ENTITY AS IS
              REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE &amp; CO., HAS AN INTEREST HEREIN.]</div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;">VULCAN MATERIALS COMPANY</div>
            <div style="text-align: center; font-weight: bold;">4.950% SENIOR NOTE DUE 2029</div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z8ff94072d3224b8598d96895d301ceee">

                <tr>
                  <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                    <div>No. <br>
                    </div>
                  </td>
                  <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 15%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">
                    <div style="text-align: right;">$</div>
                  </td>
                </tr>
                <tr>
                  <td colspan="3" style="vertical-align: top;">&#160;</td>
                  <td style="width: 50%; vertical-align: top;">
                    <div style="text-align: right;">CUSIP No. 929160 BB4</div>
                  </td>
                </tr>

            </table>
            <div style="text-align: justify; text-indent: 36pt;"> <br>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">Vulcan Materials Company, a corporation duly organized and existing under the laws of New Jersey (herein called the &#8220;<u>Company</u>&#8221;, which term includes any successor Person under the
              Indenture hereinafter referred to), for value received, hereby promises to pay to CEDE &amp; CO., or registered assigns, the principal sum of _____________ Dollars on December 1, 2029, and to pay interest thereon from November 20, 2024, or
              from the most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually on June 1 and December 1 in each year, commencing June 1, 2025 at the rate of 4.950% per annum, until the principal hereof is paid
              or made available for payment, and (to the extent that the payment of such interest shall be legally enforceable) at the rate of 4.950% per annum on any overdue principal and premium and on any overdue installment of interest.&#160; The interest
              so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of
              business on the Regular Record Date for such interest, which shall be May 15 or November 15 (whether or not a Business Day), as the case may be, next preceding such Interest Payment Date.&#160; Any such interest not so punctually paid or duly
              provided for will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a
              Special Record Date for the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such Special Record Date, or be paid at any time
              in any other lawful manner not inconsistent with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said
              Indenture.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">A-1</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">Payment of the principal of (and premium, if any) and interest on this Security will be made at the office or agency of the Company maintained for that purpose in New York, New York (or, at
              the option of the Company, payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register), in such coin or currency of the United States of America as at
              the time of payment is legal tender for payment of public and private debts.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">Reference is hereby made to the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth at
              this place.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">Unless the certificate of authentication hereon has been executed by the Trustee or an authentication agent on its behalf referred to on the reverse hereof by manual signature, this Security
              shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">A-2</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed.</div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za7ce0439391f457bb183a36577d0d60d">

                <tr>
                  <td colspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
                    <div style="text-align: justify;">Dated:</div>
                  </td>
                  <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 9.62%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td colspan="2" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
                  <td rowspan="1" colspan="3" style="vertical-align: top;">&#160;</td>
                  <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
                  <td colspan="3" style="vertical-align: top;">&#160;</td>
                  <td colspan="2" style="vertical-align: top;">
                    <div>VULCAN MATERIALS COMPANY</div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
                  <td colspan="3" style="vertical-align: top;">&#160;</td>
                  <td colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align: top; padding-bottom: 2px; width: 5%;">&#160;</td>
                  <td colspan="3" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
                    <div>By:</div>
                  </td>
                  <td style="width: 55%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
                  <td colspan="3" style="vertical-align: top;">&#160;</td>
                  <td colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
                  <td colspan="3" style="vertical-align: top;">
                    <div style="text-align: justify;">Attest:</div>
                  </td>
                  <td colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align: top; width: 5%;">&#160;</td>
                  <td colspan="3" style="vertical-align: top;">&#160;</td>
                  <td colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align: top; width: 5%; padding-bottom: 2px;">&#160;</td>
                  <td colspan="3" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td colspan="2" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
                </tr>

            </table>
            <div>
              <div style="text-align: center; font-size: 12pt;"> <br>
              </div>
              <div style="text-align: center;">[Signature Page to Global Security]</div>
              <div style="text-align: center;"> <br>
              </div>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: center;">TRUSTEE&#8217;S CERTIFICATE OF AUTHENTICATION</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture.</div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z2249a0b0f8c748498623a383783833e3">

                <tr>
                  <td colspan="4" style="vertical-align: top;">
                    <div>REGIONS BANK,</div>
                  </td>
                </tr>
                <tr>
                  <td colspan="4" style="vertical-align: top;">
                    <div style="margin-left: 9pt;">as Trustee</div>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="4" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 5%; vertical-align: top;">&#160;</td>
                  <td style="width: 5%; vertical-align: top;">
                    <div style="text-align: justify;">By:</div>
                  </td>
                  <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="2" style="vertical-align: top;">&#160;</td>
                  <td style="width: 40%; vertical-align: top;">
                    <div style="text-align: justify;">Authorized Officer</div>
                  </td>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                </tr>

            </table>
            <div>
              <div style="text-align: center; font-size: 12pt;"> <br>
              </div>
              <div style="text-align: center;">[Signature Page to Global Security]</div>
              <div style="text-align: center;"> <br>
              </div>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <!--PROfilePageNumberReset%Num%3%A-%%-->
            <div style="text-align: center;">(FORM OF REVERSE OF 2029 NOTE)</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">This Security is one of a duly authorized issue of securities of the Company (herein called the &#8220;<u>Securities</u>&#8221;), issued and to be issued in one or more series under a Senior Debt
              Indenture, dated as of December 11, 2007 (herein called the &#8220;<u>Indenture</u>&#8221;), as supplemented by the Eleventh Supplemental Indenture, dated as of November 20, 2024, between the Company and Regions Bank, as Trustee (herein called the &#8220;<u>Trustee</u>&#8221;,
              which term includes any successor trustee under the Indenture), to which Indenture and all indentures supplemental thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities
              thereunder of the Company, the Trustee and the Holders of the Securities and of the terms upon which the Securities are, and are to be, authenticated and delivered.&#160; This Security is one of the series designated on the face hereof.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">At any time prior to November 1, 2029 (the &#8220;<u>2029 Par Call Date</u>&#8221;), the Securities are subject to redemption upon not less than 10 days&#8217; nor more than 60 days&#8217; notice by mail, as a whole
              or in part, at the option of the Company, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) one hundred percent (100%) of the principal amount of the
              Securities and (ii) (a) the sum of the present values of the remaining scheduled payments of principal and interest on the Securities to be redeemed discounted to the Redemption Date (assuming such Securities matured on the 2029 Par Call
              Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined below), plus 15 basis points less (b) interest accrued to the Redemption Date, plus, in each case, accrued and unpaid
              interest, if any, on the Securities being redeemed to, but not including, the Redemption Date.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">In addition, at any time on or after the 2029 Par Call Date, the Securities are subject to redemption in whole or in part, at the option of the Company, from time to time at a redemption
              price equal to one hundred percent (100%) of the aggregate principal amount of the Securities being redeemed, plus any accrued and unpaid interest on the Securities being redeemed to, but not including, the Redemption Date.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Treasury Rate</u>&#8221; means, with respect to any Redemption Date, the yield determined by the Company in accordance with the following two paragraphs.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City time (or after such time as yields on U.S. government securities are posted daily by the Board of Governors
              of the Federal Reserve System), on the third Business Day preceding the Redemption Date based upon the yield or yields for the most recent day that appear after such time on such day in the most recent statistical release published by the
              Board of Governors of the Federal Reserve System designated as &#8220;Selected Interest Rates (Daily) - H.15&#8221; (or any successor designation or publication) (&#8220;<u>H.15</u>&#8221;) under the caption &#8220;U.S. government securities&#8211;Treasury constant
              maturities&#8211;Nominal&#8221; (or any successor caption or heading) (&#8220;<u>H.15 TCM</u>&#8221;). In determining the Treasury Rate, the Company shall select, as applicable: (1) the yield for the Treasury constant maturity on H.15 exactly equal to the period
              from the redemption date to the 2029 Par Call Date (the &#8220;<u>Remaining Life</u>&#8221;); (2) if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields &#8211; one yield corresponding to the Treasury
              constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life &#8211; and shall interpolate to the 2029 Par Call Date on a straight-line basis
              (using the actual number of days) using such yields and rounding the result to three decimal places; or (3) if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single
              Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months
              or years, as applicable, of such Treasury constant maturity from the Redemption Date.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">A-3</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">If on the third Business Day preceding the redemption date H.15 TCM is no longer published, the Company shall calculate the Treasury Rate based on the rate per annum equal to the semi-annual
              equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such redemption date of the United States Treasury security maturing on, or with a maturity that is closest to, the 2029 Par Call Date, as
              applicable.&#160; If there is no United States Treasury security maturing on the 2029 Par Call Date but there are two or more United States Treasury securities with a maturity date equally distant from the 2029 Par Call Date, one with a maturity
              date preceding the 2029 Par Call Date and one with a maturity date following the 2029 Par Call Date, the Company shall select the United States Treasury security with a maturity date preceding the 2029 Par Call Date. If there are two or more
              United States Treasury securities maturing on the 2029 Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among these two or more United States Treasury
              securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time.&#160; In determining the Treasury Rate
              in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at
              11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">The Company&#8217;s actions and determinations in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">In the event of redemption of this Security in part only, a new Security or Securities of this series and of like tenor for the unredeemed portion hereof will be issued in the name of the
              Holder hereof upon the cancellation hereof.&#160; No Securities of a principal amount of $2,000 or less will be redeemed in part.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">In connection with any redemption of Securities, any such redemption may, at the Company&#8217;s discretion, be subject to one or more conditions precedent.&#160; If such redemption is subject to
              satisfaction of one or more conditions precedent, the notice of such redemption shall state that, in the Company&#8217;s discretion, the Redemption Date may be delayed until such time as any or all such conditions shall have been satisfied, or such
              redemption may not occur and such notice may be rescinded in the event that any or all such conditions shall not have been satisfied by the Redemption Date, or by the Redemption Date so delayed.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">If an Event of Default with respect to Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due and payable in the manner
              and with the effect provided in the Indenture.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">A-4</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">The Indenture contains provisions for defeasance at any time of (i) the entire indebtedness of the Company on this Security and (ii) certain restrictive covenants and other covenants and the
              related Events of Default, upon compliance by the Company with certain conditions set forth therein, which provisions apply to this Security.&#160; In addition, upon the Company&#8217;s exercise of the option provided in Section 1301 of the Indenture to
              obtain a covenant defeasance with respect to this Security, the Company shall be released from its obligations under Section 2.10 of the Eleventh Supplemental Indenture (in addition to the Sections provided in Section 1303 of the Indenture)
              with respect to this Security on and after the date the applicable conditions set forth in Section 1304 of the Indenture are satisfied.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders of
              the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the consent of the Holders of a majority in principal amount of the Securities at the time Outstanding of each series to be
              affected.&#160; The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities of each series at the time Outstanding, on behalf of the Holders of all Securities of such series, to
              waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences.&#160; Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon
              such Holder and upon all future Holders of this Security and of any Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this
              Security.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">Except as set forth in Article Thirteen of the Indenture, no reference herein to the Indenture and no provision of this Security or of the Indenture shall alter or impair the obligation of
              the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security at the times, place and rate, and in the coin or currency, herein prescribed.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Security is registrable in the Security Register, upon surrender of this Security for
              registration of transfer at the office or agency of the Company in any place where the principal of and any premium and interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form
              satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or its attorney duly authorized in writing, and thereupon one or more new Securities of this series and of like tenor, of authorized denominations and
              for the same aggregate principal amount, will be issued to the designated transferee or transferees.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">The Securities of this series are issuable only in registered form without coupons in denominations of $2,000.00 and multiples of $1,000.00 thereof.&#160; As provided in the Indenture and subject
              to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder
              surrendering the same.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">No service charge shall be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge
              payable in connection therewith.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">A-5</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">Prior to due presentment of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name this Security
              is registered as the owner hereof for all purposes, whether or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">All terms used in this Security which are defined in the Indenture shall have the meanings assigned to them in the Indenture.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">A-6</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <!--PROfilePageNumberReset%Num%1%B-%%-->
            <div style="text-align: right; font-weight: bold;">EXHIBIT B</div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;">FORM OF 2034 NOTE</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">[<font style="font-weight: bold;">THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE OF
                A DEPOSITARY.&#160; THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE AND NO TRANSFER OF THIS SECURITY (EXCEPT AS
                A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY) MAY BE REGISTERED EXCEPT IN SUCH LIMITED CIRCUMSTANCES.</font></div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; font-weight: bold;">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#8220;DTC&#8221;) TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER,
              EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE &amp; CO. OR SUCH NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE &amp; CO. OR TO SUCH OTHER ENTITY AS IS
              REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE &amp; CO., HAS AN INTEREST HEREIN.]</div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;">VULCAN MATERIALS COMPANY</div>
            <div style="text-align: center; font-weight: bold;">5.350% SENIOR NOTE DUE 2034</div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zfd2688204a264613938c51f4af83c059">

                <tr>
                  <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                    <div>No.</div>
                  </td>
                  <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 15%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">
                    <div style="text-align: right;">$</div>
                  </td>
                </tr>
                <tr>
                  <td colspan="3" style="vertical-align: top;">&#160;</td>
                  <td style="width: 50%; vertical-align: top;">
                    <div style="text-align: right;">CUSIP No. 929160 BC2</div>
                  </td>
                </tr>

            </table>
            <div><br>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">Vulcan Materials Company, a corporation duly organized and existing under the laws of New Jersey (herein called the &#8220;<u>Company</u>&#8221;, which term includes any successor Person under the
              Indenture hereinafter referred to), for value received, hereby promises to pay to CEDE &amp; CO., or registered assigns, the principal sum of _____________ Dollars on December 1, 2034, and to pay interest thereon from November 20, 2024, or
              from the most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually on June 1 and December 1 in each year, commencing June 1, 2025 at the rate of 5.350% per annum, until the principal hereof is paid
              or made available for payment, and (to the extent that the payment of such interest shall be legally enforceable) at the rate of 5.350% per annum on any overdue principal and premium and on any overdue installment of interest.&#160; The interest
              so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of
              business on the Regular Record Date for such interest, which shall be May 15 or November 15 (whether or not a Business Day), as the case may be, next preceding such Interest Payment Date.&#160; Any such interest not so punctually paid or duly
              provided for will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a
              Special Record Date for the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such Special Record Date, or be paid at any time
              in any other lawful manner not inconsistent with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said
              Indenture.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">B-1</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">Payment of the principal of (and premium, if any) and interest on this Security will be made at the office or agency of the Company maintained for that purpose in New York, New York (or, at
              the option of the Company, payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register), in such coin or currency of the United States of America as at
              the time of payment is legal tender for payment of public and private debts.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">Reference is hereby made to the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth at
              this place.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">Unless the certificate of authentication hereon has been executed by the Trustee or an authentication agent on its behalf referred to on the reverse hereof by manual signature, this Security
              shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">B-2</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed.</div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z886f4bba336b408aad60af26721a6b02">

                <tr>
                  <td colspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
                    <div style="text-align: justify;">Dated:</div>
                  </td>
                  <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 9.62%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td colspan="2" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
                  <td rowspan="1" colspan="3" style="vertical-align: top;">&#160;</td>
                  <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
                  <td colspan="3" style="vertical-align: top;">&#160;</td>
                  <td colspan="2" style="vertical-align: top;">
                    <div>VULCAN MATERIALS COMPANY</div>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
                  <td rowspan="1" colspan="3" style="vertical-align: top;">&#160;</td>
                  <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td colspan="3" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
                    <div>By:</div>
                  </td>
                  <td style="vertical-align: top; width: 55%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
                  <td colspan="3" style="vertical-align: top;">&#160;</td>
                  <td colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
                  <td colspan="3" style="vertical-align: top;">
                    <div style="text-align: justify;">Attest:</div>
                  </td>
                  <td colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
                  <td rowspan="1" colspan="3" style="vertical-align: top;">&#160;</td>
                  <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td colspan="3" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td colspan="2" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
                </tr>

            </table>
            <div><br>
            </div>
            <div style="text-align: center;">[Signature Page to Global Security]</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: center;">TRUSTEE&#8217;S CERTIFICATE OF AUTHENTICATION</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture.</div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="za62e13ec17b24497883ab744dad96f9a">

                <tr>
                  <td colspan="4" style="vertical-align: top;">
                    <div>REGIONS BANK,</div>
                  </td>
                </tr>
                <tr>
                  <td colspan="4" style="vertical-align: top;">
                    <div style="margin-left: 9pt;">as Trustee</div>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="4" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
                    <div style="text-align: justify;">By:</div>
                  </td>
                  <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="2" style="vertical-align: top;">&#160;</td>
                  <td style="width: 40%; vertical-align: top;">
                    <div style="text-align: justify;">Authorized Officer</div>
                  </td>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                </tr>

            </table>
            <div><br>
            </div>
            <div style="text-align: center;">[Signature Page to Global Security]</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <!--PROfilePageNumberReset%Num%3%B-%%-->
            <div style="text-align: center;">(FORM OF REVERSE OF 2034 NOTE)</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">This Security is one of a duly authorized issue of securities of the Company (herein called the &#8220;<u>Securities</u>&#8221;), issued and to be issued in one or more series under a Senior Debt
              Indenture, dated as of December 11, 2007 (herein called the &#8220;<u>Indenture</u>&#8221;), as supplemented by the Eleventh Supplemental Indenture, dated as of November 20, 2024, between the Company and Regions Bank, as Trustee (herein called the &#8220;<u>Trustee</u>&#8221;,
              which term includes any successor trustee under the Indenture), to which Indenture and all indentures supplemental thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities
              thereunder of the Company, the Trustee and the Holders of the Securities and of the terms upon which the Securities are, and are to be, authenticated and delivered.&#160; This Security is one of the series designated on the face hereof.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">At any time prior to September 1, 2034 (the &#8220;<u>2034 Par Call Date</u>&#8221;), the Securities are subject to redemption upon not less than 10 days&#8217; nor more than 60 days&#8217; notice by mail, as a
              whole or in part, at the option of the Company, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) one hundred percent (100%) of the principal amount of the
              Securities and (ii) (a) the sum of the present values of the remaining scheduled payments of principal and interest on the Securities to be redeemed discounted to the Redemption Date (assuming such Securities matured on the 2034 Par Call
              Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined below), plus 15 basis points less (b) interest accrued to the Redemption Date, plus, in each case, accrued and unpaid
              interest, if any, on the Securities being redeemed to, but not including, the Redemption Date.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">In addition, at any time on or after the 2034 Par Call Date, the Securities are subject to redemption in whole or in part, at the option of the Company, from time to time at a redemption
              price equal to one hundred percent (100%) of the aggregate principal amount of the Securities being redeemed, plus any accrued and unpaid interest on the Securities being redeemed to, but not including, the Redemption Date.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Treasury Rate</u>&#8221; means, with respect to any Redemption Date, the yield determined by the Company in accordance with the following two paragraphs.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City time (or after such time as yields on U.S. government securities are posted daily by the Board of Governors
              of the Federal Reserve System), on the third Business Day preceding the Redemption Date based upon the yield or yields for the most recent day that appear after such time on such day in the most recent statistical release published by the
              Board of Governors of the Federal Reserve System designated as &#8220;Selected Interest Rates (Daily) - H.15&#8221; (or any successor designation or publication) (&#8220;<u>H.15</u>&#8221;) under the caption &#8220;U.S. government securities&#8211;Treasury constant
              maturities&#8211;Nominal&#8221; (or any successor caption or heading) (&#8220;<u>H.15 TCM</u>&#8221;). In determining the Treasury Rate, the Company shall select, as applicable: (1) the yield for the Treasury constant maturity on H.15 exactly equal to the period
              from the redemption date to the 2034 Par Call Date (the &#8220;<u>Remaining Life</u>&#8221;); (2) if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields &#8211; one yield corresponding to the Treasury
              constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life &#8211; and shall interpolate to the 2034 Par Call Date on a straight-line basis
              (using the actual number of days) using such yields and rounding the result to three decimal places; or (3) if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single
              Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months
              or years, as applicable, of such Treasury constant maturity from the Redemption Date.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">B-3</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">If on the third Business Day preceding the redemption date H.15 TCM is no longer published, the Company shall calculate the Treasury Rate based on the rate per annum equal to the semi-annual
              equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such redemption date of the United States Treasury security maturing on, or with a maturity that is closest to, the 2034 Par Call Date, as
              applicable.&#160; If there is no United States Treasury security maturing on the 2034 Par Call Date but there are two or more United States Treasury securities with a maturity date equally distant from the 2034 Par Call Date, one with a maturity
              date preceding the 2034 Par Call Date and one with a maturity date following the 2034 Par Call Date, the Company shall select the United States Treasury security with a maturity date preceding the 2034 Par Call Date. If there are two or more
              United States Treasury securities maturing on the 2034 Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among these two or more United States Treasury
              securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time.&#160; In determining the Treasury Rate
              in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at
              11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">The Company&#8217;s actions and determinations in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">In the event of redemption of this Security in part only, a new Security or Securities of this series and of like tenor for the unredeemed portion hereof will be issued in the name of the
              Holder hereof upon the cancellation hereof.&#160; No Securities of a principal amount of $2,000 or less will be redeemed in part.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">In connection with any redemption of Securities, any such redemption may, at the Company&#8217;s discretion, be subject to one or more conditions precedent.&#160; If such redemption is subject to
              satisfaction of one or more conditions precedent, the notice of such redemption shall state that, in the Company&#8217;s discretion, the Redemption Date may be delayed until such time as any or all such conditions shall have been satisfied, or such
              redemption may not occur and such notice may be rescinded in the event that any or all such conditions shall not have been satisfied by the Redemption Date, or by the Redemption Date so delayed.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">If an Event of Default with respect to Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due and payable in the manner
              and with the effect provided in the Indenture.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">B-4</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">
              <div style="text-indent: 36pt;">The Indenture contains provisions for defeasance at any time of (i) the entire indebtedness of the Company on this Security and (ii) certain restrictive covenants and other covenants and the related Events of
                Default, upon compliance by the Company with certain conditions set forth therein, which provisions apply to this Security.&#160; In addition, upon the Company&#8217;s exercise of the option provided in Section 1301 of the Indenture to obtain a
                covenant defeasance with respect to this Security, the Company shall be released from its obligations under Section 3.10 of the Eleventh Supplemental Indenture (in addition to the Sections provided in Section 1303 of the Indenture) with
                respect to this Security on and after the date the applicable conditions set forth in Section 1304 of the Indenture are satisfied.</div>
            </div>
            <div style="text-align: justify; text-indent: 36pt;"> <br>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders of
              the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the consent of the Holders of a majority in principal amount of the Securities at the time Outstanding of each series to be
              affected.&#160; The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities of each series at the time Outstanding, on behalf of the Holders of all Securities of such series, to
              waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences.&#160; Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon
              such Holder and upon all future Holders of this Security and of any Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this
              Security.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">Except as set forth in Article Thirteen of the Indenture, no reference herein to the Indenture and no provision of this Security or of the Indenture shall alter or impair the obligation of
              the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security at the times, place and rate, and in the coin or currency, herein prescribed.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Security is registrable in the Security Register, upon surrender of this Security for
              registration of transfer at the office or agency of the Company in any place where the principal of and any premium and interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form
              satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or its attorney duly authorized in writing, and thereupon one or more new Securities of this series and of like tenor, of authorized denominations and
              for the same aggregate principal amount, will be issued to the designated transferee or transferees.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">The Securities of this series are issuable only in registered form without coupons in denominations of $2,000.00 and multiples of $1,000.00 thereof.&#160; As provided in the Indenture and subject
              to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder
              surrendering the same.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">No service charge shall be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge
              payable in connection therewith.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">B-5</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">Prior to due presentment of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name this Security
              is registered as the owner hereof for all purposes, whether or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">All terms used in this Security which are defined in the Indenture shall have the meanings assigned to them in the Indenture.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">B-6</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <!--PROfilePageNumberReset%Num%1%C-%%-->
            <div style="text-align: right; font-weight: bold;">EXHIBIT C</div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;">FORM OF 2054 NOTE</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">[<font style="font-weight: bold;">THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE OF
                A DEPOSITARY.&#160; THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE AND NO TRANSFER OF THIS SECURITY (EXCEPT AS
                A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY) MAY BE REGISTERED EXCEPT IN SUCH LIMITED CIRCUMSTANCES.</font></div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; font-weight: bold;">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#8220;DTC&#8221;) TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER,
              EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE &amp; CO. OR SUCH NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE &amp; CO. OR TO SUCH OTHER ENTITY AS IS
              REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE &amp; CO., HAS AN INTEREST HEREIN.]</div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;">VULCAN MATERIALS COMPANY</div>
            <div style="text-align: center; font-weight: bold;">5.700% SENIOR NOTE DUE 2054</div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z01e2acc16f3e470da3561d41821b7b33">

                <tr>
                  <td style="width: 3%; vertical-align: top;">
                    <div>No.</div>
                  </td>
                  <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 15%; vertical-align: top;">&#160;</td>
                  <td style="width: 50%; vertical-align: top;">
                    <div style="text-align: right;">$</div>
                  </td>
                </tr>
                <tr>
                  <td colspan="3" style="vertical-align: top;">&#160;</td>
                  <td style="width: 50%; vertical-align: top;">
                    <div style="text-align: right;">CUSIP No. 929160 BD0</div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">Vulcan Materials Company, a corporation duly organized and existing under the laws of New Jersey (herein called the &#8220;<u>Company</u>&#8221;, which term includes any successor Person under the
              Indenture hereinafter referred to), for value received, hereby promises to pay to CEDE &amp; CO., or registered assigns, the principal sum of _____________ Dollars on December 1, 2054, and to pay interest thereon from November 20, 2024, or
              from the most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually on June 1 and December 1 in each year, commencing June 1, 2025 at the rate of 5.700% per annum, until the principal hereof is paid
              or made available for payment, and (to the extent that the payment of such interest shall be legally enforceable) at the rate of 5.700% per annum on any overdue principal and premium and on any overdue installment of interest.&#160; The interest
              so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of
              business on the Regular Record Date for such interest, which shall be May 15 or November 15 (whether or not a Business Day), as the case may be, next preceding such Interest Payment Date.&#160; Any such interest not so punctually paid or duly
              provided for will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a
              Special Record Date for the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such Special Record Date, or be paid at any time
              in any other lawful manner not inconsistent with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said
              Indenture.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">C-1</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">Payment of the principal of (and premium, if any) and interest on this Security will be made at the office or agency of the Company maintained for that purpose in New York, New York (or, at
              the option of the Company, payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register), in such coin or currency of the United States of America as at
              the time of payment is legal tender for payment of public and private debts.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">Reference is hereby made to the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth at
              this place.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">Unless the certificate of authentication hereon has been executed by the Trustee or an authentication agent on its behalf referred to on the reverse hereof by manual signature, this Security
              shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">C-2</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed.</div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za7e12db7d29249b3aa868d037feefc83">

                <tr>
                  <td colspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
                    <div style="text-align: justify;">Dated:</div>
                  </td>
                  <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 9.62%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td colspan="2" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
                  <td rowspan="1" colspan="3" style="vertical-align: top;">&#160;</td>
                  <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
                  <td colspan="3" style="vertical-align: top;">&#160;</td>
                  <td colspan="2" style="vertical-align: top;">
                    <div>VULCAN MATERIALS COMPANY</div>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
                  <td rowspan="1" colspan="3" style="vertical-align: top;">&#160;</td>
                  <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td colspan="3" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
                    <div>By:</div>
                  </td>
                  <td style="width: 55%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
                  <td colspan="3" style="vertical-align: top;">&#160;</td>
                  <td colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
                  <td colspan="3" style="vertical-align: top;">
                    <div style="text-align: justify;">Attest:</div>
                  </td>
                  <td colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
                  <td rowspan="1" colspan="3" style="vertical-align: top;">&#160;</td>
                  <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td colspan="3" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td colspan="2" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
                </tr>

            </table>
            <div><br>
              <div style="text-align: center;">[Signature Page to Global Security]</div>
              <div style="text-align: center;"> <br>
              </div>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: center;">TRUSTEE&#8217;S CERTIFICATE OF AUTHENTICATION</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture.</div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd17379c3f0f343558893616dbde1df2b">

                <tr>
                  <td colspan="3" style="vertical-align: top;">
                    <div>REGIONS BANK,</div>
                  </td>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="3" style="vertical-align: top;">
                    <div style="margin-left: 9pt;">as Trustee</div>
                  </td>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="3" style="vertical-align: top;">&#160;</td>
                  <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
                    <div style="text-align: justify;">By:</div>
                  </td>
                  <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="2" style="vertical-align: top;">&#160;</td>
                  <td style="width: 40%; vertical-align: top;">
                    <div style="text-align: justify;">Authorized Officer</div>
                  </td>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                </tr>

            </table>
            <div><br>
            </div>
            <div style="text-align: center;">[Signature Page to Global Security]</div>
            <div style="text-align: center;"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <!--PROfilePageNumberReset%Num%3%C-%%-->
            <div style="text-align: center;">(FORM OF REVERSE OF 2054 NOTE)</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">This Security is one of a duly authorized issue of securities of the Company (herein called the &#8220;<u>Securities</u>&#8221;), issued and to be issued in one or more series under a Senior Debt
              Indenture, dated as of December 11, 2007 (herein called the &#8220;<u>Indenture</u>&#8221;), as supplemented by the Eleventh Supplemental Indenture, dated as of November 20, 2024, between the Company and Regions Bank, as Trustee (herein called the &#8220;<u>Trustee</u>&#8221;,
              which term includes any successor trustee under the Indenture), to which Indenture and all indentures supplemental thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities
              thereunder of the Company, the Trustee and the Holders of the Securities and of the terms upon which the Securities are, and are to be, authenticated and delivered.&#160; This Security is one of the series designated on the face hereof.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">At any time prior to June 1, 2054 (the &#8220;<u>2054 Par Call Date</u>&#8221;), the Securities are subject to redemption upon not less than 10 days&#8217; nor more than 60 days&#8217; notice by mail, as a whole or
              in part, at the option of the Company, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) one hundred percent (100%) of the principal amount of the Securities
              and (ii) (a) the sum of the present values of the remaining scheduled payments of principal and interest on the Securities to be redeemed discounted to the Redemption Date (assuming such Securities matured on the 2054 Par Call Date) on a
              semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined below), plus 20 basis points less (b) interest accrued to the Redemption Date, plus, in each case, accrued and unpaid interest, if
              any, on the Securities being redeemed to, but not including, the Redemption Date.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">In addition, at any time on or after the 2054 Par Call Date, the Securities are subject to redemption in whole or in part, at the option of the Company, from time to time at a redemption
              price equal to one hundred percent (100%) of the aggregate principal amount of the Securities being redeemed, plus any accrued and unpaid interest on the Securities being redeemed to, but not including, the Redemption Date.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">&#8220;<u>Treasury Rate</u>&#8221; means, with respect to any Redemption Date, the yield determined by the Company in accordance with the following two paragraphs.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">The Treasury Rate shall be determined by the Company after 4:15 p.m., New York City time (or after such time as yields on U.S. government securities are posted daily by the Board of Governors
              of the Federal Reserve System), on the third Business Day preceding the Redemption Date based upon the yield or yields for the most recent day that appear after such time on such day in the most recent statistical release published by the
              Board of Governors of the Federal Reserve System designated as &#8220;Selected Interest Rates (Daily) - H.15&#8221; (or any successor designation or publication) (&#8220;<u>H.15</u>&#8221;) under the caption &#8220;U.S. government securities&#8211;Treasury constant
              maturities&#8211;Nominal&#8221; (or any successor caption or heading) (&#8220;<u>H.15 TCM</u>&#8221;). In determining the Treasury Rate, the Company shall select, as applicable: (1) the yield for the Treasury constant maturity on H.15 exactly equal to the period
              from the redemption date to the 2054 Par Call Date (the &#8220;<u>Remaining Life</u>&#8221;); (2) if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields &#8211; one yield corresponding to the Treasury
              constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life &#8211; and shall interpolate to the 2054 Par Call Date on a straight-line basis
              (using the actual number of days) using such yields and rounding the result to three decimal places; or (3) if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single
              Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months
              or years, as applicable, of such Treasury constant maturity from the Redemption Date.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">C-3</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">If on the third Business Day preceding the redemption date H.15 TCM is no longer published, the Company shall calculate the Treasury Rate based on the rate per annum equal to the semi-annual
              equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such redemption date of the United States Treasury security maturing on, or with a maturity that is closest to, the 2054 Par Call Date, as
              applicable.&#160; If there is no United States Treasury security maturing on the 2054 Par Call Date but there are two or more United States Treasury securities with a maturity date equally distant from the 2054 Par Call Date, one with a maturity
              date preceding the 2054 Par Call Date and one with a maturity date following the 2054 Par Call Date, the Company shall select the United States Treasury security with a maturity date preceding the 2054 Par Call Date. If there are two or more
              United States Treasury securities maturing on the 2054 Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among these two or more United States Treasury
              securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time.&#160; In determining the Treasury Rate
              in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at
              11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">The Company&#8217;s actions and determinations in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">In the event of redemption of this Security in part only, a new Security or Securities of this series and of like tenor for the unredeemed portion hereof will be issued in the name of the
              Holder hereof upon the cancellation hereof.&#160; No Securities of a principal amount of $2,000 or less will be redeemed in part.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">In connection with any redemption of Securities, any such redemption may, at the Company&#8217;s discretion, be subject to one or more conditions precedent.&#160; If such redemption is subject to
              satisfaction of one or more conditions precedent, the notice of such redemption shall state that, in the Company&#8217;s discretion, the Redemption Date may be delayed until such time as any or all such conditions shall have been satisfied, or such
              redemption may not occur and such notice may be rescinded in the event that any or all such conditions shall not have been satisfied by the Redemption Date, or by the Redemption Date so delayed.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">If an Event of Default with respect to Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due and payable in the manner
              and with the effect provided in the Indenture.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">C-4</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">The Indenture contains provisions for defeasance at any time of (i) the entire indebtedness of the Company on this Security and (ii) certain restrictive covenants and other covenants and the
              related Events of Default, upon compliance by the Company with certain conditions set forth therein, which provisions apply to this Security.&#160; In addition, upon the Company&#8217;s exercise of the option provided in Section 1301 of the Indenture to
              obtain a covenant defeasance with respect to this Security, the Company shall be released from its obligations under Section 4.10 of the Eleventh Supplemental Indenture (in addition to the Sections provided in Section 1303 of the Indenture)
              with respect to this Security on and after the date the applicable conditions set forth in Section 1304 of the Indenture are satisfied.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders of
              the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the consent of the Holders of a majority in principal amount of the Securities at the time Outstanding of each series to be
              affected.&#160; The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities of each series at the time Outstanding, on behalf of the Holders of all Securities of such series, to
              waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences.&#160; Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon
              such Holder and upon all future Holders of this Security and of any Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this
              Security.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">Except as set forth in Article Thirteen of the Indenture, no reference herein to the Indenture and no provision of this Security or of the Indenture shall alter or impair the obligation of
              the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security at the times, place and rate, and in the coin or currency, herein prescribed.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Security is registrable in the Security Register, upon surrender of this Security for
              registration of transfer at the office or agency of the Company in any place where the principal of and any premium and interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form
              satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or its attorney duly authorized in writing, and thereupon one or more new Securities of this series and of like tenor, of authorized denominations and
              for the same aggregate principal amount, will be issued to the designated transferee or transferees.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">The Securities of this series are issuable only in registered form without coupons in denominations of $2,000.00 and multiples of $1,000.00 thereof.&#160; As provided in the Indenture and subject
              to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder
              surrendering the same.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">No service charge shall be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge
              payable in connection therewith.</div>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">C-5</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: justify; text-indent: 36pt;">Prior to due presentment of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name this Security
              is registered as the owner hereof for all purposes, whether or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">All terms used in this Security which are defined in the Indenture shall have the meanings assigned to them in the Indenture.</div>
            <div>&#160;</div>
            <div> <br>
            </div>
            <div>
              <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">C-6</font></div>
            </div>
            <div>
              <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <font style="font-size: 10pt; font-weight: normal;">
  </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ef20038893_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="font-weight: bold; text-align: right;"> <font style="font-size: 10pt;">Exhibit 5.1<br>
      </font></div>
    <div> <font style="font-size: 10pt;"><br>
      </font></div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" id="zdaafc057ae8a4a4c823c8f9de03e3c0c" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 50.00%;"><img src="image00004.jpg"></td>
            <td style="width: 50%; text-align: right;"><img src="image00005.jpg"></td>
          </tr>

      </table>
    </div>
  </div>
  <div><font style="font-size: 10pt;"><br>
    </font></div>
  <div>
    <table cellspacing="0" cellpadding="0" border="0" id="zdb1c4e2a13fe46e79004bdc4b5de4f94" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

        <tr>
          <td style="width: 50.00%;">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">November 20, 2024</div>
            <br>
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Vulcan Materials Company</div>
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">1200 Urban Center Drive</div>
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Birmingham, Alabama 35242</div>
            <div>&#160;</div>
          </td>
          <td style="width: 45%; text-align: right; vertical-align: middle;"><img src="image00006.jpg"></td>
          <td style="width: 5%; text-align: left; vertical-align: middle;">&#160;</td>
        </tr>

    </table>
    <div>
      <div style="text-align: left; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Re:</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Vulcan Materials Company Registration
            Statement on Form S-3</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Ladies and Gentlemen:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">We have acted as special counsel for Vulcan Materials Company, a New Jersey corporation (the &#8220;<font style="font-family: 'Times New Roman';"><u>Company</u></font>&#8221;),


        in connection with the Registration Statement on Form S-3 (Registration No. 333-277793) filed with the Securities and Exchange Commission (the <font style="font-family: 'Times New Roman';"><u>&#8220;Registration Statement</u></font>&#8221;), together with the
        form of prospectus, dated March 8, 2024 (the &#8220;<font style="font-family: 'Times New Roman';"><u>Base Prospectus</u></font>&#8221;), included therein and the proposed sale pursuant to a preliminary prospectus supplement, dated November 18, 2024 (the &#8220;<font style="font-family: 'Times New Roman';"><u>Pricing Prospectus</u></font>&#8221;), to the Base Prospectus, the prospectus supplement, dated November 18, 2024, filed pursuant to Rule 424 promulgated under the Securities Act of 1933, as amended (the &#8220;<font style="font-family: 'Times New Roman';"><u>Act</u></font>&#8221;) (together with the Base Prospectus and the Pricing Prospectus, the &#8220;<font style="font-family: 'Times New Roman';"><u>Prospectus</u></font>&#8221;), and the Underwriting Agreement, dated
        November 18, 2024, among the Company and the representatives of the underwriters named therein (the &#8220;<font style="font-family: 'Times New Roman';"><u>Underwriting Agreement</u></font>&#8221;) by the Company of (i) $500,000,000 aggregate principal amount
        of 4.950% Notes due 2029 (the &#8220;<font style="font-family: 'Times New Roman';"><u>2029 Notes</u></font>&#8221;), (ii) $750,000,000 aggregate principal amount of 5.350% Notes due 2034 (the &#8220;<font style="font-family: 'Times New Roman';"><u>2034 Notes</u></font>&#8221;),


        and (iii) $750,000,000 aggregate principal amount of 5.700% Notes due 2054 (the &#8220;<font style="font-family: 'Times New Roman';"><u>2054 Notes&#8221;</u></font> and together with the 2029 Notes and the 2034 Notes, the &#8220;<font style="font-family: 'Times New Roman';"><u>Securities</u></font>&#8221;).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In connection with rendering the opinions contained in this letter, we have examined such corporate records, certificates and other documents, and
        such questions of law, as we have considered necessary or appropriate for the purposes of this opinion.&#160; The documents we have examined include the following:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z96b54d46924d44418e4247e743cb86ef">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 30pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the Registration Statement;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0448a5fdad854ad7a657da3583a25c46">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 30pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the Prospectus;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3d35c6f5c92f47e2864f60770bb03baf">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 30pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the Senior Debt Indenture, dated as of December 11, 2007 (the &#8220;<font style="font-family: 'Times New Roman';"><u>Base Indenture</u></font>&#8221;), together with the Eleventh Supplemental Indenture, dated
                as of even date herewith (together with the Base Indenture, the &#8220;<font style="font-family: 'Times New Roman';"><u>Indenture</u></font>&#8221;) between the Company and Regions Bank as successor to Wilmington Trust Company, as Trustee (the &#8220;<font style="font-family: 'Times New Roman';"><u>Trustee</u></font>&#8221;), relating to the Securities;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">
        <div><br>
        </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Vulcan Materials Company</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">November 20, 2024</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Page 2</div>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6746d608528b40d0b896ce1b8120ad34">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 30pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the Underwriting Agreement;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zacbf3685195b41eba7abf43b4f65d310">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 30pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the Officer&#8217;s Certificate of the Company dated as of even date herewith (the &#8220;<font style="font-family: 'Times New Roman';"><u>Officer&#8217;s Certificate</u></font>&#8221;); and</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2c7455a8b2bc4cbeac93e9751c96f22d">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 30pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">a certificate of standing relating to the Company from the Treasurer of the State of New Jersey, dated of even date herewith (the &#8220;<font style="font-family: 'Times New Roman';"><u>Good Standing
                    Certificate</u></font>&#8221;).</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Upon the basis of such examination and subject to each of the qualifications referred to herein, we advise you that, in our opinion:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Company is a corporation duly
            incorporated and validly existing in good standing under the laws of the State of New Jersey.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Indenture pursuant to which the
            Securities are being issued has been duly authorized, executed and delivered by the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Securities have been duly
            authorized, executed and delivered by the Company and constitute valid and legally binding obligations of the Company, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability
            relating to or affecting creditors&#8217; rights and to general equity principles.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The issue and sale of the Securities
            and the compliance by the Company with the provisions of the Securities, the Indenture and the Underwriting Agreement and the consummation of the transactions therein contemplated will not result in any violation of (a) the provisions of the
            Restated Certificate of Incorporation or the Amended and Restated By-Laws of the Company or (b) any New Jersey law applicable to the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This opinion letter is based upon the customary practice of lawyers who regularly give, and lawyers who regularly advise opinion recipients
        regarding, opinions of the kind rendered in this opinion letter.&#160; The foregoing opinions are limited to the federal laws of the United States and the laws of the State of New York and the State of New Jersey (including the rules or regulations
        promulgated thereunder or pursuant thereto or orders known to us issued by governmental agencies under such laws), that in our experience normally are applicable to the Company and transactions such as those contemplated by the Underwriting
        Agreement (the &#8220;<font style="font-family: 'Times New Roman';"><u>Covered Laws</u></font>&#8221;), provided that the Covered Laws do not include the (1) state securities laws, the antifraud provisions of federal securities laws or other antifraud laws,
        fraudulent transfers laws, tax laws, the Employee Retirement Income Security Act of 1974 and related laws, or antitrust laws, (2) the laws of any jurisdiction (including the laws of the State of New York and the State of New Jersey) wherein any
        holder of the Securities may be located which limit rates of interest that may be charged or collected by such holder, or (3) local laws of the State of New York or the State of New Jersey (i.e., the statutes and ordinances, the administrative
        decisions and the rules and regulations of counties, towns, municipalities and special political subdivisions of, or authorities or quasi-governmental bodies constituted under the laws of the State of New York or the State of New Jersey and
        judicial decisions to the extent they deal with any of the foregoing).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Vulcan Materials Company</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">November 20, 2024</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Page 3</div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">We have not undertaken any research for purposes of determining whether any parties to any agreement or any of the transactions which may occur in
        connection with the Underwriting Agreement are subject to any law or other governmental requirement that is not generally applicable to transactions of the type provided for in the Underwriting Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In rendering the opinions contained herein, we have, with your approval, relied without investigation or independent verification on (i) information
        obtained from public officials and officers of the Company and other sources believed by us to be responsible, (ii) factual information provided to us in the Officers&#8217; Certificate, the Registration Statement, and the Prospectus and (iii)
        representations in the Underwriting Agreement by the Company and the Underwriters.&#160; We have assumed without investigation that the information upon which we have relied is accurate and does not omit disclosures necessary to prevent such information
        from being misleading.&#160; We have also not conducted a search of any electronic databases or the dockets of any court, administrative or regulatory body, agency or other filing office in any jurisdiction or otherwise attempted to independently verify
        any information or assumptions contained herein.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">We have assumed that the Underwriting Agreement, the Indenture and the transactions contemplated thereby were duly authorized, executed and
        delivered by each party thereto other than the Company, and that the Underwriting Agreement, the Indenture and the transactions contemplated thereby constitute the valid and binding obligation of each party thereto, other than the Company,
        enforceable against each such party, other than the Company, in accordance with its terms.&#160; Other than as expressly set forth in Paragraph 4 above, we have also assumed that at the time thereof and at all times subsequent thereto, such executions,
        deliveries, performances and transactions by the Company and by each other party thereto, did not, does not now, and will not violate, result in a breach of, conflict with, or (with or without the giving of notice or the passage of time or both)
        entitle any party to terminate or call a default under any term of any contract, agreement, instrument, lease, license, arrangement or understanding to which the Company, any Underwriter (as defined in the Underwriting Agreement), or any such other
        party is or becomes a party or to which any of them or any of their respective properties, assets or security holders are or will be subject, and none of such Underwriters and none of such other parties is subject to any impediment to which
        contracting parties generally are not subject.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Vulcan Materials Company</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">November 20, 2024</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Page 4</div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">We have further assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of all documents submitted to
        us as originals, the conformity to original documents of documents submitted to us as certified, facsimile, conformed, electronic or photostatic copies and the authenticity of the originals of such copies.&#160; We have assumed that the Securities
        conform to the specimens thereof examined by us and that the certificates of authentication of the Securities by the Trustee have been manually signed by one of the Trustee&#8217;s authorized officers.&#160; We have assumed that with respect to each offer,
        issuance, sale and delivery by the Company of Securities pursuant to the Underwriting Agreement and each purchase of such Securities by the Underwriters (a) except for the Covered Laws, at the time thereof and at all times subsequent thereto such
        offer, issuance, sale, delivery, and purchase, the execution, delivery and performance of the Underwriting Agreement and of the other documents relating thereto or delivered in connection therewith, and the consummation of the transactions
        contemplated by any provision thereof, as to the Company, any Underwriter or any other party thereto, did not violate, result in a breach of, or conflict with any law, rule, regulation, order, judgment, or decree, in each case whether then or
        subsequently in effect; (b) at the time thereof and at all times subsequent thereto, the persons authorizing each such offer, issuance, sale, delivery, purchase, execution, performance or transaction for the Company, for any Underwriter or for any
        such other party did not violate any fiduciary or other duty owed by them; and (c) no event has taken place subsequent to any such offer, issuance, sale, delivery, purchase, execution, performance or transaction or will take place which would cause
        any such offer, issuance, sale, delivery, purchase, execution, performance or transaction not to comply with any such law, rule, regulation, order, judgment, decree or duty, or which would permit the Company, any Underwriter, or any such other
        party at any time thereafter to cancel, rescind, or otherwise avoid any such offer, issuance, sale, delivery, purchase, execution, performance, transaction or document.&#160; In rendering the foregoing opinions, we have assumed without investigation
        that no party to the Underwriting Agreement, other than the Company, at any time from the execution thereof until immediately after the closing contemplated thereby has been in violation of, or in default in complying with any provision thereof.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In rendering the opinion set forth in Paragraph 1 above as to the good standing of the Company, we have relied exclusively on the Good Standing
        Certificate and our opinion in that Paragraph is given solely as of the date and time of such certificate.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">We have assumed the solvency of the Company.&#160; In addition, we are expressing no opinion in Paragraph 4 above, insofar as performance by the Company
        of its obligations under the Underwriting Agreement is concerned, as to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors&#8217; rights.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In rendering the opinions set forth in Paragraphs 2 and 3 above as to the execution of the Indenture and the Securities by the Company, we have
        relied solely on the Officers&#8217; Certificate.&#160; In rendering the opinions set forth in Paragraphs 2 and 3 above as to the delivery by the Company of the Indenture and the Securities, we have assumed that electronic transmission of the Indenture and
        the Securities has been authorized by the parties to the Indenture and the Securities for purposes of delivery.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Our advice on each legal issue addressed in this letter represents our opinion as to how that issue would be resolved were it to be considered by
        the highest court of the jurisdiction upon whose law our opinion on that issue is based.&#160; The manner in which any particular issue would be treated in any actual court case would depend in part on facts and circumstances particular to the case, and
        this letter is not intended to guarantee the outcome of any legal dispute.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">We hereby consent to the filing of copies of this letter as an exhibit to the Company&#8217;s Form 8-K dated as of even date herewith and to references to
        us in the Prospectus forming a part of the Registration Statement under the caption &#8220;Legal Matters.&#8221; In giving this consent, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Act and
        the rules and regulations thereunder.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Vulcan Materials Company</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">November 20, 2024</div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Page 5</div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This letter speaks as of its date, and we undertake no (and hereby disclaim any) obligation to update this letter.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zdad8b9c54096483aaff799fd6e2cb84b">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';">Very truly yours,</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';">/s/ Womble&#160; Bond Dickinson (US) LLP</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>vmc-20241120.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.9.1.5252 Broadridge-->
<xs:schema targetNamespace="http://vulcanmaterials.com/20241120" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:vmc="http://vulcanmaterials.com/20241120" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:srt-types="http://fasb.org/srt-types/2024">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="vmc-20241120_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="vmc-20241120_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://vulcanmaterials.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2024" schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/cyd/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>vmc-20241120_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.9.1.5252 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>vmc-20241120_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.9.1.5252 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://vulcanmaterials.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="vmc-20241120.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://vulcanmaterials.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image00004.jpg
<TEXT>
begin 644 image00004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  0 *<# 2(  A$! Q$!_\0
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AC\:*O:?IT%A)>26X8-=SFXER<Y<JJ\>G"BBI=NA2/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image00005.jpg
<TEXT>
begin 644 image00005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !< /T# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#ZIHHHH **
M** "BF22)&I:1U51W8X%4FU>TZ1.\Q_Z9(6K*=>G3^.212A*6R-"BL_^TP>E
MI>$?]<J3^UH!_K4GB'J\1 K/ZW1ZR'[*?8T:S;_6;6S?RRQEF[1QC<:H75_+
MJMR;+2Y-L0&99QV'H*<K6.C$6]I"UQ>-U"C+GW)[5PULP=2_L&E%:<SUU[17
M7^MS>%!1^-7?;_/L/&HZM/S;::J+V,SX_2C[7KB<O8VSCT23!_G3P-:N>=UO
M:+V7&]O\*/L^LQ\I>P2_[+Q8S^58?OG[W-4?G:*_#<OW%I:/X_F)'K\:.(]0
MMYK1SQEQE?SK8CD61 T;!E/0@Y!K$?42G[C6[01HW'F#YHS_ (5#+;3:,?M6
MFDRV1^:2#.<#U6M*6-J4[N3YXK?2TH^JZKT%*C&6B5GTZI_,Z.BH+.YCN[=)
MH6W(PR*GKV(3C.*E%W3.1IIV844450@HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH ***:[!5+,0% R2>U#=M6 .P52S$!0,DD]*SOMD]ZVW3U"Q=#<2#@
M_P"Z._UJ+_D)9FN#Y>GIRJGCS,?Q-[>U-62?4_EM6-M8#CS0,-)_N^@]Z\RK
MB74:4;V>R6[_ ,EYG1&FHZO_ ("_S8R<:?:RC[7(]Y==E;YV_!1P*G6ZOY!_
MHNGK&G8S.%_056CN[6S<VVD6QN9_XBO0'_::I3!JLXW7-Y%:K_=B7)'XFN2,
MW=JG\^1+\92W-7'K+\?\D3?\3@\_Z&OM\QJAK%]J5O;B%XH/,G/EH8W).?H:
M>UG$#A];FW?]=0*H-;7,FN116U]Y[0Q^:CR@, 3VX_"N?%UJJI\D.:\FE\47
MOY>AI2A#FN[66NS(YFM;:QAM4MGAU D*))!L()ZMN'45>4/H)&T+>/<'/ _>
MLV/U%54NP=6GDUB$.D:B LB[D4^II]DCVYGU.R"R6T;,BQ,>D8ZE3V^E<5&2
MYN:GNM%96<4MVX[.YK-.UI=?N;?2Y?MUFU"#[1<ZAY49_P"6<!V[?8D\YJ2.
MR1^;+5+C>/642#\C18Z;'<DWE[$K2S8<1X^5!VX[GWJU<:7:RK\L2Q./NO&-
MK+^5>S2PU2<%.4;OSD[OS\O0Y)5$G9/\%;_@E9;F19!9ZM'&1+\J2@?))['T
M-0VV[2+Y;1R6L9SB(M_ W]WZ5-&C7UK<V-X09X3C>.,]U:J]P6U#PRSO_KX@
M3GT=#U_2LYN5N>.LDFTWO9?%%]_Z[%1M\+V>C^>S06H_LG7#;+Q:7>7C'97[
MBN@KG-<D\[0[._7AXV24?CUKH4.Y01W&:ZLODH3G1C\.DEZ2Z??<SKIM*;WV
M?JBO;W]I<W5Q;V]U!+<6Y FB20,T9/0,!R/QIWVRV^W?8_M$/VL1^;Y&\;]F
M<;MO7&>,UYSJ _X1OXWV-T/DLO$EF;60]OM$7*_F./QKA$UJ\'Q<_P"$V,G_
M !(VU0^'_;9LQN^F\?F*]N-'FU3Z?TCB=2Q[_<7]I;75O;7%U!%<7!(AB>0*
MTF.NT'DX]JK:SKNDZ(B-K&I6=BK_ '?M$RQ[OID\UYV+H:M\6]>UEE\RQ\*:
M<8(QV,[@L_XX!'X"HOA9X2T_Q)HZ>+_%=O%JNKZL6F'VE=Z01;B$15/ &!2]
MFHJ\G_3#G;=D>H:9J5CJML+C3+RWO+<\"2"42+^8-20WEM-=3VT-Q#)<08\V
M)7!://3<.HS[UY1XIT:U^'WC#P]KGAJ,65GJ5ZFG:A91G$4@D.%<+V(/I7,:
M[K.H>&/C;XA\06X:32;1;6'4XUY/DR# ?'^R1G\?>JC14M8OI_2$ZEMSZ#GE
MC@A>69UCB12SNYP% ZDGL*S[S7](LK6"YO=5L+>WN!F&66X1%D'7Y23@_A7E
M'QV\2SZIH\OASPW*LAEL7U&_G0Y6.U5=P&?]OC\,>M8GC&2TB\-_":34;&6_
MLUYEM8HO,:4>6O 7O]*(4+I-]0=2S:1[KI6M:7JV_P#LO4K*]V??^SSK)M^N
MTG%3I?VCWSV2W,#7B()'@$@,BJ>C%>H'O7@>E:GH;?%[PPWA_1;KPQ&4ECN#
M=P&W%UD?+&%Y!.>]=WI/_)P&O?\ 8%M__1AI2H\OW7'&=ST6[N8+.VDN+N:.
M"",;GDE8*JCU)/ K%7QEX99@J^(M'+,< "]C))_[ZK.^,'_),?$O_7F]<!\/
M'\':I'H>GMX'O4O'@C#7L^FA82ZQY+[\]"1P>^12A33AS,)2:E9'M]% HK$T
M"BBB@ -9=YF^O!9K_J4 ><COZ+^-:%Q*L,+RO]U 6-8WF26FC&4?\?=VV1_O
M-T_(?RKAQE1)<DMK7?HNGS9M2B[W6_0?(/[4NV@7BPMSB3' D8?P_05%(\FK
MS-;VK&'3XCMDD7@N1_"OM1?H;6RM=+M#B:?Y68=0O\34S4,AH-%TW]WE<RN/
MX$_Q->75DU=3\N:V[;V@O)=?^'.F"VM\O)=6'VW:WV#0+=&*</+_  +^/<TR
M?3;>,>9K>H/(QYVE]J_@*==7'V#R]+T:,&Y(^9O[ON?>H)+/3M-_?:O,;JZ;
MG#'/Y#_&N>H[W4[/EWN[4X^27VG_ %H:1TLXW5_G)^?D,\[PROR^6K>^QC56
MVMK&YUMH]/N&@B,>Y&0XPWIS5L:_:@?N=*9H_78/\*S=3N=-O;BVDAC:W^;;
M*H&T@>OX5YN)K4'&,DZ;LUHHN+?31G33A.[34E==[_@7;.[FTJ\OH;R,W$)<
M>;*!R,C@D>E000SKH]Q-I\ADB8NDT7;&>&7\*FB6?1]61KU_/M)U\OS3R".V
M:M.!X>OO,0%M.N3\P'.P_P"%:4X-Q_>MJ,6T_P":'-L[]8]_F1)J_NZMV?D[
M?DSH-/N$N;*&6,@JR@\=O:K%<K%OM=64:;=(+2[RT8(W)N[CVJZ6OKF]DLKF
M>.W4('S"O+KT.">E?0T,R;ARRBW).VEK-V[WV:U.">'L[IZ;EFQ82ZI?W"G]
MTH6/=V)7.?YU5L7">'KN9N%D,KCZ$G%5[6:2XLQI=F,,A,<TP^ZJYZY[DU8U
M8+(+;1[7C=CS,?P1CU^M<JK<U/VD==&O64GLO0TY+2Y7Y?<NOS*VH Q>#(4;
M[S(@Q]>:Z.W7;!&I[*!6)K&+K4K#3H_NJPED [*.E;XKLP,+5IVVBHQ^:U?Y
MF59^Y&_6[^__ (8\_P#C;H=[J_@QKC1DD?6-,G2]M!$,N64X('O@G\0*S&\"
MRCX&C0%C/]IBV%V./F^TY\S/UW<5=^)&M^([?Q;X;T/PQ>6EI)J:S%Y+B'S%
M&Q=WU[&HO#OB'Q/I7CRT\+^+I=.OC?VSW%M=6:%"A3.5=3VX.#7O1YU!6?F<
M#Y>9W]"Q\'/#UQ8> 2->BD_M+5GDNKY9AAR7XPWH=H'ZUA:!?:[\,(9-"U'0
M]1UG0(I&:PO=.02.D;$GRW0D8P3Z_G6UXD\5:[J?BJ?PQX&AM1=6B*]_J-V"
M8K;=T0*/O-_GZ9VI:[XV\">7J'BF:PUS0"ZI<SVD/DS6H)QOV]"O^>*?O2;Y
MK:] T6W02&#6_B)XJTF_U+2+G1?#6DS?:HHKS GNIA]TE1]U1UJ]HNA277Q.
M\=G4["1M+O[2VA5Y$/ES#:P8 ]\9J#XH?$.Z\(:SX:EM(EO-)O5DDN4C7<[1
M@ [U/L#GZ5U?B/Q J_#[4M?T.XCE"6$EU;2@;E)"$@X_I2?/965D]%]XURW]
M#CHOAO#X1^'/BZUTU[C4M0O[295=ES(4"$1Q <YQ^IK'\16NIZ;H_P +[Q-&
MU*];2SYEU;VT):1/W:C!'8Y]:U/$/BWQ*VA^ 1H]W:V^HZ\P2:6:$,@)0'..
MW)/2IM3UCX@^#;<ZGKJZ5KNCQ'-U]BC:*>%.[@="!5)SW;3;_P"&)?+T,_Q)
M>:Q\1[K1M-L_"VJZ5;6U]%>3WVI1B/RU0YPG)R3TJ?6]0O\ PU\8M3U<>'M9
MU.RN=,AMT>PM]X#!B3DD@5ZIIE];ZGIUM?64@EMKB-98W'1E(R*M5E[6VEM"
M^2^MSS/Q'K=WXR^&_BF"W\/:U87(MC''#>6^UYB1_  3FJGAOX@7>GZ'I6G3
M>"?%9DM[:*W=Q9C;E5"D_>Z<5ZOBBE[16Y;#Y7>]Q%.5!Z9'0TM%%9%A1110
M!GZX2;$1#K-(L?YGG]*BNQYNM6,/\$*-,1^@_K4NK??L/^OE?_06J-.?$DF>
MULH'_?1KRZ_O56GU<5]VITPTC?R?^1!9D3:[?W+GY+=1$OMW-5-)F\K3]0U>
M8?/*S%<^@X _.I+$D:=K3#[QEES^55+KY?!$ 7H=N?SKRI57&/M>JC.?SO9?
M<CI44WR=W%?(?8O_ &7HLNIS_-=W)R,^_0?UJ70='$X%_J69IY?F57Y %0>*
M !9:5$#B(D _D*ZI0  !P , 5K@L)"KB/93UC24;+O*6KD_,FM5<:?-'>3?W
M+H"HJC   ] *S-8T6VU"%B$6.?'RNHQ^=:M!KW:^&I8BFZ=6-TSBA4E3ES1=
MF<AIMREU:RZ-J>%E7*1L?4=/Q%4X)[IM,N[*YA>>&([-R\M$PZ?A5O4K**Z\
M6^2^=LD>6*G!!QU_05'ISW.E:M?1QQ/>JN!(1][Z^]?%25534*C]U.5/F6K:
MM=)KK8]A<O*W'=I2MY^3(RMG/H:W,3+%?PX+!6P20>N/7%7+VWM5DL;B:[EF
MC=ML@DEY"D9[=LUGV<^FM8WJ72*LY9VBW+\PST&:<[Z2FEVI01FZ#(9!@DXS
MS4PJ0<.9\GPI[VUB^J[L<HRYK:[O\?/L:%O>;;ZX@T*)9%D52#C"(1P3[]JN
MYAT*U>69S/>S'D_Q2-Z#VJD=0EN=2C_LBU(/DL@,B[5QD<UIZ=I'EW'VJ^E-
MS=G^(]$^@KV,+SU6U1]YINTK6A&_\JZO7^D<E2T5[^GEU?J&A6,L0EN[SF[N
M#EO]D=A6O117T&'H1P]-4X_\/YG#4FZDN9GD7Q9TB'7?B9X'TZZFN(89ENMS
MV\GER#"9X;MTK*UCPU:_#OQWX6U+0=1N[N[U*Z&GW%K>2B9WA89+*<9&"!^8
M]ZZ;XP+X'-SI;>.)[B&50_V4PLZG'&[[OX5F?#,?"_\ MY9/#-TDVLX*Q?:Y
M9&D [[-_&?IS7I1DU!/6UNVARM+F+?P_NX=$^)GC31=398+[4+M;^T+G'VB)
MAT4]R/3ZUK_&K6+/3O .IVMP5DO-0C^RVML.7FD8X&!U..M6O'^E^%-:N])T
MOQ/"'O;MV2Q=-RR!@,G:Z\C\>*P)M ^'_P -KB'5]5F;[;TMY+V9KB7_ ( O
M]<?C6:<924M;]BM4FC,OM.DL/%_PGTV^ >6"SEMY@W()%OM8'U[UC>.H;GX:
M:3X@TR-)9O!^MVTZ6F.?L%RR'Y/]QCTKM])\4>"/&?BK2[B"]8:WI^\VL4X:
M%CN7#84\-Q72:A/H7BB?5_"UZ%NGBA0W=NRD;5?[I!]>.".E5[1Q:YEZ_>+E
M36C/,;S_ (]/@S_UW3_T6M>C_$CQ#IV@>$=3FU*:,&2!XHH<Y>9V! 55ZGDU
M@7NC^"O%DMOX5W3W+: G @D<"#@##2#C=QTSFLK0])^&6B6$'BB)?,MUNOLL
M5W>/)*(Y0Q7@-P,$=<4G:5KIZ?\ #AJMCLOA3IEUH_PZT&QOU*W,5JN]#U0G
MG;^&<5UE(C*ZJR$,K#((.016'IWBS1M0T.ZUB"]0:;;.Z33R H$*?>ZU@[R;
MD:JR5C=HKB?#_P 4/"FO:I'I]AJ.+J8XA6:)HQ-_NDC!K:\5>*]%\*VB7&NW
M\5JKG$:GEW/^RHY-#A)/E:U#F5KW-RBN.\-?$GPOXBOQ8Z?J.V];[D%Q&T3O
M_NYZUMWWB'3+#6[#2+RZ2*_OE9K>-ACS-O4 ],^U#A).S0*2>IK452UG5+71
MM*N=1U&3RK2W3S)'P3M'T%36-U%?6-O=VS;X+B-98VQC*L,@_D:5G:X[E;6_
ME@@E[13HY^F<?UJ.;]UXAMV/2:!H_P 0<_UJ[?P?:;.6'NZD#V/:J-W;7,UG
M:2!!]K@97V[ASV(S]*\S$TYJ;E%7^%_<]?P-Z<E9)^:^\KZ>F+_5[-N/,/F#
MZ,.:IV$37GABYLB/WT!9,=\@Y%:MY:3#5+6\MDSP8YER!\OK^%1_8KBVUPW-
ML@:WN!B9=P&T^M<,L--/E<6XWE%Z?9GJG\GN;JHK73UT?S7^9ERH=8\+QF+F
MXMN"O?CM^5:WA_4TU"S4$@7"#:Z]_K5=]/N[#56N=.026\QS+"6 P?49I-1T
M#S9OM5A(;6YZD#H3^%9T:>+H3]M"%Y12C);<R6THO:_D7.5*:Y&[)ZKR[IF_
M4%Y<Q6D#33N%11^=<_M\2QC8#"X_O$K2Q:#=WDRRZQ<EP.D:'BNN68UZBY:%
M"7-_>5DOG_D8K#PB[SFK>6K(]!W7-[>:Q<_)%@A,]A_^H5)H,FVVU'59A@2L
M67/H*L:I8W=V8K&WB6WL!C>X89(] *DU33YIH+:PM4"68(\U\CA1VQ7#3PU:
MCJHM\EW>WQ3EU]%W-I5(3W=KV^45^IFQQB#PC))*BF6<DKD<Y8XJ[=6D40TJ
MV2)!(9%+$*,D*,FK5[92W%Y91*@6R@^=N1R1T&*E%M+)K'VB1<111[(^>I/4
MUO# N/N<NW+&]NVLG^A#K7]Z_=_HD(GSZ\^.D4 4^Q9L_P!*T:I:?!(DES-,
M,/+)D#.<*.!5VO8PT6HMM6NV_P#+\#DJ/6R"BBBN@@\S\< 'XQ^ ,\_+=_\
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MJ:5!JR6EK<:FZDBU3!Z'H"W(!->CVTGQ&U[4[,7EI9>&=-@E62<K.MS-.!_
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MPM=VETHP\3I\PPW7!Q@BO/?&&GR>._$/P[CN+B2TO+S29KA)XSAHY@BLK?\
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>%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image00006.jpg
<TEXT>
begin 644 image00006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" "! ,D# 2(  A$! Q$!_\0
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M>59$9FCP&48WH2>O.,9XIE[X:U'56>22QM+!1%:P?9UD#+(([A)&8X&,!5(
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M2/6M"JFEZ;:Z7:"VL8O+B#%SEBS,Q.2S,2223W)S5NH=KZ%KS"BBBD 4444
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MXO[2*&?_ %4CS*%D_P!TYYKDKCPK?IIM@+:0)<6VI7-XZPN$,BRR2$'<5(W
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# ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45892418260560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 20, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 20,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33841<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VULCAN MATERIALS COMPANY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001396009<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-8579133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1200 Urban Center Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Birmingham<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">AL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">35242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">298-3000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $1 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VMC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9
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M)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04
M"  'B'19EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    "  'B'19!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    (  >(=%GM[&2\[0   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (  >(=%F97)PC$ 8  )PG   3
M          "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M!XAT62%XW/Q2!   CQ   !@              ("!# @  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    (  >(=%F?H!OPL0(  .(,   -
M          "  90,  !X;"]S='EL97,N>&UL4$L! A0#%     @ !XAT69>*
MNQS     $P(   L              ( !< \  %]R96QS+RYR96QS4$L! A0#
M%     @ !XAT61PX9>H_ 0  / (   \              ( !61   'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    (  >(=%DD'INBK0   /@!   :
M      "  <41  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   (  >(=%EED'F2&0$  ,\#   3              "  :H2  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /03      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20038893_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vulcanmaterials.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20038893_8k.htm">ef20038893_8k.htm</File>
    <File>vmc-20241120.xsd</File>
    <File>vmc-20241120_lab.xml</File>
    <File>vmc-20241120_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20038893_8k.htm": {
   "nsprefix": "vmc",
   "nsuri": "http://vulcanmaterials.com/20241120",
   "dts": {
    "inline": {
     "local": [
      "ef20038893_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "vmc-20241120.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "vmc-20241120_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vmc-20241120_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://vulcanmaterials.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20241120to20241120",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20038893_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20241120to20241120",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20038893_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://vulcanmaterials.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001140361-24-047402-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-24-047402-xbrl.zip
M4$L#!!0    (  >(=%E/G0$E'1,  -5\   1    968R,# S.#@Y,U\X:RYH
M=&WM/6M3XSBVW^=7:)E'0Q5._'X$FBTZ0&_NT#1%Z)G9_;(E2S+QMF-G90?(
M_OI[)-N)G<000IH&FJZI(;:.Y:.C\]:1O/_WVV&$KAE/PR1^_TYKJ>\0BTE"
MP_CJ_;O#?K?7>_?W@Y_V!QF  6B<=FY]'H7OMP99-NJTVS<W-RUQIY7PJ[:N
MJD8[C-,,QX1M%?!1&'^] UPT^SB=@M\NP-\8$EKS/*\M6Z>@:;@,$+K5VG]]
M.NV3 1MB91X?\7HZ>["*C=W.&TO0,$U,77/N&FP.43Z0\FP*'.#4EX!P$X!U
M<]KK;5.'FJ >C)#]]>'B= :>+8>?@;8SCN,T2/@09S"/XFVJHNJ*IE<Z45)&
M:AW!=>LJN;ZS'\U25%<QM+*?<:I<83Q:'&314!LH97-D+M\(#35 DHSCC$^6
M Q>-]0?&G .;-CU1M-:1R;B2348L74Y,:&Z+9O&,KJA&=<P9;^0 KPVM)6",
M0Y(N1TDVU?!)0[(<%!KJ@-F(-T!"2PV4W9+!<E#14J<@"QJ(QX(ZX(0V $YH
M#?!Z.!O0]3@B. 8N8CS$4=HBR5#":IJN%O#-(BYTS=;!3PCM#QBFX@?\S,(L
M8@?[[?QO?N]OBH).0\+BE%&4)1WT@2>8\I!>,0D@_QTE9#QD<88(9X /1>,4
M=%L%%)U?? ["B"'=;'DMK67IECY[O)N,)CR\&F0(D+.0@L0PJD\K2H'-D&48
MB3$I[+_C\/K]5C>),WBQ<@ELM85(?O5^*V.W65N.L0V*M9V/\:=]/Z$3E&:3
MB+W?"@!6"? PC"8=].XR'+(4G;$;=)$,<?QN#\GV-/P?ZR!-'65[2/2IX"B\
MBCLH8@'<(4F4\ [Z697_]I"/R=<K#J)$E;(ID/_V@-3[-+Q&(<SS4?_\)!2:
MX!\AI2S>*A&B83J*," 3)S&#)_;#VXY G/'\IX26/P'@#.C-0X)B/!2/LK!S
M"!- Q22<1/AJ2[[I!)/LW[9AF-0/B ^:SS1UW=,#WW<UDQJVZKHL**AVFUT(
M;B4E!V7)C)=R9?5^"Q1<)PAO&06Z16!-#N2?_78-I68,CV-@K$D74.0XZL64
MW?[.)A5,M< //$UGU&&&B3WFZX9)+*8YKD]M6]?NQ_0 ID$S/!MTQ@)6[3H-
M.0N84& L/=@7]JZ32DL&72-I_SH#+MX" J>4W;=N4[I5M HU]GXK#8>CB &/
MR=ZK7<K+-!ES>27->:? 7@YX*?8%')-T*J]"*JZ#D'$D461+[4NW]WM]]/,/
M'Y2WZKV/@#@)+:_ B//L""3X0""E:!J,O7QNUC9%DS: EBWE=?F2=HT.)=&F
M5&I7&+X-TE+(3"$>PGXJ R;41 >%<9B!TMO+59B W4]'.%Y7MK<.T'Y;=%"^
MN.PUUSH#7G;L)QS0*T04Y5>*GV19,H2N1K<H3:*0(C\"33!MSY)1!YGSC>50
M (';F2HI],4=JJ2FAT O@_K?0T/,K\)8$6JI@_ X2Z:W>/X6>4\H0SF@Z=#J
MO_.K<JS+WO,0PII":<H;-\50_22B0.LO9[W+XR/4OSR\/.[/"/Z$&/2/NU\N
M>I>]XSXZ/#M"QW]U_W%X]O$8=3]_^M3K]WN?S[XE6GH36G_B= !V,TOB7734
M!2MHF=Y=B#R<S?=]WJ[,]D;[GMGSFL0L,O+47-;%9\AH.![612MGZ&4M!5\O
M:Y+R5FO(9:&#0-0*Z2BE3Q?"=Q/2; "_K5\7;?JCI.U;<I':Q$5H]4E^+ YN
M$PXGGR\^H49'H'07<Z=M:O]=US$"9CN!87NFZGF^9AK,P)JGJY@PUU[!_KO*
M[XN&__L(T#>;7U!=%\=GE^CB^/SSQ>5W0>%\S-,Q!G\_2U"?$1''(LU "4>:
MM4UW4!*@;,!$TYB#H897'$-LA&-PY0]))IHUSS!?W<P(IT<,[H*-$IZA[?*:
M87![6)HA=BV")"Z;&=WI_/:S9H..N5=0SJ4#=9R[516)P:KO4\O33-MS3,^V
MO, UJ.7:MF.YEF:S!_KV%'I7AO#$0*"@4#Q1)H"[ D'*P5ERS88^.*&ZNBOC
MLU<B9WJCDW!/''/!KL)4Y'*R,VBI3(KN&G9@.,0*J&KZ:H 9]72+06QC45,/
MO!74V!]?3KN'9^@3.$@7O</3OG!,S@_/_KE \R?E^:V#[>-;&*$DA>!K/B4!
MPBE*1XR(4(."=X["+$4@\<#F?.=).2/#?L1@B%$$_CP1&=8MX')Q/<*4EM>Y
MIR!_KIL.*)P&355_G7H>X#Q$>)0"3/EKA;1!S7.J_)07^QD_J-TK0/8SBGAR
M(V*6]UO:=!0%4H8..%TSGH4$1^7+P2U:QNA+/9PYUTR?!B_\RM\&!2#^VUF'
M@^X1JEY,$@[:4:9&^QGHHVZ>F>PFM"9C1">!JVJN20+3<$V/J8YFF)9CF2XV
M5?PPQ2>RMB*^S=B()]<")ZGQ8"#_QWC*)G>+7<F(&6V<*9CQZ4PUS]JZDY9S
M5<'>U3E;9X)RDW3G:%XAWYV$$8,VL&\5)C--0JCC.,S5F.EY&&PL-IGI!IC0
M@.(5F.Q 537% /[4?B06>O#87B%#7>+;7I%[(U*9+7"717QJ4U\/L$I,W0PP
MMN%_GFWJ#%N!I:_ 7;JJN);C:8:Q'GO])&_RQ9MW&)T'S<^Z^8,"X5IJZO[[
M=[7<ZPV!<R/MC0AB$@A>./H/Q"XI#?/H!KR=L&J;2J=FZ9N:FAH:EMY>61FL
MJ  VXP"N8!V>F$'NGM)N,AR&J5AW1T+%HUP*ET_>IBG^!(KS6=&Z=]%'Q\-1
ME$Q >.K*#YTEK56)OD0I37_^!"W"OU^>L'[&469SSN >.W)(*6=I6OPY#6.F
M5=?V+#70J&?;NN^83F!AQU =FP8.M8GN.<X*-@3^IZ(OW,<QZLIQH2,>7B\N
MZKT42G7AYV=^F=S$55OK&)Z+P= Z,&[+LK%EN,S27<=3-4O75LB3''P(^1!\
MHP$>SI-FMSE_4\-,FI?/_!Q"C%"6RDS1,RP+,QV\2R/031=P#0AC;@ S8V%-
M-=5-1#.'$?;Q$,\COR+NYPET&/TK',W%88"L[UB^I@-9354W/-M0/>)CDU"F
M^<18@;"&I9OZ0Y))&TIE%",3EGW$84+"$8X0NV5DG '_PVU07BS=0=O_"T<P
M"LJ>-H_Q%!*UW3CY0HH..<-STZT&KA<X@<^8[9E4I.4IH1K3;1=;FJ>Z*_FL
MUOQD[S0SX6D"INQ\D,1+HC,]T$S5]/S -DS34'W+TSS7I:KCN=2@*PC-@>ZY
MBJ&JZM-SWRQY^-O/KJXY>RDX:!$;B9&B6 YU5SB<T5@$9 C#5$@>? XL^)]Q
M"I9]LLZPNP-&OLJE 3P"Y01R)SQN/[E%/HN2&Q3FZP8GH,R0J_R.@C 2PP]3
MH$7&8BI+D% :#L=1AF.6C--H@E)P,=)@(I\L'DA\0!67CKMHJ*0JQ] /1SB>
ME&U!$L'+X;F*RR%49RC\QK3S#-.7&\E9WI^81"3":9I7+)T"^2X%<FNG*^O.
MJF8+A#;E.#?ICS]YF 'CB#!@'!?.:%K-(_J>X7M$=XE*3<W4?94%GN8:#C,\
M0E:Q7PN6UT^2R,? 41GPM8B8/,<T]Q95S,IN?;[ ?&]0ET_AIL+N@G P_"KE
MT*BR\'<Q!DXU=:L0J+D%/['.MZTYJ'MR@71#;0'@-XH WD1FHR+33Z*0P!S&
M5Y^*TM**O 0&>'4XL*Q <TS?8"X.3&8'X 7:'G:\%9)6KU1>9E1#947NHK!H
M)E8TO2(OM57QJ;28:BN'?!.8ER PYYP)^R(*/V51B_!3^.<@J'FKJNJ8AHMM
M']NZ21S7#315(P2B)L8(T>D/*SA /854R'>OQ=%,JNC;_LYJ8I3#O@G2"Q2D
M7IJ.&5\N3M355=-T'%_3J&EZU*66H]D6!K?-\0SFOXG3RN)D,,7<)JN)4P'[
M>E*YZQ*_XNCFD27C$)N.EI7%25U51)I T.<83KZ*:IBYM1"C:2VD0*Y<O1%+
MW,4MV4,G7Q^N#D*@]]CEXH>OIUR*35AY]2 9Y,K]X<M6<T0Q7SQ1.)8)L?YD
MZ"?1=KK&2MYKXY.SHAA/L@DK53=HGIM!"'=FZFE]I;UIV<L+YYMJ,>H%_O=
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MVJ'Y&P6=VK?J'K3/9.ZCE1O^%&;Y+<ZV^'JN_)IN-HP._A]02P,$%     @
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M@YP.C^%DI**%0]\F4I /ZGKZ[#A*[7Q,JZ"IK!PC!%5!-),<&^8Z*W/]8O%
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MJ&*#B-WDK$RC*JP4W[*:13&W%'!T1:%E!89 @IX:O'7$!T#UWX+GV0$67(_
M<K!)$7)TJGWGE;07H;T=8>*PEAH&7I<%,"ER!:5?QYP9#C?=M0GDSI_B^?-6
MGR,P!"Z-0S"T%I@E'PD]RRG3<JK$S RE5M,NSO*W('3DI^9#OU 1_C]/Y=Y:
M.5RE-(S#$%:W?W2[JL0H2<)#^\;/5H^M0*LP%<VQX6=9%!'CM;O:;&ZL)*LK
MV[JR"U6]%<6:.>:B'W^34.2@J]E)["9J2SN*J>BQIA7%]#X4BEW#;Z;9@P"(
MPQ)Y:Q1P9("TJS&OA'-62L[;[J5723Z$Z<*"B/([2I,"KHAE"3'--D^H2*-
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M[GHQS*JVLN8L2Q>*HXFBM\+NB95G((%G.^SN-AR:'5TSH/UVX.B1TCC)#2#
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M><N47UND#_KS0QAB-?V@*/";;\<8P[I7/#-CG*E^)IX9T*=Q4\*C$\/?'J
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MP@?.2=&\N2K-FFK(.ZTV>:US6L^*<9W4ZV4IVA-;?117X5.X(Z>Q,#FDF&Q
MP.M8R3\:Y^4M1_T)XH\7RO97)@:=UR,SD>JM+5=<)PA4:>,4M(MP8+-4(S>^
M1]\2V-E)@2:^#Z#,4U+LW8%%T(UI'#!&21W\EXO,W>LZO18F;^"$X"N0P> H
ME5@+GQ!:&!IKJ&+YC@!Q:S7>2'V)C*Q(1O*+>#'\[?20>S$A&4Q&<\^J;A2
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MD-5>2^ 5J['+*$T*T>F5Q;BYN3+4&$&'_68U'%1W6*%.@9!!860:]6[D+'J
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M(N(07H+2I_9C;;Q)E):KCHA7FBL!YQ8A&:>]BA,Q[E)'?$K"^A5610@JFB7
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MIZ2I,C!EJ0/+!2K2T<G)"5[Q:=(#2;H.S]U?V]V+5A#BAPPD.*-8/ORQWY1
MA1'J32!K-U>EB[WK>*XLYXM=WU'V,!4NCH"A27,B:N-<#9R:-DZ*P@7A1*E6
MF4$_S_CD&WO6<9BIW!OS2$[[XT08O!31S%@3=@1;QVNL:E95=^N-EE@:EHG=
MN)ZGB1^EJ,IQBFB',KW;SK?>AQU],XMS9WZ+\^&>[K"OJ9=Q31:R=-4?;5*Y
M*&!EGAI,<JDGCI3/J14%LCW=/MAET&-P0*_=W'1<6;J'HYU''72F6UG4W<G3
MXJ!R_,1B([OD@W^[#G]NBU>253T8904K:/0W=0^MZU*&"9P7:$>L[Z)4J9J2
M-";6/$?CRDJEG=]*,(^-2"ZBO,ZJ9A)H1&K788D#J%)F=]N5K,NC@E5T4DF8
MF$G0(M$4O,:44D\V2LE#H%)&U A>@HMG]PD.'*:&ZM56M:UU;4#.0SM[Z)27
M4V*B[>^T<QE[JIGM(+E5R8S\/BP/D&I"K(8P"5>BV>K.XGS(\##^GE 'W0:9
MP+OUHW5$; !6RYAIZDTO8:?W[NO,6W#94! I7_N.!#1?$%*]<FJ.PU.D"7V[
M[8/='=53R&352.WQ6I["ME[9;=8;RW.@,"O=@)E;CF^\B:&89>Q4YL<,%^:6
M$I.%(!B3=E]O1'\ ^I76&(Z+6[6OM8;:ZL*&<V5H")%05+-MY5I(T23G8I#Y
M/,P&$UB#B@2"[I@>4?_Q5IE.+/"M7ATR%4H0@.&  <_H7GFB>CQ*%*Q>%S<Z
MAE>3ZW8AD)W6Z\U?A""C83AMRB7_6:75N*O(BPWWKV25)=8((X_1(8)%Q30+
M-I)A6;DA/25UX_>>@H@;[G3^775A$MW"$_M&A2?NUG^YPE9U*I@2!8^YT[S]
M9)P#VM,"QR+HR5P7CW30VNO:TTRR1DM$"ZB&.B%?(PD4^B BS5WK!)E0#">$
M*6-1<NUL9SNT9;6'8! "AB4?2 >$S/A8<2Y]=BG $<CZ6:-#L@9%/QAI\O/)
M:7<8Y %!$)-F@N><59<@L(7%Q3+1W_&L,8*@!J'U&$5E:2JCF#8-Z&R [AD7
M>U6.%*@WUYDT]J D(!Q7RB"S-'1Z9GE#Z^2<;85'.Y@TMQX5!O$W6]QF^NEZ
M"9)P?QY)^.!05L.(;PJ1V(BZ@4#5M*-1;DQ3**8%?%M1^MPHJ;+<8JL"^SM"
MQ[=B3W=#A;WG^*9KIB"2<X:59ESN9 M7<O6Y-1A:TGFT73@MT3TQ55;:::?G
MXN%(W6M:+X *7\^:3_$X9NX$65A*\*DY@7VXKDVOGE?HEV%*:H,+JQ! R$9*
M\M60VA3,(6SS/)_QDEK%/>M$G+Z@R/G!MV0Q%[^>G$>'OYP='_]V?'H1G?]Z
M^.%#]/8X^N7C/X_/3H_?16__B Y/WT5''T_/+\X^PQ?PE[V[)Z<7QV>?SHXO
MX*>3T^CPZ.CCV;O#TZ/CZ/>3BU^CBU^/^9+3PP_1A\/?SZ./[^G+\XO#BV/\
MX_3X]^B/CV?_H.L_?KZ(SHY_.3Q[%UU\Q)>^_W!R=$$WP<W1I[.3TZ.33Q^.
MS_$99\<?WVLQ"H\\^OC;I\/3/Z*5CZ?1"=ST]AAF\YZ&#P_#*X[_^P)G^>GX
M[+>3BPN9W:=/\([#MQ^.\15Q!#?+C?!2? RLR=GQKQ\_O#L^._=G?_C^_<F'
M$YC)^2J]Y_CPZ%<UP\^G<,?O9R<7>!^.%@:!_X%WGIR='?_S([[TC^CWPY-_
M'I_':HCO/W^ Z5W,-%2<[-G)+[]>P#BCWP[_B'X]_.<Q/N@PNC@[@06'>_[K
M\]D?M#%P[0=8V0^PB!^/CH_?G9S^$KT[.3L^NH!!?#R#:_1?AV<GY_@S[@9,
M!GX\._YP>(%?77QT*@%=ZH$+<0H79X>GYX='%R= ,[B'%\>_?8+;80XR?;Z.
M/J[\_NLQ?H[>'I[#!;#X>,,9W(TK<D;/Q*%_I(O@7Q_/_M!85+3:GP[/+OY0
MZXNIDT?'9Q<G[T^(1@XOHM./,'H@T',8(<SAG\>P;K_(: \OX!VGQW_@+,U;
M8,W/82"_'IZ;.X_?Q; E^,<Y+9>]"G37[R?G\&1ZX_EG) +[4;]__/SA'8P$
M)@5;093X3QH"D/7)Q<DOA[A6<71^?/P/W+[CT_<?S^ $$3U\A//P$9>>".6,
MR P3'@^/_G'Z\?</Q^]^43,%(B!:A[OD[; TN Z*^) ZWAX?G^)>?SXZ?L?O
M OK$(_K1W\VW?\!*_?81Z4 6'T:!A/KKL3W[WSY?? :JXM&=,[/@'3@Z9!*@
M*<.CSX^))B+#X9;1K45$MS:7T:TGE]I;&T^5[W:HH>KJ2=;$%ER< ($2KIR#
M4.\DO%5NNU<_,7ZJF:V\)BOB/3V3+B6?])MKU3C0SN32==Z2H#%,!^0!ZY=@
M2E@.@ ROH3P-^O)P!"I[/Z%&(=;=1YGT@3G"*B#2"G56C4S ?3 ]42ZSEX+N
M<'!)YWB37/*VY)Q8^.FWI #;!_3>: 5H.3?U WB=+-@Y=VA*Z9$P1+5:L16$
M81C!JDJORSYW2IKT1EEC^5KZ^:1&?Y33"&;%JMA!RJ@5:;#^;(C#<16YF\.U
M":;=!!4R&)A3W5)!/ G>;*BD-VK31+221![!_)<\R9J_U96:;$!G<H0I7:SI
MJ9LJ7&]!%2!#>Q1*B3AG=XC,P?$:LYL"(U*C$:V;2=54T XJ\44[5VF[="R@
MG=+")60F991R/W#S:C,.Y1]1&>"!)53-^F1ZWK2=B@9Q#]@4A,3EM+W MGA)
M)J&SD@PG#_A":"!/;L5JODZ+B4:C"HQ0#D1K0R@:.N-8Q-O!#N<RHN9=3K>2
M$-6IA*?YE\UT3I/K/  @PC2%D<+4,RDEF8Q>@$FY=8]2L 7[#&SO*_.2!B.V
M5L9SJ]+3 C7RQ!)W3PLX(3R7 E.0P+&#S(+OBK2D!KOXHRE%\WT4%.1(+^&T
M2[' [ X&??*<$4N3'(YZBT"Y*56K-A?];()*)4X>QL6YZ$5JVO&8!H*%1CJ)
M+91US"%QX%'H6^J)-:G26D<R<(KRD3!576 V% /5Q(FA8I*;>DQ@3V2&3AV*
M3@&,N5=55199G]FEU9AO/$",4J<8@QSGY@[S7FSIDQ,',AW%,17VO6@0Q^<G
MOYQ2!A$LV!;HC4H#T'+ZV#SV7#\6%^.,<GYJOEDA0CFIBX*]S'#NM_9.(4R2
MF7D 5YC2$HBS#";"\Z[AX _@L[[/+W2%!] U5N$@P9E+I8U 1&LU "L-,<=8
M)85TMUO0YK-5Z."5-.AZ3#X+4HVIW^6ACEEX4:1M)>.DKU0E:3O) 0.A?Y]V
MI)#("5E9])(F-@I_B^H$Y9M0DCC8-BH'S-6E,Y1;=$1E2J%9ZQ03+8Q4[&A%
M(F@4R1M1?NBJHGB25?I5\I?[1DN/N[D23'[S#NSIF[:KT20ER!;E*B?WBN,F
MM1H>NO.'6M45\60*(=4LJ2.$J;4D8#;3>XPX=#71UD-&Q(W)T.&"Q)<@]X)U
MA]]"^OG@W, OG")T.4>45954;F]0V_V-T7C3MQ7N0GC '-MQ2GB1@XFUX83*
MEJ)];KA_+2;J1TWRE0'HM0C%;WC+*?XGQ**[KMF!.R5(54,"'3S\DF$PUTIY
MA&<*KIA=N8U?)R"I;JG5A$Y8:_? 5A/GI@/XP%+"6,[0];#=_GM>BPF0^+5J
M_9J#('(#N3AT=;I^5:UNN$.:2:1TQW'W*CKUWQ0$&\ARKJA0!G;@N"R=%CET
ME[T,=#:!:=^N>A%U U2'[)1K)2T0-0+S1A$I 5B3W@)\WT3L2@%7$QD2*W/,
MF8M*?X+K:/&DKJT@N=X(VQ<FJ+NHM+;K);"))ZM51)WCLL@,@Y5#3'8)T,Q9
M6I<Y(UU@$<OHQ6+2W1OM=0'5H'1Z-/2F;^0[4&*DR&#:PU')JMPQ9V^L)(3\
MP:T_TKR\P6 E<M5:6P$$26IYW*0V_([]##PY-BZWH<(A:647M:1QK-52DMNI
M=#RQLH8(&I.'U8TH$^N0NE$XE;E#E@5S(=5S2 V2VZTX=RD(Q[LHFDV4\%2D
MI49P/C&;+9>X486I_$8VU^% K%1[S8"MZ5RZC$XL,CJQM8Q./$N6? ^8T$=A
MQ@%@& ]EHH,ITX%^^^L16>R'&A\_P*M5<KW-01?#O^/HG0!@GR'=U*&W6V"V
MMLFKE2>O+(+PR-#QB0AI3:!8$G.WM''/\%OFM@8!MZ-+:C15*7;-,,GX(&^T
M?<VW]0/NS[?OSY ] (9%,N3'JVY#)5K[8)0\5A;ZUG:L\M"=\H(6N2HE6_E.
M5!,"+ADQ9:CV0Q+_YJRP,91ZJ;'=R15AEM<KQXL1L0BW^6B=LL;VWT2;KW<V
M5[ZLON&,<WFA>_#46\DO8U?)#$NL-8/1_Q2M?%V-=)"G+[>GSNV)'&V:669.
M3:8KINPY!(=^M/Y^_4P/?6MW:_WU%O U6/K;P.M[2?%EAI=;JW6?4>SLKV_3
M&!"7ZE^!8;P_/WFT)=A^O;6.*_!&DNSEU<ZIGXWB]*@\TC*K,^_@[%W:C'&=
MMG"-<,B;%.XS3DK&#J!T= 4Q/I47N12I\%N0!G&"RC?\+D5W0!.=%/6DHH&J
MUBL-5:5>3G+Q]B/Z^B2_I.!1X\ 4$V6IVM26Y'I7#@9K[^'97Z+?<;D8> $&
MB?X$"1P76.-084RJ$5XQWRB><PGFUCU*,!>D62@.I%PK61T@2H*][TQ-C2F^
M6'.T1,J FTE%3I4)ZA^VPU]555+T4H5.+ PZ04Q0&%<.GD\WP% PSD4M /T'
MZS;#$E6#X:FB4Q-34PFUU@L[U2P/^E6WKO!3T%7?B:J%N.=FCLPRX2CSRZY2
M*U[@U*HD$9TAS (QRT,I\.U2676E%S#CM(EP=T'E=D0O>OHUT;!\-MP# WXI
M=Z.$1*ANAY:#R,+ ,IIYE"8&Q_KL(C.1Q<AS3_/6_OU4FO_OW,0)WY,PQ]F=
MPJ,C-+W^S](@7H1!O+TTB-V_I"\MHC]AX+"X_/NKC5?T]Q@[ LC?/#+Z./_.
M,;6%9HJI6<FXAFO4)SE,0C1H<[<F_BK*!G]_]:_^0;J[N3E(MOO;VSL;^YO)
MSM;F_N9.,DQW]K;VTGU[5YS]:2IGO_ ;!#;&^1=_?[6I9R@#WCF \8+VV(!Z
ME*N!P2G"A>VU'O5C,YCV].U7457>^&\*/]U]C!SY^YX>83+_1#3%IL(P./+-
M.NXX#<&YP!?N?%_,4L[P])<[N4>AD\\?C@Y/H]\.+XZQEN%<E7<\ KG8\WR&
MJ_NDI!,)#]8R&@7!'#-V7[,]WUMFI*NY3(6WMS_-0T*A66QMK^]V343$BC4/
MJB(>1+T<A.4CG94?ZQ\1!_(V.BP&57I3(XA?GM5Y^I@S#6^94@BG$ZC1!$CX
MOVA=8$%"?K?K;-S[L'7MW..<J]-DE/[4'BF/]F%4N+/5O30/&_3T0[-H)OO2
MMY@<7R]NC\_3 G.#_XG)]9_ M*6,'/;&767I4(\\,*U%+-I[#9+QD=&W'J#
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M41T.$\?W^EZBTGK@^3Z/'I OZ&*(0]]SZ8_B!:"9#?U$D)!'?G5!F/A%N4/
MV7$8Z,@ODT^0U@./*RU&*_'U/7=_KZZ=Q\V?@G.<1C?9!X$DZ90%I@3+!6 B
MD4DA(OP8&O5<CR&;[0.9@M24VD*'!Z!U=3'3!<@;AL7)&8I8>PC\ 1-R#^HD
MZO"G$R-7(#.UBN-2S(D2QS"%1/Y6P7E01@=-&@/U<F5_A,1H=TG8_9&/?. 2
M:*69A\@]+S8Z/T!N![*C>>B()N^ U_/0TY>>)/[&Y3I<.F3Q8P6),!Y*3^23
M>-,@?(8I@8#09Q"0%4[B_1$D5PP'?"0H0ZS?W M087UT&"']@4I1$8K&2/BZ
MU'I=+P;1*4PB\[!A$L^,;BI-C]DE9XFS8D^G$?J,3^Y6@P]B.B1T4N*5($+I
MF "%HAX_%+L)V\>30HQ*>;#2O^:)#I;,?G!*(F%P>B%M0IB9W3?BD7@<>6<I
M.I?.8I+W!WP2F2>]_E%1@+T45,.</OM7&'G)2"VC3[%$O:KI 52ZZ?KH*G3%
M:8COP[I(@42]$ 6;%U#(6P]S*"437'(H:'"'7143Q\2QAY"$$,N()](&<,0.
MT!.Z]>D*](*GT'_*W9(V!<#K:4&H9J_8G]GH$\_&'QV@+'#3?17JD0-_<X7F
MD9X[T/I>8RRY/TIWZQAVIWLU/ZH'&IV+44L@O53;$0+3V)B"DI E6FTO2MMQ
MRDPRQVM,P% F<^]'*KO<GW6V0>B(2R!#W\4MC8%WX]Y(D84T_45T5P4?8O21
M@<3(Q=P]NT1_O5"VG=(4G6;EBLC;U8V<-M?1D3&&DE"6;#$!&7 26G-.S:Y8
MM"OT<%OE"(4>G%GLN-5INRN+-ZRC5D3'#"9L6+Y,Y&AJE<C.!U"V4"!8-(GQ
M(D DOPOO"!5CY QICC:'1!!6MHU27VT)XQ9E"-4<U"F>29E+OT[7A$UY$GH<
MS6>*X0^J-5>9]_Y(987C37LDWB?AC[F(V7)?&$P5\9-X-$TE4X8[S:E@'!@+
M4AFRE#'U1/4I%C71=A"T&31K0XD<MQ$R^26!8]:/I7C.%;T<8Q4D9/>D6P;T
M?Q#B(,^Q=QO:(\+I,,K,VW:(\->?.?LPQEH=&MU3BC'-1QXG[37KBVH*)F;)
M>6;3Q5]<N;K4=@X[_Y(/J/U/USC-%5*J#2^O%,G>R6,]*MIY!K1RR5A=^*T2
M$ M9 @&R^AJ&;DI$Z =%LPXU4J U?)-P Y#:BL4Q<1Q&:G1,YWD(%7=G1@(+
M+3.)R\N#=!+XWKN_L?[@P[=7O5&.L?\AS>A)1_'2S1(.O2[8^%ZB1NI%83]G
M6:&QDWI/34\B:=5YUV*LY%'6R5Q2_Y*H/T-?8TD_2\^"8U NW_$((V45^*A[
M6'"J9(D-;6\@24DI3%! 9QA[6"A5GN^2SC?#<&//%RN3E,,_>]:%>A<I'H1T
MP#(BKV<$/[)?AE-7$JG+62QJKJ(9M!GX8H]Y?JSS*$VQ-^6[:9SE"89@JD\E
M:./D)(.+%@,MXR[\KK#:T)<DMUS<OZ15P84=/E!1;U$EP/K>+D@X-4]1_DO?
M57N-][R,T*M0/,I;>>?7X1#V3D%;L[N(*^-$(QP>5MY@4P1TSPI=)\W1GUT]
MW1=Z2<0'/I.1/LFE*LM/_DHN&CI0E]24G.&L-H".D*>YL%YB.9N2\9?$^)+Q
MQK*\8LQ/?MC1%S.:0:"8BH3]@@F4^XJ4^:68WX#3-AV/EB.7AJVT@( G)T;7
M<B'"%X7:<M9T&I/LL@'V"X;%F3Y2Z>%586G3WL.,]43*$;+<@*1X)*Q<(4Q3
MZT_,I*-$FVN&(8SW;#<9KB+]-,T_'9L*25^Q^!^7FO38L395$E/]U+QIMAM?
MG/MF^^N=T[BY=JYN;ZY%HBJ"J=U_;LID<H&JMM+LR*6FKAXM(G5UW+^7G\4:
M UDS73'R3?<Z:?2QM>;NI;3>/W)17H?_[62J82AG2C4IP-\-]3=M%V'K2%"A
MO@</@6KT852R9IH19-DKVYF@HC59E:Z!X55*^9"5.@\/F!J4<*-C#:-35!'<
M>U(CQSU5K/G(=KF('QEE>.$"TI)R3R2U*7WX%GWHJ<Z:*WHJU"1E*TR,\L6<
M\J/4]&J]4)DXYCY9JT X6H) 6+8H^,H2I.#13K*\: +E.FH3D,I2_E#D;'"&
MS'8T^O501?=%&49<6QBQ7H819P@C+EOTU;=6%_HXC,B31DAY.UC,<V^XM?IL
M1/$$805B'A'\-PV6J015HUC[<S91R;S627\P Q&RG5?/8O *C4HI+ WAW7@L
M?IGD+]5%ZXRI2'2WJXBJ!E#4R-M9@;5(F4[&,.H@,I6)"EZE-I;.=^J[IS0I
M0KT1E")==]L344:8+NX8F-/4.8"J8$P':D'AF:!.'D[;&)EX%_9Z5)"NITG[
M=/7]KO5-I7\6E@_OH]1R^^B8)ZBRY857 %[3&P8/&I+H^^'=H=/C6#KM8X5/
MB/3#?JHBY=BV9\N_-)<M]8ZW4.'[J#I0?6.C/M]%6^^;T=FS(JK[A_T*!E5$
M.\7 366)3 <Q&$7;0P,VHD@'<#U1OXL8!=$;H.J3+:1JZ1^WMF_<$;+^/I#$
M&BKP7]4SJ3+.C(DX4#\EZ%(,RTQP+VPH//S@Q:KK$(V(.3>%.^P*+@&'HA:@
M5AR*5ZN,'*DE7'.J& BC4;:5J;/W4E_\]?V5K0.MX0!)>[+YOE1-<IL"BX+]
MU-D_I*G\QU$%].S#:E5+A0>\X/I#/_$&OM!F_J,FG\DE.&,GF:ZLDZ:V?#@$
MO=X5ZZ<)%/>9;DI8D",32KJP0Z'K,>%(4:<PYLO9D\D=QM9+IM,ME$RJ8P#H
MK'CU[IY<:O4HU\%@?"S1$!$G*F]#6V,8(&?((/8PH(L5U$Q,#?""(3D?W?3+
M6/6DDQLZE*J0"B<RNV&D7&*,B(I2MU%D39$^T85!,/Z:QE+=S!2I:#K?[2\5
M)91;<"&K4[%U;9A@$;MNUX.Y&L"WE&E.<7_>8UA]A[6I,I5=JNFBNE/5 6>;
MG]+C0K?G 8B#2*2./C.@*5@-)IQVLT4S8F=S,47<9B'%1,%3Z&,13-R-N.B@
M+I-MN7@7S$3;6<9T<C=&00!EFP&A/3E>UFJ^H*:H0EZ*<"85^J(E4AA?B?16
MH&+@Z(L6G52IZ;FH"T1IF\L03 M-M'('K[1<BF;P<_ XBBG%1/NO+3,/>QF[
ME__WD%Y2]+2K%%/;7&0',_N>FQ<O]4"6I4):%S7C$^B:SUW)II=^^V^!LRV\
M!5KRG'=/_-];54_J R))?P^KM*CCGE1@.RSV1"X##%(]P(+($7Z#7!"QSDE[
MYCXP2UT\T(?Y/,;[EG38(HJ%3'6() "$C,4-*%<W0%-0F78QF(8'^!FF/GQ(
M9ZS^#O.E%#YUNLJF=JYQ:*%JBFXG!J-WNQ'&U<C/5IP;YG"1!PXSUD+T9G'T
MOH]YA:XNUL/#79$7?'!I#)A'=P9U^C-]5!^DB\DR>)Q6H4HQ*Q\J6,#H'OK'
M$(R'&HDQ,SAB=+R T<1#M-*3--<94_S@[B,_G88&L&PUBC#[-LABPJXO^N'E
M-D F0N$07X%2:B<.M3E737E/L*.%<.R%$=U]HH$"$TJ*<ZF^?\U&^Q7E.D/-
M@>ZW#MP[ ;9 &N!)N6DMI,^?V+B#VWXA?+Z%0KB1!O6O34MOYX6RYFCR&$BG
MUNN,X:+]6\9(UQ8C/2YCI!L0([W8VAAIF[N\/\!U[+RH9 291%6#5%FA=T9I
ME>' 4@)02)Z2732RQB,,D8 Z*9+%YCZDYL]'K^,E3L,X(PGTM/7J1JVZA>K&
MI,91.\(\RZ"*/;:_*8(T#;EDNWY96E+D^V)45,3=E!+HZ.,_>=3U*/$?:SIP
M/4K0\+[9W0C%1C$Q6_O7TM;Y:>S=D%8Z#:(@E@QA!_;0H^BP)2J/\K[)B=_.
MN@*%BBD*RP+'@\UZ"D4Q&:4K$.8'FM(BH<2>E!JE>RA:/Q67CZ\:L C+T,D-
MAVV;(D,7M:BQTS39?5W)(.:FR[G,G4A$%9>:WB!"/S VE&?QHZ.G4JO6=-^:
MR1FY69>K'-;%=JFQ]B#@](<!FO;%?5#V<QK6+D:RS8&3L *&<D+FK]%B3K="
MH#9<ZO&YA->&5W9LJQ#L;(P0_%.$0>J%?J*SB$$'TZ2DYI0OEQ2:5"7M:F49
M4%"M%Q0Y(!OAZ:F0J:VYZMA>IW81YOD4=!&_=MDP5M"#?2J^K% +"A$(FB+4
M1&H=0=D.1BKX(U$1?EUUM4S1*BQ:=Z]EH@Q[G-:+[/'"/LI%_O#VG4Q[>.M_
M%+W/R$DV5BX\@MTL:+BX&X$^+MV!N5YL9BM#6=N;9@EB"@8U"]:?$!5.Y:4/
M$XS\UY_=3(MW)E:+6;T/LQKG;XP\O?W)0GB:B)Z99$F]*H3#Q3]%G<I4N+"%
M,VB,)5F]EJRDPQ$)1B$892CMZ&RIE#8_J<U!7AGH(7'#RC@'Z8VO!]0MRCTS
MD&*#MU4Q)(.T;3<O1;9<':CK8)J:C4DXBWQ/]<!46@[JWD'H8&-:^1?=I%Q%
M[VAHV5**M $OEAK"!SLY.R69OX+,GY9)Y6!$B:/+]NM7IE&^:[?UOJZ(GB6Z
MW^JC8?H:I"H:TXL$?!$2GTV/)@^$C+,B"( YSRPCV2C/QEM&[P+0[PU*+F^$
MK6:5^3GEA5R#V65^&&N21R,J=793EIG4,1S1+DC3M"J<$<E_:/J1ST.[-21"
M3$F%6TR%+]6 YU%.2(#I_M2#*.QR=P@$)'0$(C[\8Z8FZ>T2U5OR?W67Y_]Z
MD1?LON HPJPV?V0ZW[/=T1&LPJD=\X/:V/9CU,<:T03(E16G:?X^>XY5.<#0
M%RD:19*AQ LYME $")@'=0],E+(-0O%-H].;P$0-N&KOK]<R7K56+<T4SL@L
MZHNNU,A-4^I)64!KVN+<7MAB >:R8!$]6%.2+F$&G2K[VDG1#7E?90\\TS!O
MXM&EI2$%[ 0! AQQ$1?&D) )&:P)I[CZ5ZZ/0$2\*!FFW7_5'FZ(^[_,!7I1
M+M!)F0NT8U>ENV%7Y6U@,4JM%J@E_E+)764@3GM#_TT&2S+J^18&2P0R.JG:
MRB>8<S'C7\)(14%$E21<2@,>(2:.L@V-_E#B(B*WR20GQ.9:6<L\QOD-AVU:
M'89,%DJ>J@I7ZVL@>53?YH00*$4VAL[>R&5M%'(]%'R-1":;E\ZG^31*HGZ3
M1#U%]LY#SU2B2,6Q1E*"_)B[N?R"O+ZOZ5&(;<QCR#:\ 8ZX[?6 UJ-8IF@X
M5Z(#=I><Q=JY/4=NDXTQ.AR',9.3"K@$"_.$3#WH!>E@%BK>Q.2II:B??!GJ
MYTL2-;$^RQOHUE72'^-B(R-7VO.9*X ,<F"+_@#AZ%PO3B*O,TRFI_58=!BK
MB9Z[0G35LS&2O*3,;DZ9.699P^*4X#]Y=R@;8!G<7W&&*G=5/%%HU%E$G,[-
MK9+;(*/K)S>'(F04DD@6#Q6)* 4P*K%+.V'XXP!&BD;[^:UF3@#'FL80)M9:
MX[2'@9$\*22-<B&9]4^4O"MO85T>2>XG>GOVI2I<C$FV5@''+#FEUKB;SC$M
MT\%?+E]Z&Y,)6?0!2W>>%C4:6R.PQG[S/=D&LT9_,<D7ONWED<-(RK H&=%K
M57LW]7(%C,$"0MXT.L#':<.\9R^6;N#^P/?R^>2&2[M'N 1RZ+Z$-,_4P 0"
MNT),5,Y++23.Z\Q%&2IR+H3"[D;L.9#N3W**XEO3YA"6Q'#9T\Z6THF#FGE0
M6>'@]81JDNW:0;GCL8I1RKC[C&X-:T^0G %!/F[59CJ0+?HL':8S^*RN'LL:
M#-!F>*BQDRE?/I6+2S9Q;.&$F<(#;ZMS?&T9G>.77CQM8/S!49'ZL8.5TVW^
M0#1^R8(?JL.#0H#L" DNN]6,G#8U;HE8I/HMIGJ;I;>TC@$Q8# F9748^-3.
MIX B'I(I1I4GYI0JP$,1,"*RK^BM=LU1T/:IY*AV4:TZ)[_%PX':O2>TX+K,
M5SM(2T["P0?']P)^H/SLM<R6Q; [/L%A)(^__0*C_>XT@$V''%82)8\5Y^AT
M&>_XZ(=8+7#I89NBAT?6KS@-GW58GSGUDZ-J_8,2:$(F@L2/1(&5O-B,-FD3
M3@93KW7;?M6<2>,2PSEP/Z?)%3KFXL675@!DM.[\?9BD/72WOTAS&_O?&T3Q
MT<,&9#LHT]YXE2:(5V1C;!+F9M(O%2,B2GU:TBWS&U"9(3]4-FLCA6)":5,[
MV7.M:$Q4=1BG&K0M.R&U"<3K1(\;1_0;(ND UFV4D 8E6R(%5#0>9UKX"#4^
M),75\LUT*68<)1KZO)B&@+;\T']@V69W?2^.27..0\</L;"KT#T:LT80Y4]M
M\9XL;M65HS:-E#D^Z)F^? @MBWV+ V/OY[[3\WS#ZDBGI-^3^UBG4L@0%%VE
M/6+O?9%5LS?:EY:81BS,N4>I4R!98,\@'T"#I1.CDDI#:(^KZ<)VZ5ULWR3]
M$$7,/OQ'#%+)Y8QK^LQML !D676HLTRD&)-(<5HF4NQ<-&JV2/D<01L#GY0T
M1["7O="-C=1[*8<SE\N>+M$F,]Q(-*.L")*!<B22=^IF2.\9Z@)?JQ[\D[RS
M63A)=->B!(X4D&M_G_P<S M4@,<+\&-1[V!>9!VNGA0^;\1$L)4;[%&ZM_R>
M*BZ8.(,R.KJ3T='EYXBOA ,+^IC)@_^Y+3RXB,AK&5Y]LXT@6C*>^)3)W3:,
M+-3(!]AD.DD$J9)>C^Y[>3\!S>49);;J_:8I8_)FD<XIC][B\N?HE7KD9#WD
M# %BA RWJZD4383)M@!:2EZV$=@S6X*QF<HPB]]_64)-%- :4Y;M4)T8D=G5
M2P:A:-A+FZKV489*\@T_GGD'8]TF:+LQAS$+2>&18_)!(:2[MV^Q-M'JP[^!
M"L<ZX=-\76QVUX^SE$*;5WMPZ$;B#Z'N4B39%VS\9)1F> ARB[A,+D 'KI5<
MBM0A:=125Z&ED*;;)H)A1V'@=3&\QYQ/#*]=FEHC8/X(73?X@C9/(H\_(1+W
M" 1(WW+OBS]4TAY,.<FGWTEMA;&#"$R57FI,HB&8AD2'&'!?RZJ7\UQQ*Z8Q
MH6575>Y$6N BI(601BE*K*7&!3;1]#67[+N^Y/\YV??: /^5/%G)J*^4+11V
MA^+BLSGB,,%!DZ6N 9@ETN919D*1>(WW T-JG#H1<!/,XD4J](-<9J2/92ZS
M-(? Z-A#/T9#\4T9"Y)A?7/A!46=FK1+) ZA>*-K<.)7+,(BVT;+"(H5M^$;
M*"Z&6,EG><C4+\(A OX-&!Z0-1%!,.@0#HF4 =A3_4>G&.S<8W':O#X3(9OE
M3-$;:L)T1!P.C?^$78AAOWU$LIJ4JQHK9*CB=MP0!E:O&+2S3 M6E9F5[J(M
MI9?,]P&1G"A[*NAY4;\BFCH8J2/2NQ^E\8+*U*.<=G+X_?3(7$[MJ&!**9WE
M8ILVE2G5PM7D##[M44,,"S&(\QY+#IL055..Y44*W0Z8 3!BHWW?NOK2=%JM
MUN%4V4O?L:QGJ5'/23ZC3\V;9KOQQ;EOMK_>.8V;:^?J]N:Z==^ZO;ES;C\Z
M]Y^;P,?U8^?F]KYY]Y;R<NJ'U6W,R[F6N0KJ'DW1+1N4D+I[X>Q[RM;S!"9O
M1R0F2]@'W" 3*XD927:3P7<K:5*(JP*@LJ_5R6$=\6/N>.#E%0V9Q#WDQ#,5
MV:)*8;8(CXCO]2G!&].)Q]9-F%"&DZLKQ$6+#*K:YG94Z#"]H?*=>U'29U"B
M=(*2D=5=2!$OO*UB.F:R.Z&YK%I7WS,OA#*(N9X@YED9Q%R7T]JX=[8Q<>JK
MQ%??R?O%N4OH(E";X%"VLQ+&:7*G%L/*[V%B8^&?MSSI#VBWOH6T^W$8D2W3
MPFMQ!Q/^S$(5=-H7,EC3)"9A1@8Q3[6+0K@CO?X%V*>JM6"^K%R@)UF2O1*$
MYJ44FX9"\RQ\F5A'XV+&"'T9L> 'N5<U3%Q$W2+ZBAU=58,FRR,4V$%VOE/?
MG2^!S3&U-*7-9+R*;EVG/$&@8L)4J0>0U#0+BM$$M?-PVL;("B.J?S&K!&F?
MKK[?M;XY >D9Q>4K! K[Z.AC(<!%EZ>!Y=XP>/!D/%B@WO<X_)UJ\+HAT@_[
MF?K2+'NV_?+N>!OE'68:2"\:>F-V3^*E5C'B,@\BWO<0Z%.!8RA .Y(ENI!+
M,TH!\1*XGJC?#7V?;7WJ/E#UR192=0$<>O?(.@4@BCPPD% .(X(C@6&/T4!S
M"-[D[XZ<?@CBOK"A.>AI')&@I_-WV!5< L[?6'_P =2*0_%J H_DY$R_OK\R
M_1>9]&X3'ES/=0GHDVEYE>K[@N\LKICN+)@P)?!CU ,.,70]%JAD>=J/8FBX
M.%)VPW)[M/4"XW0+!<9U"MR.-^+NB8M6#\/Q1);7@@M8)%".17-F,@&& ;()
M531'\(NJC=#=F)GN2H%?QK 6I_IMH2$R4V:0#Z> /<$>>- =R;AND /J,7(A
MW,P4J9Q#U* 66L*H[(4+V8-?E$Q3_9W@_HJSU]FWEEUGBKIE1.R!1;I;CB&5
M4 #@XT+EY@'(!OP21M(8T)1+J$![W?ULD1_M;'8#:)L5^!A&D$/88FR6'7%B
M+Q4 YN)=J@MH;CHY05X00-FTMS[!68^3M9HO")-2"$^1%Z:;DA3&3ZOM=84+
M?!-S=/#VP4X SX'HCL*RR^_P %[8]<AJD#H7O-)R5YDQWL'C*,8JTM3];)DY
M=1=*S=&)[4%HPK:Y4/1_W)Z;]R&>'8EW9JB(9G@!/>NYF])TLI=^[[7YO<]+
MO_<&^+W/ME"):$DQL7O:P[W5H&!1*CGW, EEF C8$A2=,K$%N]/43ZL'<#D[
M(_P&.99$8C#Z!I^Y#[*V+A[HPWP>XWUR2N:CJ4_">7Y41>_YT;%J61-)'!89
MB1V@MRL(T,!7!GL,!O^!R#+W89/TC-7?8;[4Z4F=;K9?B^SS@%E6W+@G) XG
M>4^+<X.+4]=U]K$4%!/(8$3[*W0RE!X>5(W\O0DZ!\)]4I+8T!]E/(\?I./0
M,C@E7(O1Y2TM'RKX-=#I]X\AF(0UN@7-: 4<+0S8E9UNQ$.TTI,/.KD45@@"
M37A?51#$MM5X ]JWP1-.2H0-*9J9G6&,2A$MYRM02NT$=T+O//RZ]_PHW+5A
M1*H3+==E0L=U+M7WK]D(JW+DN[#-C$A=KS@!T#VZA[I<Y]-%W.=/;-S!;;\E
M=[Z%0KB1IG1<FXZ"G1?*FJ/)#R1=E8OVI6P_S5]L(<VW-7CWSE,Y7E-&$94!
M:ZZ U089*#9EBUOPR@MF(PR1"+ ->'SN0VK^?/0Z7N)<&F=$<<)D^WU^M>H6
M<DVAN=SN,<\;;^^3QD"$&R^0I18S]!6L.-G^,20ET,7'?_*HZ\42<2?"]2A!
MP_NB=V*:_&"K(I">-3 10"'.-\W4TDKG)13$DB'L0)5]9$8KG;Q7<N*W[0CF
MH@.I!YOU%(I"+]V-U-K8V,PFS0$&VTIKJ*DDB\ >U+WS19LBJ498-)!I2LB^
M+KL1<]-E#^9.).1]+G:M! W_,6WC7ZO6WEMZ75H;E9O.UK2/L#^,M?&'TQ\&
M:)792HR$P9#&F8NA97/@)!1P]FBYZ)J>2MH82)1/R<=+X;61-?,O$F%_BO"%
M A?NA;X?/E,9]DS0KVGOWD+!T$#TO-5HL)8!!<W9>D1D(S,]&?=T!L..[W71
MPP*,TN6J(RAQIV5TFP#R? J62* \ ZU H.QB'"AMH#A1)%54%]EN.!CE2@=+
M5* -1 62E6C*NT*]WYE0,9%$TU]EYTXCE0[S%-C(_(1H:RJ'; M44-DD:*5-
M@N8F75*2B' +:I"I(RDD@9+JWC35S4]V\R 7\X2B(T*MIUM7.IU)$]PSRL_F
M-HF)5B=WJ#>,9%FSMJ\=^C;L5^,VIC"#RPR<C "O\,CW5)]ZI>:(?OZ.#\]:
MC A'/'RJ=*),BTP#C!Y=^T)K*!GN33/</+#U<W :F&:"?%(EV32X4-D8]F7O
M!>5/+"JY*?J5\D!:X#T$7H3(LQ<QTMGT>_)KR, ;XBR8\YR!F6V\E6G=8G!3
MR4-OF8?F8:%7,14FL_EAK#E"0*HH#SLEM2E(D!ZU(=0DK\IG1*XA6JSD:-&^
ME&WJ [JA1+K49+!)^[;)"6$7DQ+"\HMZ=5(8#;@5B6%V#EH$=ZQ2[JV@CZRX
M44?*KS&(PBYWAR"RA.),X@[_F*F%>[T8*]NI+M8UO)1VAR]R"M\7_*;4XFDT
M!GX-E+_VT.=.[9@?U(Q24K/#IRAT2UM(Q6FUBL^>"W@01:E%"2!R[ P,NP"@
ML U"P7JCI: % FR:58DQ+HSLQ)BP/V-H3Q<<Y:8IU7/*G(M5/HQ 6\ONA2VP
M92X+FWG!F@S\Z!E4^>QK)X7JI!Z4/7!C&Z<<75KN) N$TX:+E->.EQ<E.1!X
MGJ7;HJWSY>O6AT4*3UZ4#+F.%J@]G"N6M3PILSL!L*5TA7R%K+L-9C5F+?&D
M2DX6 3_TAGX9_'EE\.<UIN+<VI,$ZD%523DZ<V[UV0 FS<;@ D /_3#;XM48
M<QBO.^$W[]58!4J$*AJVHW!C=;#(&M%9)KGLDNE(JO,1^C:Y04JJ?FF :4$@
M0PJ(7>&PRUP+^3%W<VD3>;U-$Y\0TIB>D6V+PR9VVS5\XW,D7-FXH,,%2$*:
M,94M RX-Z@U4-?D&-""G%%&C?[=A/+O8T\B5QE=&J)/UA(B(@P1HW\6FSUYG
MF$Q/2;*H)59[*G<IZ$IK8R1Y[9B-G3)SS-*_Q8+D/\%.3%*H$MW3>JBR9L43
MA=Z>N0)[9;%E$Z_,#3(:A7)S* (Y(+%C<2>0'**<'XG0 *_MA.&/ Q@I&NWG
MMYHY 1QK&DB86-^-TQX&1MIF"G.>"4=@ RQ,&Y;WJJZI(U\!O3W[4A76QO1>
MJQ1CEFS60BT;_J.S6\M<SI?+E]ZR3=D%.>^D'\9$ZE*)V+98<;Y5VV#6:+%7
MZ+= G/;H12XE98_HM:KKFWJY3!R'V0<\32=-:&&ZCQXVIA?^NV*K^8POLD>-
MZN70?>;RO#C!(6D"YKS40N*\1ER4IR)U1*CC;L2> ^FW*L"DXS\T#;-;A6QU
M9\6%"I-,:E=64 @LIXAGNX90!GML]O,/9W9G6'N2Y,P#<DZJ+M6![-QG:5 M
M>QUBUHR% MQT<#.=2-H?$EG D)%+-F!L?N"9_+IOJ^5\;1M;SC=$&QY%/Z2*
M[&#I+2*!((U?LN"':A$ @@4[#)!:8T<-*8"96+H%:^<] P9C4E8+9)JD*.-"
MLKVH_L6<4@5X* )&1/8EM0][/H&@[5/A4^VB6G5.?HN' [5["(B'#7;4#M*2
MDW#PP?&]@!^HF'(MLV4Q[(Y/0!K)XV^_P&B_.PU@TR&'E43)8\4Y.EW&.S[Z
M(58]7'K8)NGAD?4K3L-G'=9G3OT$-O)#%BH%)'XDRKSDQ6:T:9MP,IALKKO^
MY^%2\!RXG]/J"HUT\>)+*QDR&GC^/DS2UKIE8Z"UY8'4JF5GH/5W!JHMHR/^
M:BY'0[1\]+"-W@[>C&^\XK@(1UG$NETXQBM6T,:I'69+3D@MRQ1D.@5_QSLF
M1=>5G9D"5#_Z<::3D# 10C)_+-],EV(&VZ*ASXM9".@=&OH""RTU 2669<6)
M0\</L<RQT)H<DT;"8:*W>$\6:NLJ:%N](G-\L%9\^1#:I_L6E]C>SWT!/&P#
M%M[+%H2KCW4FA8Q3DD+6(_;>%TDU>Z/]/(ZP#<>0[/CG"!&0!6HWE0<;5_^X
M"D?LQ=_%+E+2LX4S*.Z &*22JY;0])G;8($*5 ;*UQ(HWS2(>BTGB@#U_]P6
M@/JMBHJNC$3??*!T8IQT,[FM<)^:_/:?V\)O9<!U _7D)3:WF%-/;LD(XU,F
M]=90DE&C&F"KZT2"Y9)>ABFI\BX"FLLS2FS5VTQ5U.3-(IU3&K3%\<_1-_7(
M2?O+*7+$"!EN5U,IJGB3=3G4=+UL4[)GM@1C(95AEE#0LH2:*/TUIBR[:DJ(
M=_F202CZOF8PM&7 Y.7@]&.PZ.L:B]YB+>3!Z3<D"]DJ*7;%R%]*^<6KS7NZ
M[OA#J-LQ2=D !F R2A-*!"U'7.8RH(_82HM%TI,,8,FYUR).,T73AQ&C,/"Z
M&$%DSB>&=SI-K1$P?X1V/;Z@S9/(XT\@1>,12*>^1:D0?[  R.??2:UOF4"S
MIY<:DV@(CB2Y) ;<UX+PY0Q=W(II'&[9596JD18_"%$D1%V*8VNI?T#T<L,=
M6<J&]<N&I10MS"D;K@WL8\GPE8SB39E/87<HKFR;"P@3-#3-Z]J%62*%'F56
M%#G#>#]PNX;?$P%#P8E>I$)7R,)&*ESF&DYS((P>2_1C-!3?E+$LF99@+KQ@
M8E"7<HED(DP&=$I-_(I%$F7;F1E!O>(V? .5RY!9^2P5F<9&H$X@' *&!V1-
MI!#</X1#(C4&]E3_T2D&:_=8G'9OST3X9CE3],.9,"<1AT/C/V$78MAO'P&Z
M)B77QOLRL:6X'3<$[=4K!ATMTX)596:EVTA+T2CSE4#>)\H2#'I>U*^()A9&
MZHOT*T>II[HR]2BGG1Q^/STRV4 ,II3262XV:U/V4OM!3<[@TQXU +$0@SCO
ML>2PKGA.&;;-AVUK9=AV!F?+I&-=Y*7= 0,81FRT[UM77YI.ZX_#J5<W?<7"
M#DL-UTYRC'YJWC3;C2_.?;/]]<YIW%P[5[<WUZW[UNW-G7/[T;G_W(1KX 2N
M@=O[YMU;2DL[/JQN8UK:M4S546I8BOG:H-SLW8O#WU.RJB>0JCLB1U_"9N &
MF5!ES,@QG0Q)74ESHEP5N96MZ$X.ST".P?<#+Z^GRGJ&(2>>J<BN<@KS1K@"
M?:]/M0Z863^V3LA$$IU<323TM!.C=W5'Q3Q3!2??/AL5A0Q(F\[/,PH<"M42
MA;=53(]D=B>T65FMJ^^9^L26"XYE).XL6W!\E;#Q.RD@G+N$.%EM@D/9VHJ;
MTN14S4?*J6*"0^&?MY]VZUM(NQ^'$=DR+91K.YAJ9A;:8+BAD(&;IL\(,S*(
M>7H]% (UJ?P68*FJ5H3YLO*"GF1)5J2+JU/=3 V%AEKX,K&.QA6-$3HT8L$/
M\MUJG+2(NEST%3NZJIY.EG<HR(CL?*>^.U^SFV-J:4J;:6 5W8M/>8) 1X"I
M4O,9J2H4;K8)>L/AM(V1%5)4KF-6/-(^77V_:WUS C(UB\M7.![VT=''0HB#
M+D]#XKUA\.#)2+;S_?#NT.EQ^#O5$W9#I!_V,_6E6?9L^^7=\3;*.\R1D%XT
M],;LGL1+S1K$M1Y$O.\ATJ6"&%&(;B1+="&:9I0"Y"-P/5&_&_H^6T7IP;*I
M^F0+J;H KKU[9)W".$7>@X?"FR ,"4Q\C ::0T G?W?D]$,0]X4-S4%WXX@$
MW9V_PZ[@$G#^QOJ##Z!6'(I7$WHB)V?Z]?V5:8!F$HM->'4]UR7 +Z;E8:HK
M#;ZSN&*ZLV#"E#J.40\XQ-#U6*#2M&D_BG'GXDC9#<OMT=8+C-,M%!C7*? ]
MWHB[)RY:/8SU$UE>"RY@D8#Y%=VFR008!L@F5)$=P2\J*U^WEV:ZPP9^&<-:
MG.K/A8;(3)E!7GP8*<LJ[($'W9&,ZP8YP"0CT<+-3)$*"40-;:&'C4J-N)"X
M!Z+DF^H'!?=7G+W.OK5L/%.4+B-B#RS2[7T,J80" !\7*C</0#;@ES"2QH"F
M7$)GVNON9XL4:6>S&T#;K"#<,((<PA9C]^^($WNI # 7[U+M)W/3R0GR@@#*
M)NSU"<]YG*S5?$'(GD)XBHPVW6"E,+[9'$#9*%Z "4!X^V G@^= ='K)%=9W
M>  O['ID-4B="UYIN:O,&._@<11C%6SJ/[3,G-HAI>;HQ%8G-&';7"CZ/V[/
MS?L0SX[$.S-41-,_[!6:"F2\I&7%ZOI"GT=EZ'/=%:N@19QMH1:A$.UW3WVX
MMUH4+$I%YQYFH0P3@=."LE-FMF#[Z?II]0!N9V>$WR#/DLAI1N?@,_=!V-;%
M WV8SV.\3U[)?#SL27C/CZKH/C\Z5CUW(@D\(V-I W1W!0%:^,IBC\'B/Q )
M\CYLDIZQ^CO,E]I6J=/--IR1C2HPS8H;%X6$,R7W:7%N<'/JDL(^5B%B!AF,
M:'^%SH;2PX.ND;\X0>E U%3*$AOZHXSK\8/T'%H&IUQQ,;J\IN5#!<<&>OW^
M,02;L$;7H!FN@*.% ;NR58]XB%9Z\D&GKL(*0: )]ZN*@MBV&J] ^S9XPDN)
M0"A%.[,SC%$KHN5\!4JIG>!.Z)V'7_>>'X6_-HQ(=Z+ENDPHN<ZE^OXU&V%!
MD7P7]LD16?<5)P"Z1_]0E^N$NHC[_(F-.[CM-^7.MU (-]*@_+7I*=AYH:PY
MFAQ!TE>Y:&?*]M/\Q1;2?%MCH.\\E>,U9=1_&>CP"DEND,&>4\:X!?:]8#?"
M$(F >8#'YSZDYL]'K^,ESI5Q1A0H3+;?Z5>K;B'7%+KC[1[SO/'.,FD01/CQ
M EEK,4-CQ(J3;5U"4@)]?/PGC[I>++%>(ER/$C2\+YH_IMD/MC("Z5H#$P$4
MXGS73RVM=&)"02P9P@Y4V4=F='')NR4G?ML.)2]:J'JP64^A*"/3[52M79K-
M?, <B+.MMH:Z8K(([$'=VE]TR)%JA$4#F::$[.NZ&S$W7?=@[D1"[N=BVTW0
M\!]3E(%:M?;>TJS3VEK=]+:F39']8:R-/YS^,$"KS%9C) R&--!<C"V; R=A
M!6R<A"P77=1327O2B/HI^7@IO-Y"N?^?(G*AX)U[H>^'SU0[/A/*;=IVN% K
M-!#M>C7PK65 06VVQA;9H$Q/ACR=P;#C>UWTK0"+=+EJ9DI\:1G=)GH\G^(D
M$IS-0%80@,(8 DI[/TX41A75 +<;#D:YJL&R/],K^S--1-%X89,8682F_"K4
MPIX)Y1))-/U5-ATULN@P18&-S$^(MJ9RR-: &)6-C5;2V&A^'!A2C(AD"ZJ/
MJ1<I*(22WA9,;R7PLBU\62^1EZUA3#M7;1?'$(K5$CLC@K5(@3=A,9):)^,9
M9&3L&;5I<WM;2"1.1F\P_"^RH&U?QXIL@+:&ND<1+)<9>#(!ZHB1[RD,!Z5'
M"ZP+QX=G+?:I(QX^54IWIO$G*;-2!?5BJ9:6<GW7](BG10')@>DO:"@UQ4R#
M'E7:85\V]U#^ZJ(IE>+!*0^W!?]& *J(0@X1@Y_-BB2_F0SL(A").<\9.-K&
M8)G&0P9+E8RT8XSTM%I,7$RC],-8LXH (U*A'4JG5& Z/6K=J7E!%6Z)+%=T
MF)"'3SOQRCZYNTB]*X9T%F)SI%PD@RCL<G<(Y"=4)")=_&.FHN[U)%FVDUVL
M?WDI'1E?Y%^^+[A@J5'4: P('=SP[:'/G=HQ/Z@9!:EFAU-1+I<VHHK3FA>?
M/1?P#(K"@;)(Y-@9$'H!H& ;A"+^1M=#"Q#:-/L! V48'HHQ[7_&^* N6\I-
M4^I@E'X7JZ0:@3F7W0M;=,Q<%K8$@S49&-DSZ&O9UTZ*]\D[+7O@QC9..;JT
M:$J6&:<](2D['GT*E"F!05);0TA;<\[7K0]+'9Z\*!ER'7A0>U@&Q#:L3>0K
MQ-9M,*OQ88DR57)B!4B[-_3+D- &AH0D- PJ-\H)E?.LSP:,:;8R%\!_:!Z7
MQN:.J>N+AK50M<)V('$L"A:Y(CJW))=3,AT =CXZ+VW0G23JI88#%.2\0IR7
MZ1CR8^[F,BOR^IBF42'*,8,CVS2'3>S%:S@VY\C&LC%+APOPAS2=*ELD7!K*
M&ZAW\HTQE"F+U.CQ;9C&+O8]<J5IE;D!R#9"O+Y! AS@8F-HKS-,IN<N6508
MJ[64NT%T-;8QDKRCS.9/F3EFN<!B'_*?8 4F*1"+[GL]5(FUXHE" \=<$;ZR
MQ[(96N8&&=T@N3D4H2R0\+$X"T@:47*0A(B UW;"\,<!C!2-]O-;S9P CC5U
M^4ZL <=I#P,CLS.%<L\XCK%)%F86RTM8E]V1)X#>GGVI"D]B!K!5EC%+PFNA
MW W_T0FP&P*FL#LF<6_#3.*B)T\Z94S8,I7:;8L.YKN_#6:-#V+R,C9TCRPI
MSICF/:+7JD9RZN4R%1UF'_ T336AA>G6?-CK7CCSBMWK,X[)'O6^ET/WF<OS
MT@>'I G01.6\U$+BO+9=%+\B8T"H^F[$G@/IQ"+7%KXU[7=A27B7W?.L(%EA
MDDD<R\H5 6P5\6PC$LJ)CTV(@'!FAXBUS4G.]"!/I>I<',AF@):FQ;)](B9+
M,"Q D&-97;K:@)>VC00K,$3JDHTCFU-X)B=OB4>P(5EMQV53CO4WY:AM8QO[
MAN@,I>0/:;X[6 R.X#0H(R]9\$,UK8"+"7M>D!9M![(IX.M8&ECK2! # <WD
M72_ DA*\([,,%I+!3Q59YI0J((,C$.0H_LG*P#9D<%'WJ12O=E&M.B>_Q<.!
MVCU$E\2>3VH':<D@(C\XOA?P \5IM<R6Q; [/F%S)(^__0*C_>XT0,P/.:PD
M2AXKSM'I,M[QT0^Q&N?2P\Y=#X^L7W$:/NNP/G/J)T?5^H<L>@]H#)$H/)2*
MD=$Y<,+)8!&$1A+((_C@.7 _9T04>CNCXI16V&0,OKP^E:3=GK>_>'D;F^P;
M1/'1PYY\.RC3MJUZ>?*_7XNJ6<0#7C@.+I;J6K(V4GO--#A3(&YJD4H Q"@Z
M4@1BV0(JP%NE'V=:%@D;,22KR/+-="EF>"\:^KR8J8 ^IJ$O4-=2RU!"<E:<
M.'3\$*LJ"TW0,;$D'"9ZB_=$17AQ_;K^FIPZ/A@QOOP,S=9]BV-M[^>^ &>V
M@2_O92O/U<<ZVT)&1NF>[1'O[XO$F[W1?AYKV8:82.;]<X0HT0+9G.J0#8D^
MKJ 2N_YWPSBQNN)TIT<Q2"67.Z_I,[?! D"FC, O,0(_=]S'@),U,607BFZ=
MRH143E S^EKUX)\6;%T"200.BI@$&>CO*\!+%2,RL3!-0=3A16A,6V+Z'F7]
MRN^IW/2),]BJH*O]K%]'D#L085U4L<=*F*IP19IL]9_;PE9E/'8#]>(E-L9X
MD<74D@'(ITS>K:']HJHTP&[9B<3;)84+G?;RX@'*R[-+;%7(3!W3Y- BM5,.
MM,71S]&7\,A)K<MI:,0.&9Y74RGJ;I.5-%1AO6Q;LV>V!"L@E60617!9HDU4
M>!I3EGTY)02]?,D@%)UC,S#<,D"2;X/RS#L8'#>68\YAS$+@0;E-,7D.P%P$
M[<L2]D%U'/\&]P?KA$]E3YXW43-1M+KIRN(/H6[')#D;[+)DE&:+"$J,N$Q4
M0(^<E9**A"/)UY(NKP64)NFF#R-&8>!U,=['G$\,[V6:6B-@_@C-;7Q!FR>1
MQY] !L8CD"U]BV(@_F!!D,^_DUK?,@%G3R\U)M$0_$1210RXK\78R]FQN!73
M^-.RJRH/(ZU;$()$"*H4B=12NH#PY8;SL P2;DJ0\*0,$LZ@&;^EFV'IQ2F+
M<=9>&\#&\BZH9.PJRG@+NT.AB]F<=IAIH\6A+F.9)61G\]@*#ZM^/UP$&II1
M1.Z$D/8B%4-"Z6ZD0&;TJS29Q6C"13]&0_%-&522^27FP@L6)#6PER@WPB)$
M-^+$KU@NJ6R_NZ@(M(/_B'#;-]"EC>LLGVXDTQ<)\ ONC8#A 5DS8L3%,(1#
M(OT4]E3_T2E&3?=8G#;VSX3:9CE3])R:$#@1AT/C/V$78MAO'\';\JG5%@4B
MS;6.]U4.TPW!OO6*T3_+M&!5F5GI#N/RUI2)9Z *),K0#WI>U*^(_A-&#I.,
M!$1I**$RX2AG.SG\?GIDLL,<3$G367%'\E%3?)>V(N3D##[M4>\."S&(\QY+
M#IM@"ZB+?)%RN0.6*8S8:-^WKKXTG3\.IPIG^H9E-<N-GD[R6'Z\;7]U;C\Z
M-[?WS;M51R66&><^.:QN8_K.1]V$_>A"B,[=BW/?T]6AUI_/QM<"T*R=P4RG
M-*6>&DJ' C?-#:-8W9THAB-5UA,/.VC7RIP@HP=^EE<R':5?W 2_\>::X -_
M;6,>2<I?]>/=YJ_Z\1OBK\NWR%_UK>:ODQWGKY.WQ%]K 7%9EQ[?>KDBOS8]
M_K;=^M2Z:7QQ6G=WWYMO4J,_W4Z-_E8!TK<(=+C4[4W=OL]&,D$OK:PE;\Q8
M9T*%Q*(HU"V@7QN5M(5R_5PR.+I6,A*WDA?4JH4.32\#5UP97[\KZWY3XR76
M.2"9(73VYY:K*:?;:0;8F+(T"-XX4]:/=X<IM]%VL#%E:46\<:8\V2"F+%,-
MQJ4:G):I!B],-5B)P?H*BW45HGV2X?JU=7?5_/*E<=.\_?ZFS-6S[317VTPZ
MI>0%HZ^3W;R!C=N4<HO51:MNU FWKR=P3WU?A=AC)Z+-E6U-9'8 (?W1?9K/
M7!F37*'3#F0N'^&+RA2&]*E,TQGQ@DPK6)D6(&]R^EE=M//16.;*\&"J7A?V
M3A<W2AH9TREZYD5C,M#(B4.?JP;.1MY"DG$J5/+!C4R+^"T7*=MH;"LM$8[
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MWO^"ET M8#QE:2]Y77.3;6&+W*27[L?5][O6-P=)]N+H B;C7%X>+V:+"HZ
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M@8684@LED.4*F-3E:RX;>16>^O'M!"9U(1C;8.25K00:![4)?K?5!A<VH*N
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MDO^^5?L_X":7W9DJS5C/D>17E;U.]G+G)"X_+G4?01*4X*$(!2!'5O[ZZVX
M)$A1FJ?CC,NSM<X,10*-[D;WKQ^@GBZ+5?;\[W]C[.E2\(1^@]\+663B^=-'
M]K_NXG^<GK+7,A:Y$0DKU&/V4BN>:)DLA+V#?EZIN%R)O&"Q%KR .TLC\T5P
M+WOS]M=49H(-QV?SL\'99#@9!L__2ZVW6BZ6!1O,YQ-VRH;]X3A\_/34TOO(
M$?PT4LF618M894H_._HNI9\C9HIM)IX=I2HO3E.^DMGV,?OG>[D2AOTB-NRM
M6O'\GT\8?6[D'^(Q&_37Q1-6B$_%*<_D(G_,,I'"%1KY,?NN3S]/CNS\^&!C
MDF"0H^= 'UZTMR;RTC-QJ5FNS)(G\)3[Y8C1;,^.@+6%T!7E2X%L>,S&ZT\[
M-+"(QQ<+K<H\.6U_%"[ #OF$K;A>R/P4U_.8\;)0U25M)['7(J43 6/E*A=N
MG9;\QD(WCK!(94ES.AJ,5G^8.S]\6LI(%FQR-G@:Z>=>_(YG3Q\%#,-?KQKN
M.F-4GQ<\ N6+19:9-8]!-Y\=]8_H[S5/$O^WY03]*I-G1W\DG*=Q?S+E8L;'
M?!S/AJ-XELX3T1^)4=R/;Z]O;?%M9%(L\</^]Y4(\"?8([ (_3S\&Z\DG@(W
MP*1_9H=X*E<+9G3\[$BN^$+@+..SC^O%$6[PY!KC?-\MY(YQ)WO&A0NZ8REP
M&87AQ52)+/@-?[FV]'=D'^Z\6\H]&L1C,>2#42K&YV(Z!^9%23R.)HD8I_/Q
MYY9[S;2VS ](O"728/^&<OQ8FD*F6T?:#4@_>OZ+NA2K2&@PSCTRT.%VJ^:-
M=I3T_BGYWS*+><Y^!E>C)<\,^(_5FN?;3H+N?_K!L-]G'W0$)/R+3"U[I>6E
M^)-F?RGU"A1WR5<]]B+C$5]Q-IH,Q\-]\S__QW>#\_Z3W8]W=^R.=HTGG7:
M70I=R)AG_O)*)DDFNNW#^3[[L*O+WW=YXKUS^74UQFU8'6\A&A:GX1CVR,?.
M?)73N<Y(E:3IHLP3T)C';'1NASMDY*[2C:/G;\5C;_T.6TO+J</_=OC;0W/O
MVX/LK5A(4VA>2)4WE?%= 3<33%0Y^U'I%7MW.JK,]XX'[P A'8NZH11NOM]>
M\T3"33Q/V+^!]@Q7\/BST[FK+;<@_3?!EOQ2,!XC)N>&F;6(05C@ADH ]!D\
MHMD^0?88I^'_6V@CMO"(7BLK579<+ 7[QW>SX1#6=2.M>5H^KVQUZ85.(PV>
MG/3^_C?\GU<7F<.D>2YBFG,CBR7#>4/]ZE8I=MRXYQ=UQD:CT>EP.IW.1R<,
MXY"D'N^=B$LM"R_C'S[%2YY#R %TKJ0QU7IOO%#'H&YZNY8/\=5"P%2Z(JYF
M1HIK4RE;:X5"+$K38PF%6C]S'2_9S+KDNXGF)3<0J54S=-(H\S@K$PP&@5 !
M,D*FX:1 V5IAE&@X0*YUJ4W)8?I"@1ZMM<@D>"VNM\$*F"G7:]I/A5],A3$&
M][*@-UHBZ+MJ34 CSM):?L\OZP;D]IQVA<M_6P(_QK 4&&I59@L;(,/6UFW]
M>Q$7*./!?#3JX7;E,!>R^DX\@$$[%@UCMI6MO?Y*LKM<M*RYO50.2L-/^P%9
MM$'6P-PO%EJ$K*]W1H<,^$K!(SB&=TI^3"U %0T, ]OQ$D@#;N/ETD\%MH[E
MP/9:O>_$^^XE=(DCVC;H!;J.Y0G[STF_W^O;_S.^@ %0>T"18!?*-1AR6&F9
M%S4SX+GQV1RB-V!+ 00EI4">S.^V#!J!!NP4V+%$4J>3ZY"*%$[.1FT*1W?<
MZ#3"7@J;?@5U 4B^*<W3?HOFR9UIGCB:':$!Z59A=W9H+8A*H^N5WVU3UF:H
M@X-G#P/O_+2+&#1:4"V=.5!KF<-'!F\KN,QAG\,6+Y;2 .(O8/?WV,9A)O$)
M9L8;3 GNU:,?M"#P>P+,CC$L22$P\=)0)*O$I4(-&;):ZVB8WTMA"B( 5"KC
M&[+R?D:@R4@@%N:$)0ACT%L"0.-K=*V S6!V!&SDE4J-SM89,"#?K>S,8?GW
M<$]%R>Z:G!.GH5*596H#'+H[J+U>MN6VN9,P5W*-A"V+,V[,LZ-7[][\^!H0
MV'LDSB5XYN?19)R,S^=#^'<\'LP$^.>IF(Y'<30[%^E=4G"!\NX-'7T >8U,
MW(C6WHZ!"[6^S08YYB?7FM0FACLGW1]5-69JSM"A38?,T7Z8WY'%Z,IC7"?S
M^'5K>'\\GO%)FO!D-AGS9,K/)].$CR:S$1].XO'Y5ZOAT8/1\!H&?]/J:VKU
M*!E-XO-T$L^'*=CKX>Q\G)[WI]-^%/5'$?]Z[7;\8+3ZG0 <HMDK$17L)\)S
MI18^7N8$6%X!NK$1VP CMO[T'K(6U5372ZRP'S)Q"0\LV;LJJ >\WR:XS0WF
M5H#/TAT,HT0:=%\\'0QYET4>6A^+1+$1(M^)>-&'(MA\R?,+2O^5,>)*Q)"*
M_28SK",4X%[?:U"((.]G[!4A[B88-TBG1+3(.$7%+O=2AQ]?VA@>?"*H,U"1
MLF$;6@/M'3;.!-=822^6544>]JBWE^X*?%RHE9_96\67;]_\^(8OQ$LM^,4+
M^*=-DY]D#3>=1GC7*4\+K._S;,.W9L]0S9W?W;'@1K;T48L"ZV.;0L/ VUKJ
MJ;L&H8CO:!C>L*,AY-+1\[92T%);"_DO 636K13[:NI?N"3Y92JSGV%69#G;
MJ3H>W 0/!FB<3\?GR7E_-AG.HG$_Z4>S^7DL!M%L,.SS9#3^:H%&\F" 1G=N
M]4M[CP>CX3R.TM'Y;#*83Z+Q0$1\RJ-T/(H 4$^2T:#_U6JX># :_FN:REAH
M!$V#Z1-P*77&T1<N/-H+X74G.+T#C#M 1@>T>X+(\]LFO-XF',;3\63"9]$P
MBL=Q)'@\'XGY=#*(Y^?I<)A\M9LP?1";D(=)?MQ:I@#E1G_3#E_\/DRU6M&%
M]P"J#81KVN]42F'B'W5/A8^*/\.>_;=2"4Y)U.Y&L?AS>!N?_76BL,]7+_JP
M5C9HCKB19#NI2F/+)#;SC&&T*:./(J9:/NS0I9?H[R4010RD(%N+5&A-7?+,
MUHZIF,232VD$VZH2'N(%-E P56I?L/D2G41W[CL;G-U?V]F^?V^F\N^#/0B2
MY(UVI:3,MDU%EGE5T$M(Q)? M23;@NC!0N.^!BDM< ]5.[YNV,CXQAS8U6=_
M<D?;9Y#O\"\IWRH%UNBNV2QEW.J5PI^PJPN>B 0)U9@2!+X$G!1AO@P5 WW,
M4FE85M(#\<-C7B<2D<E+*L<VFS.^ @&/[EW -VR/>]]L?*+J="62IB1O+!_Z
M$(OIA2S@9KNWZ6(F%CP#D4?2[FD5 :MY59 /QNB%1C_B^84NUT6\1>MM5 ;.
M&G]/-2^!7NP^+#3/38K] UHHO>"Y_(/&[;$56AF@OUQ97R*!*5Q71F0A<J&Q
MTV2]SL"51#*318L!(=; =H TQ08'^#N&M4L8VSAH;INS76N(JH86OY<PIN]J
MR83Y"A1X_)DLU"W4F(R*E2TV/GK'4"EW2YM=VTX,>I9)GL>BK;U5^6"M%4"'
M4#GK06TQH;:(AWOF@EES4ZY6UBVZ04EU>6QW@>]ZP_X8 122@]S(+&.Y*D 3
M39D5C)H^M^Q2JJP:Z9B?=!/=7/Y;80H:LQ7+_I2'#MLUN;QP[8^VE.$>?+D]
M?1TXX*IA3K/CZ(3H"IJ689=5.PMDTP3K7WX;W *RO@^:?5S/$@(> +#85.KQ
M; QSPA#4;8NBC85K.-IB@^-FJ4"4BQ+L$!C#!1A1VW39_;D#L'Y.+<"(2&PK
MJB6+?7,:+6JO[K!R\KF !;LFK*#9JKF L&DI53"8(N/L1T+_C=W#A<76U+,D
M$C)M(13[D-,=A,CJ]KB]8.W_E+ZH[NJ <>S8-DGYUC$-AMZ@FEG.T':I.1"V
M]M(>LG 1;J^Q"EZV)IQ*)(9=Y&J3XY)*XZ$)V(*% J>6NX(D!R,>HX>TXU%X
M@DO"FB9$$SZ8$)_60H-00,ZYTBMR<LBVO;IO5Q[N?!J:HP501C3WOS-0H6VI
M5UX;F3N>"K"N'/=V9\&0#(OM.^>%6TK]"$L46:BPL>UX<,+(:#!3(PUDGC6>
M(!-)'KQEL[QNM1XBN5%]MWZ0!@MZ]'?Q0#4A_Q1,_0-P5FT%-CD54EONH05<
M529^6_>"3\<D+$(!PLU). #(**AP:R\=#T\:&H]2_@ACF43:?LB60M]Z9YR
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M'S5?\57XWM<ZPW%5PT(3>H052X*?OK#G&4IG&YN5T%T4Z*'8 01^)<JFDE4
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M@;VV&+TU]-YM)V>^V_02I"P.)5EK%I"'!)VM(^X#.:2]":B @]5)AFJ1E?G
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MU]^T^?01=M+2+^YK3?\?4$L#!!0    (  >(=%EH@(?C4@,  ,$/   0
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M3>A:.LV8;1CM&%%E1:5YOS [5)*XYER&VZP7D#\#CNYA/\OS%:;.R!OE,/B
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MF>V/_P-02P$"% ,4    "  'B'193YT!)1T3  #5?   $0
M@ $     968R,# S.#@Y,U\X:RYH=&U02P$"% ,4    "  'B'19W7-UM"5T
M  !1)@, %               @ %,$P  968R,# S.#@Y,U]E>#$M,2YH=&U0
M2P$"% ,4    "  'B'19=+A=R4QI  #S: 0 %               @ &CAP
M968R,# S.#@Y,U]E>#0M,2YH=&U02P$"% ,4    "  'B'190C>G6<(6  #?
M=   %               @ $A\0  968R,# S.#@Y,U]E>#4M,2YH=&U02P$"
M% ,4    "  'B'19:("'XU(#  #!#P  $               @ $5" $ =FUC
M+3(P,C0Q,3(P+GAS9%!+ 0(4 Q0    (  >(=%E72*\9>P@  #!6   4
M          "  94+ 0!V;6,M,C R-#$Q,C!?;&%B+GAM;%!+ 0(4 Q0    (
M  >(=%GF6^$IWP4  /X^   4              "  4(4 0!V;6,M,C R-#$Q
@,C!?<')E+GAM;%!+!08     !P ' ,<!  !3&@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>ef20038893_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vmc-20241120.xsd" xlink:type="simple"/>
    <context id="c20241120to20241120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396009</identifier>
        </entity>
        <period>
            <startDate>2024-11-20</startDate>
            <endDate>2024-11-20</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20241120to20241120"
      id="Fact_6334dbfcb013442292fbb814d36088ef">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20241120to20241120"
      id="Fact_1fbf912ed7e34a9eb234c5e178bd6621">0001396009</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20241120to20241120"
      id="Fact_8873fe67f3694099b143e3a1920ace86">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20241120to20241120"
      id="Fact_a0bbd591469749659f83d5866758516e">2024-11-20</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20241120to20241120"
      id="Fact_2836f37c5fd04b0faed925ebf95d42f9">VULCAN MATERIALS COMPANY</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20241120to20241120"
      id="Fact_2c2cf80184cf43849e0713457548a40a">NJ</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20241120to20241120"
      id="Fact_44ccd777e81e499a974a4e48facdfdaa">001-33841</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20241120to20241120"
      id="Fact_5cbd6db2fa0c424faa64fa9642ea5f52">20-8579133</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20241120to20241120"
      id="Fact_650f1d9662b747f5a73076df7d6c2977">1200 Urban Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20241120to20241120"
      id="Fact_57398aa0c7024556a538e5287901521e">Birmingham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20241120to20241120"
      id="Fact_355ae274a3f248739fcee8f2005a1040">AL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20241120to20241120"
      id="Fact_873b75b12245402396309cba4cde1bc3">35242</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20241120to20241120"
      id="Fact_0f89f7fbee694d20acdcd1e268a51908">205</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20241120to20241120"
      id="Fact_42f14049bf634430b591988d0798d3d0">298-3000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20241120to20241120"
      id="Fact_2b93b9c28c0d4142b0ef91837e39ccc3">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20241120to20241120"
      id="Fact_f31bcaf55f174b3e8af4e6f73b69a792">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20241120to20241120"
      id="Fact_007438a6ba624c788f101cc454eecc2d">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20241120to20241120"
      id="Fact_d8204477b11d449d8d57165ae39793eb">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20241120to20241120"
      id="Fact_6ffa83ed11a9401a84f564fed3c61ed5">Common Stock, $1 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20241120to20241120"
      id="Fact_9445cc606bcb43fc8a9c5a7fd1d6eab9">VMC</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20241120to20241120"
      id="Fact_6f80ed1663db4498b490d536ecdfc646">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20241120to20241120"
      id="Fact_b29941f2eb26460f9487abc14027b3f6">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
